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Poly (1, 8-octanediol-co-citric acid) (POC) is a synthetic biodegradable 
biocompatible elastomer that can be processed by solid freeform fabrication into 3D 
scaffolds for cartilage tissue engineering. We investigated the effect of designed porosity 
on the mechanical properties, permeability, and degradation profiles of the POC scaffolds. 
Increased porosity was associated with increased degradation rate, increased permeability, 
and decreased mechanical stiffness that also became less nonlinear.   
 
One goal of this work was to examine the effects of pore shape and permeability 
of two different POC scaffold designs on matrix production, mRNA gene expression, and 
differentiation of chondrocytes in both in vitro and in vivo models and the consequent 
mechanical property changes of the scaffold/tissue constructs. We also examined the 
effects of collagen I gel concentration on chondrogenesis as a cell carrier and found that a 
lower collagen gel concentration provides a favorable microenvironment for 
chondrocytes. With regards to scaffold design, low permeability with a spherical pore 
shape better enhanced the chondrogenic performance of chondrocytes in terms of matrix 
production, cell phenotype, and mRNA gene expression in vitro and in vivo compared to 
the highly permeable scaffold with a cubical pore shape. There were higher mRNA 
expressions for cartilage specific proteins and matrix degradation proteins in the high 
permeable design in vivo, resulting in overall less sGAG retained in the high permeable 




Another goal of this work was to determine material effects on cartilage 
regeneration for scaffolds with the same controlled architecture. Three dimensional 
polycaprolactone (PCL), poly (glycerol sebacate) (PGS), and poly (1, 8 octanediol-co-
citrate) (POC) scaffolds of the same design were physically characterized and tissue 
regeneration was compared to find which material would be most optimal for cartilage 
regeneration in vitro. POC provided the best support for cartilage regeneration while PGS 
was seen as the least favorable material based on mRNA expressions. PCL still provided 
microenvironments suitable for chondrocytes to be active, yet it seemed to cause de-
differentiation of chondrocytes inside the scaffold while growing cartilage outside the 
scaffold.   
 
Scaffold architectures and materials characterization and analysis in this work will 
provide design guidance for scaffolds to meet the mechanical and biological parameters 












1.1 Problem Statement 
Over the past several decades, much has been learned about articular cartilage and 
its notoriously poor physiological capacity to restore itself. Despite many scientists and 
clinicians’ efforts to find cures for cartilage damage, no technique has been completely 
successful in achieving normal regenerative articular cartilage to date. Osteoarthritis 
(OA), or degenerative joint disease, is the most prevalent joint disease in the United 
States, affecting approximately 60% of individuals over 70 years of age. Not only is OA 
the most common cause of disability in the elderly but it also costs $65 billion in the 
United States annually with an increasingly affected population and rising costs.  This is 
not limited to the United States alone; in fact, musculoskeletal impairments are the most 
common cause of physical disability and reduced quality of life worldwide 1,2.  
 
1.2 Causes of Articular Cartilage Damage 
The poor self-repair and regenerative capability of articular cartilage stems from 
its avasculature nature and absence of lymphatic vessels and nerves. For its main function 
of load support and distribution, transport of fluid and solutes through the extracellular 
matrix (ECM) plays a critical role in providing necessary nutrients like oxygen and 
glucose for cells to maintain viability. In general, aging leads to poor nutrient supply to 
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and inadequate removal of waste products from articular cartilage. This triggers 
inefficient regulation of matrix degradation and synthesis, which are known to be the 
primary causes of the onset and progression of tissue degeneration that lead to 
osteoarthritis. Obesity, abnormal joint trauma or rotations due to sports or accidents are 
secondary causes of osteoarthritis with anticipation that these will steadily increase3-6.   
 
1.3 Current Treatments 
Spontaneous repair of cartilage takes place only when the damage reaches the 
subchondral bone and mesenchymal stem cells are released from bone marrow. There are 
a number of treatments utilizing this repair capacity from bone marrow: drilling, abrasion 
arthroplasty, and microfracture. However these methods are applicable only for small 
lesions and tend to form fibrocartilage-like tissues rather than the desired hyaline-like 
tissues and eventually undergo progressive degeneration. Another technique developed 
by orthopedic surgeons, osteochondral transplantation (mosaicplasty), resurfaces the 
damaged cartilage but is also limited by the size of the injured area and donor-site 
morbidity 5,7-10.  
 
Finally, a treatment option inspired by tissue engineering techniques called 
autologous chondrocyte implantation (ACI) has been introduced and it has been applied 
successfully for more than a decade. This technique, however, is still limited by a number 
of factors including the necessity of two surgeries (one to obtain cells, the second to re-
implant cells) and the wide arthrotomy incision often required. In addition, the outcomes 
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after ACI repair were not better than microfracture despite the much greater cost of 
ACI10-12. 
An improved version of the ACI technique retains cells within matrices instead of 
using a periosteal flap, which involves additional tissue-engineering-based strategies and 
has been applied as a clinical treatment. For instance, membranes formed out of type I 
or/and III collagens are clinically available for autologous chondrocyte implantation such 
as matrix-induced autologous chondrocyte implantation (MACI® (Verigen, Germany), 
Chondro-gide® (Geistlich Biomaterials, Switzerland), and Atelocollagen® (Koken Co. 
Ltd, Japan). A hyaluronic-acid-based matrix called HYAFF-11®( Hyalograft® C, Fidia 
Advanced Biopolymers, Italy), fibrin glue based treatments (Tissucol®, DeNovo NT 
graft), and implantation of minced cartilage in combination with copolymers of 
polyglycolic acid (Bio-Seed-® C (BioTissue Technologies, Germany)) and 
polycaprolactone (cartilage autograft implantation system) are currently available 
treatments showing promising clinical outcomes 12,13. 
 
To date, ACI and MACI are prime examples of clinical tissue engineering 
treatments for articular cartilage defects that incorporate the well-known tissue 
engineering triad: cells, biomaterials, and growth factors, in order to repair and regenerate 
tissues. Among various cell sources that have been contemplated for cartilage tissue 
engineering, chondrocytes from articular cartilage have been considered the most logical 
cells of choice. However, they still have major disadvantages such as their difficult 
expansion in monolayer culture and the rare donor tissue availability 14. Multipotent 
mesenchymal stromal cells or mesenchymal stem cells (MSCs) such as bone marrow 
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stromal cells and pre-adipocytes 15-19 have been considered an attractive source of cells 
for cartilage engineering. These cells overcome the disadvantages of chondrocytes 
because of their relative ease of availability and their high capacity of in vitro expansion. 
Implantation of MSCs often requires the proper use of growth and differentiation factors 
which will effectively induce specific differentiation pathways and the maintenance of 
the chondrocyte phenotype. Hence, wide ranges of growth factors have been actively 
explored for enhancing chondrogenesis including transforming growth factor beta (TGF-
β), the bone morphogenetic protein (BMP) family, the fibroblastic growth factor (FGF) 
family, and the insulin-like growth factor (IGF) family 20-25. Sole or combined effects of 
various growth factors have been studied with multiple cell types and culture conditions. 
Together with the other two components of the tissue engineering triad, various aspects 
of scaffolds have been explored for further advances in tissue engineered cartilage. Not 
only does the scaffold play a role as cell carrier, but it can also provide a proper 
microenvironment for cell maintenance/differentiation and/or as a tool for controlled 
release of growth factors. The scaffold should also provide biomimetic mechanical 
integrity and proper mass transport properties to enhance the quality of tissue engineered 
cartilage.  
  
Potentials of Scaffold Tissue Engineering Strategies 
Although the currently available treatment options mentioned above, especially 
ACI and MACI, are showing some positive clinical outcomes, there is a need and desire 
to develop more robust treatment for cartilage damage using scaffolds and cells 26.  ACI 
and MACI typically do not provide sufficient mechanical support and cell retention at the 
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defect site, a limitation that could be addressed with improved biomaterial scaffolds. A 
scaffold can play a significant role by not only offering mechanical integrity withstanding 
loads in the body but also providing an adequate mechanical environment to cells. 
Chondrocytes are known to favor a three-dimensional (3D) environments for their 
differentiation, and mechanical stimulation has been shown to be directly related to the 
maintenance of the chondrocytic phenotype and extracellular matrix formation, which are 
directly related to the mechanical environments 27,28. Not only could the scaffold help to 
retain cells and deliver biofactors, but it could also provide proper mechanical and mass 
transport properties that are similar to native cartilage, thus enhancing cartilage repair and 
regeneration.   
 
1.4 Aims of this Thesis 
The work in this thesis will examine two aspects of scaffolds via 
physical/mechanical and biochemical assessments: (1) scaffold architectural effects using 
poly (1, 8 octanediol-co-citrate) (POC) in vitro and in vivo and (2) scaffold material 
effects on chondrogenesis in vitro using chondrocytes for cartilage tissue regeneration. 
These two specific aspects are derived from the global hypothesis of scaffold tissue 
engineering: a combination of a biocompatible and biodegradable polymer scaffold with 
mechanical and mass transport properties in the range of normal articular cartilage that 
delivers chondrogenically favorable factors enhance cartilage matrix production and will 
provide an alternative method for repairing cartilage injuries. For the scaffold 
architectural effects, we investigate the scaffold permeability and pore shape effects on 
chondrogenesis in vitro and in vivo using primary chondrocytes and POC as the scaffold 
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material. For scaffold material effects, we first examine if architectural effects are 
consistent across scaffold materials and if not, what material would be most favorable for 
chondrogenesis among three biocompatible materials that we have selected based on their 
different mechanical, physical, and biochemical properties. The more detailed rationale 
of the three material selections will follow in chapters 3 and 8. 
The two main criteria for successful cartilage scaffolds are (1) mechanical 
integrity that mimics the target effective stiffness of native cartilage and provides a 
sufficiently supportive frame for cell retention and growth into desired tissues, and (2) 
optimally designed mass transport properties that induce regenerated cartilage tissue 
quality that mimics native cartilage in terms of cell phenotype, genotype, and matrix 
production. Several biomaterials have been used and developed in order to create optimal 
scaffolds for soft tissues including cartilage and are reviewed in depth in chapter 3. In this 
thesis, polycaprolactone (PCL), poly (glycerol-co-sebacate) (PGS), and poly (1, 8 
octanediol-co-citrate) (POC) are the three biomaterials that are explored and compared to 
each other as 3D scaffold materials. Among the three materials, the main focus is on 
evaluating the feasibility and potential of POC as a cartilage scaffold material. POC is 
relatively new in the field of tissue engineering and has not been explored in depth for 
cartilage engineering using controlled 3D architectures made with solid freeform 
fabrication. As an additional investigation, a study comparing two dimensional (2D) discs 
of four materials (three materials mentioned above and RGD modified PCL (PCL-RGD)) 
was conducted to support the data obtained for the three selected scaffold materials 
(shown in chapter 7) and to further explain the observations obtained in the scaffold 
material comparison study.  
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1.5 Dissertation Overview 
Chapter 2 reviews the structural and biochemical aspects of articular cartilage that 
we aim to regenerate and specifies the targeted metrics for native articular cartilage in 
terms of compressive, tensile and permeability properties. Chapter 3 describes and 
thoroughly reviews currently available biomaterials for cartilage applications and how 
they could provide mechanical support to damaged cartilage regions. In particular, 
mechanical properties of three materials—PCL, PGS, and POC—are explored in depth 
and the rationales for choosing these three materials for cartilage scaffolds are provided. 
Chapter 3 will also have a comprehensive review on scaffold design factors for cartilage 
tissue engineering that are related to mass transport properties. These include pore size, 
porosity, pore shape, pore interconnectivity, permeability, and other relevant factors. 
Chapter 4 characterizes and explains the mechanical, permeability, and degradation 
properties of solid freeform fabricated POC scaffolds of several designs and how we 
optimized our design for cartilage regeneration. Chapter 5 & 6 introduce and compare the 
performance of two optimized designs (selected from chapter 4) to examine the coupled 
effects of scaffold pore shape and permeability on chondrogenesis in vitro and in vivo. 
Chapter 7 explores and compares scaffold architectural effects vs. scaffold material 
effects on chondrogenesis in vitro using the most optimal design (selected from Chapter 5 
& 6) for three different materials (PCL, PGS, and POC). Here, the important scaffold 
design considerations and the selected scaffold material for cartilage tissue engineering 
are revealed. Chapter 8 describes a follow up experiment to chapter 7 to further 
investigate material affects, specifically hydrophilicity, on chondrogenesis using two-
dimensional discs with the three different materials (PCL, PGS, & POC) and one 
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additional material (PCL-RGD) in order to clarify any cell-material interactions that may 
further explain the results obtained from Chapter 7. This part is rooted from the results 
illustrated in chapter 7 and is more of a supplementary study. In Chapter 9, the 
conclusions and future directions of this work are presented. The simple flow chart of the 
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Articular cartilage is a highly specialized tissue that reduces joint friction at the 
extremities of long bones, and is a unique and complex organ due to its isolation from the 
body with avasculature, and absence of lymphatic vessel and nerves. It is hyaline 
cartilage which mainly consists of water (75%), a limited number of chondrocytes, and a 
rich extracellular matrix (ECM) that is composed of a network of collagens (20%), in 
particular, type II collagen, which gives the tissue its shape, strength, and functionality, 
and proteoglycans (5%), which give resistance to mechanical loading 1,2. In addition, the 
synovial fluid around it allows frictionless movements between articulating surfaces and 
provides nutrient supply to articular cartilage 3. These components form the intricate 
macromolecular structure of this tissue and work in harmony remarkably to absorb 
everyday forces and to serve as a bearing material for movable joints such as the hip, 
knee or shoulder 4. 
 
In spite of relatively simple components, articular cartilage is extremely 
challenging tissue to repair and regenerate with our native self-repair mechanisms and/or 
modern remedies. It has a very poor intrinsic healing capacity because it lacks blood 
vessels and lymphatic vessels isolated from systemic regulation and chondrocytes are 
surrounded by a dense ECM, thus the usual wound healing mechanism through cell 
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infiltration or cell migration is not likely to occur when cartilage damage takes place2. 
Furthermore, the complexity in cartilage tissue repair and regeneration relies on its 
unique zonal structures. Cartilage is divided into four zones from the articular surface to 
the subchondral bone: superficial, middle, deep and calcified cartilage (Figure 2.1) and 
each zone is different in extracellular macromolecular composition, chondrocyte 
morphology, collagen fiber composition and arrangement, hydrophilic proteoglycan 
accumulation and its consequent variation in functionality.  
 
 
Figure 2.1: A schematic diagram of chondrocyte organization in the three main zones of the 
uncalcified cartilage (STZ = superficial tangential zone), the tidemark, calcified zone, and the 
subchondral bone (right) and sagittal cross-sectional diagram of collagen fiber architecture shows 
the three salient zones of articular cartilage (left) 5. 
 
The superficial zone is exposed to the synovial fluid of the intra-articular space 
and contains elongated fibroblast-like cells with the highest and lowest quantities of 
collagen and aggrecan, respectively. The middle zone comprising 40-60% of articular 
cartilage thickness is occupied by randomly distributed spherical chondrocytes with the 
randomly oriented collagen fibrils that are thicker but less dense than the superficial zone, 
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and the richest aggrecan contents. The deep zone contains resident oblong cells with large 
collagen fibril bundles and significantly lower aggrecan contents 5-7.  
 
All this delicate and complex organization of articular cartilage requires a variety 
of qualitative and quantitative assessments to evaluate tissue engineered cartilage, 
including histological, immunohistological, biochemical, mechanical, and molecular 
genetic measures. Hence, with the brief survey of the development of articular cartilage 
as an introduction, we will review and detail the biochemical and molecular genetic 
measures we used in this study highlighting molecules responsible for formation and 
degradation of ECM constituents. Also, mechanical properties of native articular cartilage 
will be reviewed, which we will strive to target and match our engineered scaffold/tissue 
constructs’ mechanical properties with. 
For engineered cartilage grown within scaffolds in vitro and in vivo, we quantify 
matrix production by seeded chondrocytes and measure the cellular expression of genes 
that relate to chondrogenic differentiation, ossification, and matrix degradation. More 
specifically, we measure the amount of sulfated-glycosaminoglycans (sGAGs) formed 
and contained by chondrocytes seeded scaffolds and compare the sGAG contents with the 
cellular mRNA expression of collagens (Type 1, 2, and 10), aggrecan, and matrix 
metalloproteinase (MMPs - 3 & 13). The significance and relevance of each component 
in native tissue will be detailed in this chapter. Then, other relevant roles of biophysical 
and mechanical stimuli present in cartilage which affect chondrogenesis will be briefly 
reviewed as well. 
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2.1 Articular Cartilage Development 
The formation and development of the cartilage proceeds via an analogous series 
of events but they can be summarized into two main steps: condensation and 
differentiation of skeletal progenitor cells which have potentials to form a skeletal cell 
and tissue type in embryos and in adults. First, undifferentiated prechondrogenic 
mesenchymal cells migrate to the sites of the prospective skeletal elements and 
subsequently assemble into compact cellular condensations mediated by a combination of 
precartilage matrix and cell adhesion molecules 8. Once this cellular condensation reaches 
a critical size, the aggregated mesencymal cells enable crucial cell-cell interactions and 
signaling events that trigger overt chondrocyte differentiation: changing from an 
elongated fibroblastic-like shape to the spherical morphology of hyaline chondrocytes 
and synthesizing cartilage-specific ECM molecules such as collagen types 2, 4, and 6 and 
the highly-sulfated proteoglycan aggrecan 9. From this stage, there are only two possible 
developmental paths hyaline chondrocytes can take: (1) further differentiation into 
hypertrophic chondrocytes expressing collagen type 10 and forming the growth plate or 
(2) remaining hyaline chondrocytes responsible for organization and maintenance of the 
ECM 10. In this study, we focus on how scaffold pore shape and permeability and 
materials may affect chondrogenic differentiation of chondrocytes measuring the mRNA 






2.2 Articular Cartilage Extracellular Matrix Molecules 
Matrix Glycosaminoglycans  
Two major constituents of the cartilage ECM are proteoglycans and collagens. 
The two most abundant proteoglycans in the cartilage matrix are aggrecan and decorin. 
Aggrecan is a glycosaminoglycan-containing molecule with three globular (G1, G2 and 
G3) domains and the G1 domain binds to hyaluronan chains with the aid of a link protein. 
It is a large proteoglycan consisting of a 200kDa core protein to which keratin sulfate, 
chondroitin sulfate, and hyaluronic acid GAG side-chains are attached. The sulfated 
GAG side-chains attached to the aggrecan core protein are highly negatively charged and 
capable of attracting osmotically active cations and their associated water, which confers 
upon cartilage the ability to withstand compressive force 9. For this reason, the two 
sulfated GAGs are commonly measured through biochemical assays as an indication of 
production and accumulation of extracellular cartilaginous matrix.  
As aggrecan is the main proteoglycan found in cartilage, it is also a typical 
biomarker for differentiated chondrocytes. During chondrogenesis, aggrecan messenger-
RNA (mRNA) begins to accumulate immediately before cellular condensation and 
continues to be expressed throughout the differentiation process 11. Here, mRNA 
expression of aggrecan normalized to GAPDH was used to quantify the extent of 
chondrogenesis when comparing scaffold designs and materials along with sGAG 
quantification. Even though not measured in this study, decorin is a member of the small 
leucine-rich proteoglycan (SLRP) family and it has one GAG side-chain attached to its 
core protein. Decorin is able to bind collagen types 1, 2, and 6 and has been shown to 
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regulate fibrillar diameter of collagens 2 and 6. Overall, decorin as one of the SLRP 
family helps to maintain the integrity of cartilage tissue and its metabolism 6,12,13. 
 
Cartilage Collagens 
Collagen type 2 is the major collagen type found in both embryonic and adult 
cartilages accounting for 90-95% of the overall collage content and it is categorized as a 
fibril-forming or interstitial collagen 14. Collagen type 2 is responsible for the tensile 
properties of cartilage tissue 6and collagen type 2 based hydrogels have been shown to 
maintain the typical rounded chondrocyte phenotype significantly better than collagen 
type 1 based hydrogels with highest GAG production per cell seeded in hydrogels and 
enhanced mRNA expression of collagen type 2 and aggrecan 15-17. Also, a significant 
increase in the type 2 collagen mRNA takes place coincidentally with the condensation in 
chondrogenesis and a continuous increase in the type 2 collagen mRNA expression has 
been found with progressive accumulation of ECM. Due to these reasons, collagen type 2 
alone is used as a positive biomarker for chondrocyte differentiation. However, when 
Type 2 collagen is destroyed, it is replaced with a type I collagen fibro-cartilage that does 
not have the same functional properties as type II collagen. The ratio of collagen 2 gene 
expression to collagen 1 gene expression, recently known as the “differentiation index”, 
attains a higher value with a more chondrocytic genotype, and a lower value with a more 
fibroblastic gene expression 18,19 
 
Collagen type 1 is categorized as a fibril-forming or interstitial collagen and is 
mostly associated with bone and partly with fibrocartilage. It is generally accepted as a 
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biomarker for chondrocyte de-differentiation and is known to cause chondrocytic 
rounded morphology to change to be fibroblastic-like. However, collagen type 1 gels are 
a popular scaffold in which to seed chondroprogenitor or chondrocytic cells to generate 
cartilage constructs in vitro and in vivo with successful outcomes of producing cartilage 
15,16,20.  
Collagen type 10 is specific to cartilage and is developmentally regulated. It is 
synthesized by terminally differentiating chondrocytes such as hypertrophic chondrocytes 
and it is known to facilitate the process of calcification through metrical organization 
changes. Type 10 collagen gene expressions have been detected in chondrocytes present 
in osteoarthritis (OA) tissue, particularly in areas where the endochondral ossification and 
bone formation appear to be initiated. Hence, type 10 collagen is a reliable marker for 
terminally differentiated or hypertrophic chondrocytes in engineered articular cartilage 
and it is used as a negative marker for chondrogenesis 21.  
 
Matrix metalloproteinase (MMPs) 
Matrix metalloproteinase (MMPs) along with a disintegrin and metalloproteinase 
with thrombospondin motifs (ADAMTS) are capable of degrading aggrecan and only 
MMPs are known to be capable of degrading fibrillar collagens including type 2 collagen 
which is extremely resistant to most proteinases. Among MMP members, MMP-13 and 
MMP-3 play critical roles in cartilage extracellular matrix degradation. MMP-13, known 
as the collagenase, is a product of the chondrocytes that reside in the cartilage and MMP-
3, known as stromelysins, is elevated in arthritis, which degrades non-collagen matrix 
components of the joints. In addition to collagen, MMP-13 also degrades the 
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proteoglycan molecule, aggrecan, giving it a dual role in matrix destruction 22-24. The 
mRNA expressions of MMP-13 and MMP-3 were measured in this study to have a more 
comprehensive view on matrix production (sGAG quantification) along with mRNA 
expressions representing matrix formation (i.e. collagen 2 and aggrecan) as the overall 
sGAG amount per scaffold would be an outcome of matrix formation and matrix 
degradation.  
All these quantitative measures of these genes expressed in engineered cartilage 
tissue are compared within each study of tissue/scaffold constructs in this work rather 
than to gene expression levels normally found in native healthy cartilage due to the wide 
variance in the gene expression levels reported. Since the goal in this work is not to 
exactly match the gene expression levels with native cartilage tissue, it is more accurate 
to compare expression levels within scaffold designs or materials to compare and 
determine the best choice for chondrogenesis.  
 
2.3 Roles of three-dimensional environment and biophysical and mechanical stimuli 
Chondrocytes are infamous for monolayer cell culture expansion as isolated 
chondrocytes will lose their differentiated phenotype in two-dimensional (2D) culture 
whereas chondrocytes proliferate and differentiate happily within a complex three-
dimensional (3D) environment 25. The de-differentiation process usually causes cell 
phenotype changes from rounded chondrocytic to fibroblast-like with an increased 
expression of type I collagen, which is easy to find in 2D culture. However, it has been 
shown to be reversible when cells are cultured back in a 3D environment, confirming that 
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the 3D environment is a crucial condition that has a significant role in supporting and 
restoring the chondrocytic phenotype and chondrogenesis 26,27.  
Chondrocytes receive oxygen and nutrients via a passive diffusion from the 
synovial fluid hence articular chondrocytes are not metabolically active and experience 
low oxygen tension. Hypoxia conditions not only help to maintain the chondrocytic 
phenotype but also have been shown to increase the synthesis of ECM proteins in 
cultured chondrocytes in vitro 27,28. In addition, hypoxia has also recently been suggested 
to inhibit the expression of type 10 collagen during the chondrogenesis of epiphyseal 
chondrocytes, assuring that hypoxia is probably a required condition for cartilage 
engineering along with 3D environments 29. 
Cartilage is well-known for its weight bearing and under physiological conditions 
it is subjected to various mechanical stimuli such as hydrostatic, compressive, and tensile 
pressure and shear strain. The mechanical stimuli are considered to be an essential factor 
influencing the chondrogenic differentiation and the maintenance of cartilage integrity as 
mechanical stimuli also affect gene expressions that are relevant to ECM molecules and 
degradation proteins mentioned above 30,31. Bioreactors are commonly used in cartilage 
tissue engineering to accommodate such conditions. 
 
Aging affects the properties of healthy cartilage by altering the content, 
composition, and structural organization of collagen and proteoglycan 32. The matrix 
functions to maintain the homeostasis of the cellular environment and the structure of 
cartilage. When the degradation of the extracellular matrix (ECM) exceeds its synthesis, a 
net decrease in the amount of cartilage matrix and a subsequent elevation in the 
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proteolytic enzymes’ activities eventually lead to the destruction of articular cartilage as 
shown in diseases such as osteoarthritis (OA) and rheumatoid arthritis (RA). The main 
enzymes responsible for degradation of aggrecan and collagens in cartilage, the matrix 
metalloproteinases (MMPs), are overexpressed in cartilage of patients with RA and OA 33. 
This disruption in cartilage homeostasis causes not only an imbalance in biochemical 
composition of cartilage but also its mechanical instability. Hence it is crucial to 
regenerate an engineered cartilage with well-balanced biochemical compositions and 
proper material/mechanical properties similar to native cartilage. The permeability and 
mechanical properties of native cartilage are discussed more in detail in chapter 3, which 
are also the targeted properties for our tissue/scaffold constructs in this work.  The 
biochemical assessments of chondrogenesis to examine the matrix formation and 
chondrocyte phenotype shift during differentiation or de-differentiation/ossification 
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INFLUENCE OF POLYMERIC SCAFFOLD DESIGN AND MATERIAL ON  
CARTILAGE TISSUE ENGINEERING 
 
 
There have been numerous natural and synthetic materials used for cartilage 
tissue engineering scaffolds.  These scaffolds have been fabricated using a number of 
techniques and researchers are still investigating new synthetic materials to support 
cartilage regeneration.   The ideal scaffold should be biocompatible (no inflammatory 
response), non-cytotoxic, capable of supporting cell attachment and proliferation, and 
biodegradable serving as a temporary support for the cells yet allowing eventual 
replacement by at the implanted sites. Also, it should be permeable and well-
interconnected for cells to be distributed and grown evenly throughout the scaffold and to 
allow nutrient diffusion throughout for cellular proliferation and extracellular matrix 
formation. In addition to appropriate effective mass transport properties, scaffolds should 
possess effective mechanical properties to provide protect seeded and host cells from 
joint loading until desired tissues are grown to provide sufficient mechanical support. 
Furthermore, scaffold materials should be readily available and able to be processed into 
a variety of shapes and sizes with relatively low cost1,2. To fulfill these requirements, 
many researchers have hypothesized that scaffolds should have mechanical and transport 
properties similar or close to native cartilage tissue.  This would allow the scaffold to 
support cartilage regeneration by providing appropriate local mass transport, mechanical 
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and biochemical microenvironments to stimulate chondrogenic differentiation and 
cartilage matrix production by seeded and/or host cells.  
 
Figure 3.1 A schematic diagram displaying the optimum model of mechanical properties of 
scaffold with gradual mass loss of a scaffold and new tissue development (figure taken from 
Raghunath et al.) 3.  
 
The optimal scaffold/tissue response for a biodegradable scaffold that this work 
aims to achieve is shown schematically in Figure 3.1. The scaffold initially carries 
mechanical forces resulting from joint loading. However as the scaffold starts to degrade 
and tissue in-growth takes place, the cells seeded within the scaffold and/or host cells 
migrating into the scaffold gradually making cartilage matrix and neotissues.  The newly 
formed cartilage tissues experience physiological loading that further enhances cartilage 
matrix production.  Eventually the scaffold completely degrades and gets reabsorbed by 
the body and the regenerated tissue alone bears the joint loads 3.   
Cartilage regeneration using seeded biologics thus significantly depends on the 
initial scaffold mechanical, mass transport and biocompatibility properties, and on how 
these properties change during scaffold degradation and cartilaginous matrix production.  
There are thus two critical questions regarding scaffolds.  First, what is the best material 
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for a cartilage tissue engineering scaffold?  Second, what are the mechanical and mass 
transport properties a scaffold should possess to carry joint forces and provide an 
appropriate microenvironment for cartilage tissue regeneration initially and during 
degradation?  An appropriate starting point for defining scaffold properties is the 
mechanical and mass transport properties of native articular cartilage.   
 
3.1 Mechanical Properties of Native Articular Cartilage 
Articular cartilage is a complex tissue which consists of chondrocytes and an 
extracellular matrix (ECM) that is mainly composed of a network of collagens and 
proteoglycans.  The ECM serves to support and distribute applied loads.  The ECM 
achieves this load bearing through its composition as a multiphasic material with 
anisotropic, inhomogeneous, nonlinear and viscoelastic properties 4. Its distinct 
mechanical properties not only serve its crucial function as a load-supporting and low-
friction bearing surface, but also give matrix proper signals and biomechanical stimuli for 
maintaining a proper balance between development and degradation 5.  
A long postulated design goal for any cartilage tissue engineering scaffold is to 
replicate native articular cartilage mechanical and mass transport properties.  Generally, 
mass transport is characterized by effective permeability, as effective permeability is 
known to play a significant role not only in cartilage nutrition, but also in its mechanical 
response as characterized using biphasic theory 6.  Mechanical properties are typically 
characterized by linear aggregate modulus (if biphasic theory is used to model cartilage) 
or nonlinear elastic strain energy functions.  Articular cartilage has also been represented 
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by straight nonlinear elasticity theory 12.  A summary of native articular cartilage 
properties is presented in Table 3.1 
Matching native articular cartilage properties, however, especially permeability 
raises a significant conundrum.  The extremely low articular cartilage effective 
permeability is likely due to two factors.  First, proteoglycans in the articular cartilage 
matrix bind water through negative electrostatic charges.  This in itself restricts fluid flow 
in and out of the cartilage matrix, effectively reducing cartilage effective permeability.  
Second, pores in cartilage matrix are on the nanometer or single micron scale which 
further reduces fluid movement in the matrix.   With current fabrication methods, it is 
difficult to achieve low effective permeability on the scale of articular cartilage, simply 
because pore sizes in synthetic scaffolds are likely to be on the order of hundreds of 
microns, not single microns or hundreds of nanometers.  It is unclear, even, whether 
producing scaffolds with effective permeability in the measured range of cartilage (10-14 
to 10-15 m4/Ns) is even advantageous for cartilage tissue engineering.  One limitation is 
that creating the pore sizes to reach this permeability level would make it extremely 
difficult to seed chondrocytes or progenitor cells within the scaffold, as these cells have a 
typical diameter of 10-40μm (10-12μm smaller, 30-40μm larger cells) 7. Although our 
group has shown that lower permeability is generally beneficial for chondrogenesis using 
primary chondrocytes 8,9  it is unclear what the lower floor is for permeability that would 
benefit chondrogenesis by primary chondrocytes.  Malda's 10 results showing less 
cartilage matrix production in sponge scaffold architecture with significant tortuosity and 
thus lower permeability when compared with scaffolds having designed regular 
interconnected porosity and higher permeability suggests there may be a lower floor on 
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effective permeability that promotes enhanced chondrogenesis even with primary 
chondrocytes.  Furthermore, Kemppainen and Hollister 8 demonstrated conclusively that 
chondrogenesis with chondrogenically pulsed bone marrow stromal cells (BMSC) is 
significantly enhanced with higher permeability, since BMSC likely have higher 
metabolic activity.    
A second difficulty in determining effective mass transport and mechanical 
property design targets that enhance chondrogenesis is simply the plethora of possible 
design targets.  As Table 3.1 demonstrates, cartilage exhibits a tremendous variation in 
compressive and tensile mechanical properties such that it may not be feasible with 
available synthetic materials and computational design techniques to match all the 
reported properties.    Therefore, this work will focus on how well synthetic polymer 
scaffolds match two basic articular cartilage effective properties, namely hydraulic 
permeability, and compressive Young’s modulus.  
Table 3.1 Biomechanical properties of human native articular cartilage 4  
Tensile Properties Human Articular cartilage 
Ultimate tensile stress 15-35 MPa 
Ultimate tensile strain 10-40% 
Tensile modulus (10% strain) 5-25.5 MPa 
Poisson's ratio 0.9-2.2 
Equilibrium relaxation modulus 6.5-45 MPa 
Compressive properties  
Aggregate modulus 0.1-2.0 MPa 
Hydraulic permeability 0.5-5.0 x 10-15m4N-1s-1 
Young's modulus 0.4-0.8 MPa 
Shear properties  
Equilibrium shear modulus 0.05-0.25 MPa 
Complex shear modulus 0.2-2.0 MPa 





3.2 Scaffold Materials and Stiffness for Cartilage Engineering 
The two main material types which have been successfully applied in developing 
cartilage scaffolds are (1) natural polymers such as agarose, alginate, hyaluronic acid, 
gelatin, fibrin glue, collagen derivatives and acellular cartilage matrix, and (2) synthetic 
polymers, based on polyhydroxyacids (i.e. polylactic acid (PLA), polyglycolic acid (PGA 
and their co-polymers), and polycaprolactone (PCL)), and other several bioelastomers (i.e. 
poly(glycerol sebacate) (PGS), poly (1, 8 Octanediol-co-citrate) (POC), polyurethanes) 
3,11.   Even though there are many advantageous properties of natural polymers reported 
for cartilage engineering, natural polymers also present significant limitations for 
cartilage tissue engineering and eventual clinical application.  First of all, it is difficult to 
reproducibly control the architecture and thus effective mechanical and mass transport 
properties when manufacturing natural polymers.  Thus, if we determine that controlled 
effective permeability and compressive modulus are indeed important for enhancing 
chondrogenesis, it will be difficult to achieve reproducible results with natural materials.  
Second, the mechanical properties and strength of natural polymers actually falls 
significantly below that of natural articular cartilage 3.  
.  Third, the ability to mass produce natural polymer scaffolds with controlled 
effective properties is also limited.  Thus, in this work, we will focus on reviewing 
synthetic polymer scaffolds for cartilage regeneration. There are numerous synthetic 
materials that possess promising compressive modulus  values that fall within or close to 
the ranges of native cartilage tissue (Table 3.1: 0.1-2.0 MPa for aggregate modulus, 0.4-
0.8 MPa for compressive young’s modulus). Table 3.2 shows a list of example materials 
that have been fabricated into 3D scaffolds with architectures for cartilage engineering.  
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These synthetic materials readily manufactured in a variety of designs and dimensions, 
while presenting a range of hydrophilicity and other cell-material interaction 
characteristics. 
Table 3.2 Review of compressive modulus, pore diameter and dimension values for synthetic 






Diameter(μm) Young's Modulus (MPa) 
PCL/CH 
3(D)x1-2(H)/ 3D 
cylinder 70 ± 2 %, 200μm 0.26-0.5712 
PCL/agarose-fibrin 
gel/CH 3D woven 
70-74%, 
390x320x104μm 0.005-0.14 
PCL/CH or MSC or 
None 
8(D)x2(H)/ 
3D nanofibers -  
0.2-1.5  





7(D) x 3(H)mm 
/cylinder 85-%, 50-250μm 
1.44-3.35  
(depending on CS%)15 
PLLA/CH 
7(D) x 3(H)mm 









48.1 ± 4.24 %,  
1004 ± 0.04μm 0.57 ± 0.2417 
POC  
6.35(D)x3.5(H)mm
/cylinder 32-62%, 890μm 0.29-0.78 9,18 
polyurethane 
8(D)x4(H)mm 
/cylindrical sponges 85%, 200-400μm 0.023-0.05019 
*CH - chondrocytes, MSC - mesenchymal stem cells 
PLCL – poly(L-lactide-co-epsilon-caprolactone,  
CS-PLLA - chondroitan sulfate-PLLA 
PLGA – poly(lactic-glycolic acid) 
 
As synthetic materials offer the potential for designed control of scaffold 
properties, solid freeform fabrication (SFF) is an ideal choice for scaffold fabrication 
using synthetic polymers.   SFF provides the capability for translating the computational 
design of controlled effective properties into a realizable physical scaffold embodying 
those properties.    Furthermore, SFF also allows relatively precise fabrication, accurate 
reproducibility of the design, and the ability to regulate scaffold pore size, pore shape, 
interconnectivity, porosity, and entire scaffold dimension. This advantage of SFF in 
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control over scaffold design and manufacture compared to conventional methods (i.e. 
solvent casting/salt leaching, freeze-drying, electrospinning etc.), provides benefits not 
only for cartilage but also for many other tissues and clinical applications. Table 3.3 
shows elastic properties of selected scaffolds manufactured by the SFF technique, 
demonstrating that SFF techniques enable a broader range of architectures with wider 
porosity ranges and lower variation in resultant effective properties than conventional 
methods.  
Table 3.3 Elastic properties of selected scaffolds fabricated by SFF 20. 
SFF  







ABeBE Variation (%) 
Fused Deposition Molding PCL 48-77 4-77 4-12 
Nozzle Deposition PLGA/PLLA/TCP 74-81 17-23 5-17 
Nozzle Deposition HA 41 1110-1240 7-23 
Nozzle Deposition PEOT/PBT 29-91 0.2-13.7 3-19 
3D Printing PLLA 0 187-601 0.7-11 
Selective Laser Sintering PCL 37-55 54-65 4-5 
Inverse SFF HA 40 1400 28 
Inverse SFF Col1 - 0.1-1 - 
Inverse SFF POC 30/50/70 0.35-1.05 14-53 
 
Since SFF may provide a reproducible and scalable manufacturing technique that 
can satisfy current Good Manufacturing Practices (cGMP) requirements in addition to 
scalable commercialization demands, we will focus on reviewing scaffold materials for 
cartilage tissue engineering that either have been or have the potential for SFF based 
manufacturing.  We first focus on synthetic material characteristics and their possible 
impact on cartilage tissue engineering followed by a review of design factors that may 
impact cartilage tissue engineering. In this work, we exploit SFF methods to fabricate 
scaffolds from three synthetic polymers in order to reach our goal of matching the 
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mechanical properties of 3D designed scaffolds to target compressive properties of native 
cartilage. The three biomaterials used in this work are poly (1, 8 Octanediol-co-Citrate) 
(POC), polycaprolactone (PCL), and poly (glycerol sebacate) (PGS). POC and PGS are 
relatively new materials developed in the field of tissue engineering and PCL is a widely 
used in various designs for cartilage application. The main focus of this work will be to 
test the feasibility of POC mechanically and biochemically in vitro and in vivo as a 
cartilage scaffold material with 3D controlled design solid-freeform scaffolds. Then, the 
performance of POC as a scaffold will be compared to that of PGS and PCL in vitro with 
the same 3D scaffold design to see which material is more suitable for cartilage 
regeneration and to check if either scaffold material or design factor is more influential or 
not in chondrogenesis. In order to access the feasibility of POC as cartilage scaffold 
material, we also look at the effects of physical parameters—coupled effects of scaffold 
pore shape and permeability on chondrogenesis, which precise and almost identical 
scaffolds with controlled design permeability are reproduced via SFF. The rationale for 
selection of the three candidate materials was based on their mechanical stiffness, 
hydrophilicity, and potential use in the field of cartilage engineering. We wanted to 
choose a biocompatible material which can be fabricated via solid freeform fabrication 
method with a higher stiffness than any other two materials with slow or no degradation 
over short periods and PCL is a perfect fit for such requirement. Whereas, we wanted to 
choose two other materials which are relatively similar in their mechanical performance 
but different in some other physical properties such as hydrophilicity, permeability, and 
degradation etc. POC and PGS are perfect candidates to fulfill our interests since both of 
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them are relatively new materials in this field and they have similar mechanical stiffness 
(much less than PCL), but differ in material permeability. 
 
Poly (1, 8 Octanediol-co-Citrate) (POC) 
Poly (1, 8 Octanediol-co-Citrate) (POC) is a family of poly (diol citrates) recently 
developed by Yang et al. 21 POC is an elastomeric, biodegradable, hydrophilic “cell-
friendly” material. Furthermore, it has the following advantages: non-toxic monomers, a 
relatively simple synthesis without addition of catalysts or crosslinking reagents, cost-
effective scale-up, controllable mechanical and biodegradation properties and easy 
processing, and inherent surface affinity for various cell types including chondrocytes 22, 
human aortic endothelial cells23, and cardiomyocytes24. POC is synthesized by first 
creating a pre-polymer via reacting the polyfunctional monomer citric acid with the 
difunctional monomer 1, 8-octanediol, then it can further post-polymerized to create a 
polyester network with a controllable number of crosslinks to tailor the elasticity and 
biodegradability of the resulting material (Figure 3.2).  
 




POC is degraded by hydrolysis of its ester linkages in physiological conditions 
and its byproducts, citric acid and 1, 8-octanediol, are excreted by the body. Citric acid is 
a non-toxic metabolic product of Krebs cycle in the body and 1, 8-octanediol enables 
ester bonds to form with citric acid and is water-soluble with no reported toxicity. These 
monomers ensure a beneficial property of the degradation process leaving no insoluble or 
toxic complexes in the body. One of the unique properties of POC is that its mechanical 
and degradation properties can be tailored easily by changing curing temperature and 
reaction time, the molar ratio of monomers, and the presence and the level of vacuum 
when curing 21,25. In general, harsher curing conditions such as high temperature, longer 
reaction time, and high vacuum increase the mechanical strength and decrease the overall 
degradation rate. The tensile strength was as high as 6.1 MPa and the Young’s moduli 
ranged from 0.92 to 16.4 MPa with the maximum elongation at break at 265% of initial 
length. The complete degradation time of POC in PBS at 37°C is reported to be about 6 
months yet the degradation rate may get accelerated in vivo due to enzymatic, cellular 
effects and friction due to movements.21 In this thesis, the 1:1 molar ratio between 
monomers was used when creating the pre-polymer and post-polymerize the pre-polymer 
with one curing condition (100°C for 1 day of curing followed by 3 days of curing with 
high vacuum) in order to reduce variation in manufacturing.  The overall mechanical 
properties of scaffolds were varied through different scaffold designs to match native 
cartilage. The Chapter 4 presents the more detailed mechanical characterization of solids 
and scaffolds with various designs for the specific curing conditions.  
In fact, Kang et al. 22 reported a study using POC as a scaffold material for 
cartilage engineering. The scaffolds used by Kang et al were fabricated through a salt-
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leaching method.  They demonstrated that chondrocytes attached well and grew cartilage 
within POC scaffolds. The current thesis work was the first study to demonstrate the 
ability to fabricate POC scaffolds through SFF methods in order to create regularly 
interconnected and controlled pore. In order to create such controlled scaffold 
architectures by SFF methods, a two step mold fabrication was involved.  First, since as 
POC must be cured at temperatures greater than the melting temperature of ProtoBuild 
wax molds used in SFF methods, an intermediate hydroxyapatite (HA) mold (inverse of 
the wax mold) must be made using the wax mold then cast into the pre- poly (1, 8 
Octanediol-co-Citrate) (pPOC).  Second, the POC is cured within the HA mold followed 
by removal of the HA mold to obtain the final POC scaffold. A schematic of fabrication 
steps is shown in Figure 3.3. 
 
Figure 3.3: A schematic of designing, fabrication, and porosity analysis of 3D POC scaffolds: 
with 3D scaffold designs by IDL, first wax molds are built in Solidscape, which then are cast into 
HA creating a secondary inverse mold. POC prepolymer/HA constructs are cured and a resulting 
3D POC scaffold is analyzed by micro-CT for its porosities and defects. 18,26 
  
Scaffold Design by IDL 




Green & Red wax 











Burn out/ Sinter 













Wax/HA Mold Casting -> POC 
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To date since 2004, POC has been most actively used in heart24 and vascular23,27,28 
tissue engineering, with composite materials of POC with HA29, chitosan30 or PLA30 
being used for orthopedic applications. Also, the degradation properties make POC a 
good candidate for drug delivery reservoirs 31 broadening its potential application areas in 
tissue engineering. 
 
Poly (ε-caprolactone) (PCL) 
PCL, the stiffest material out of three materials used in this work, is probably one 
of the most widely used polymers in the field of tissue engineering as it is FDA approved, 
non-toxic, and readily available with relatively low cost. Unlike POC and PGS 
(thermoset), PCL is a biodegradable thermoplastic semi-crystalline polyester which is 
synthesized via ring opening polymerization of ε-caprolactone (Figure 3.4).12  
 
Figure 3.4 Ring opening polymerization of ε-caprolactone to polycaprolactone 
Even though it is degraded by hydrolysis like POC and PGS, it degrades much 
slower than other biodegradable polymers via hydrolysis of its ester linkages in 
physiological conditions. Because of the rather slow degradation properties of PCL, it is 
also a good candidate for long-term in vitro and in vivo applications as the scaffolds will 
maintain their architectural integrity and strengths during tissue growth 32. PCL is used 
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not only for a scaffold material, but also as drug delivery devices, adhesion barriers, 
sutures, and staples. 
PCL has biocompatibility with a variety of cell types for skeletal tissue 
engineering including adipose stem cells33, bone marrow stromal cells8,34, 
chondrocytes8,12, fibroblasts35-38, osteoblasts39 in skeletal tissue engineering. In particular, 
several studies 8,12,40-42 have shown that PCL scaffolds provide suitable 
microenvironments for cell infiltration, differentiation, re-differentiation and proliferation 
of seeded chondrocytes.  These studies have demonstrated gene expression and formation 
of cartilaginous tissues such as type II collagen expression and matrix formation (i.e. rich 
proteoglycan contents) both in vitro and in vivo. However, PCL is relatively hydrophobic 
compared to biodegradable elastomers, which is considered as a disadvantage for tissue 
engineering as it may lead to poor cell attachment. To improve cell attachment, PCL has 
been modified to increase hydrophilicity using surface hydrolysis with the use of acid or 
alkaline solution43, adsorption of cell-adhesive proteins (i.e. collagen and fibronectin)43 or 
Arg-Gly-Asp (RGD) peptides34,44.  These modifications improve PCL hydrophilicity and 
hence cell attachment, increasing its applicability for many tissue engineering 
applications.    Another advantage of PCL is that scaffolds can be fabricated using many 
methods including porogen leaching and solvent casting, SFF techniques, 
photopolymerization, selective laser sintering, bioextrusion, salt leaching and melt 
casting. In this work, we used the SFF method of melt-casting in order to create 
accurately designed and controlled 3D PCL scaffolds (Figure 3.5); unlike POC and PGS, 
we use the ProtoBuild Wax mold directly to cast into the melted PCL powders instead of 
using the intermediate HA mold (Figure 3.3) 
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Figure 3.5: Direct PCL scaffold fabrication from a SFF fabricated wax mold without use of an 
intermediate HA mold (modified from a work by Kemppainen 26) 
.  
Poly (glycerol sebacate) (PGS) 
Poly (glycerol sebacate) (PGS) is another recently developed biodegradable 
elastomer that has potential application in soft tissue engineering like cartilage. There are 
many similarities between POC and PGS; PGS is also synthesized via a polycondensation 
reaction of two monomers. Glycerol is the basic building block of lipids and sebacic acid 
is the natural metabolic intermediate in fatty acid oxidation thus the degradation 
byproducts of PGS are presumably non-toxic. It shares the same advantages as POC 
including a simple and relatively cheap synthesis process, adjustable mechanical and 
degradation properties, excellent biocompatibility, and rubber-like behavior. In fact, it 
has been more widely used than POC so far in various applications for cartilage, 17 
arterial constructs, 45 heart, 46,47 and as a drug carrier 48. 
PGS is synthesized exactly the same way as POC. First, the pre-polymer of PGS 
(pPGS) is made at high temperatures with monomers (glycerols and sebacic acids).  Then 
a thermoset PGS is fabricated through a polycondensation reaction of pPGS with desired 
temperatures (mostly 120~150°C) and duration shown in Figure 3.6. Again, the molar 
ratios of monomers and curing conditions such as temperature, reaction time, and vacuum 
levels determine the mechanical and degradation properties of PGS, which makes PGS as 
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a good candidate for scaffold materials in soft tissue engineering. According to Wang et 
al.49, PGS showed a Young’s modulus of 0.282 ± 0.025 MPa, a tensile strain of at least 
267 ± 59.4% and a tensile strength of at least 0.5 MPa. 
 
 
Figure 3.6 Polycondensation reaction of glycerol and sebacic acid to make PGS.49 
 
The degradation profiles can be easily controlled by molar ratios and crosslinking 
density, which is highly related with the post-polymerization conditions. The mechanical 
properties represented by compressive modulus decreased linearly and in parallel with 
the degradation rates of PGS suggesting that the mechanism of PGS degradation is 
surface erosion 50. PGS has shown to degrade much faster than PCL does such that PGS 
has lost 17% of its original mass after 2 months, 49,50 which is similar to POC (even 
though the degradation profiles of POC and PGS all depend on its curing conditions.). In 
this work, we fabricated PGS scaffolds via SFF methods with one curing condition such 
that mechanical properties were within the ranges of native cartilage in order to compare 
the performance of PGS scaffolds in chondrogenesis compared to POC and PCL 
scaffolds. Details of the fabrication steps are the same as shown for POC in Figure 3.3. 
There has not been much study done with PGS scaffolds for cartilage application. 
From our previous work 17, Kemppainen et al. demonstrated the feasibility of creating 
PGS scaffolds via SFF methods and grew cartilage on PGS scaffolds for 2 weeks in vitro 
with seeded chondrocytes as proof of concept. In this work, PGS scaffolds were 
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compared to other two material scaffolds (POC and PCL) in terms of permeability with 
and without tissues, mechanical and physical properties, and cellular activities for 
chondrogenesis (details in Chapter 7 & 8). 
   
3.3 Factors involved in Scaffold Design for Cartilage Tissue Engineering  
The optimal properties of a cartilage tissue engineering scaffold should be defined 
as those properties that enhance cartilaginous tissue formation in vitro or/and in vivo. 
Besides a careful selection of suitable scaffold material which will determine the basic 
material stiffness ranges and approximate degradation profiles for a specific application, 
ensuring required scaffold mass transport properties is another critical issues (Figure 3.7). 
Unlike native cells and tissues in the body, nutrient supply through blood is not available 
for most of tissue engineered constructs either in vitro or during the immediate post-
implantation in vivo, hence the ability of a scaffold to enable the adequate supply of 
nutrients to resident cells and effective removal of wastes is a key to the success of any 
scaffold-based tissue engineering.  
 
 
Figure 3.7: The factors need to be considered for 3D scaffolds in tissue engineering. 
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Mass transport is related to oxygen and nutrient delivery, waste removal, protein 
transport and cell migration, which in turn are governed by scaffold architectural 
properties; the pore size, geometry (shape), orientation, interconnectivity, porosity, 
diffusivity and permeability. Furthermore, surface chemistry of pores and surface area 
directly influence the extent and nature of nutrient/wastes exchanges and tissue in-growth 
51. All these scaffold architectural properties are closely linked. Effective diffusivity and 
permeability are physical properties that can be computed and measures, and thus 
incorporate in a quantitative manner architectural parameters like pore shape, pore size, 
interconnectivity and orientation 52. Also, these design parameters are often bounded by 
fabrication methods so even the optimized design produced by computational models 
may not be realized due to limitations of actual scaffold fabrication. 
 
Permeability 
Permeability of the scaffold or tissue/scaffold construct in cartilage engineering is 
important as it controls the migration of cells into the scaffolds as well as the diffusion of 
nutrients and removal of wastes. Since permeability is probably the best representative 
measure accounting for all the scaffold architectural factors51, the effects of permeability 
have been studied in various biological materials such as bone 53, tumor tissue54, 
cartilage55 and tissue/scaffold constructs 8,9,56. Coupled with mechanical loading, scaffold 
permeability affects the magnitude of pressure and fluid shear stresses within the 
construct or tissue, which in turn work as potential stimuli for cellular differentiation or 
functional adaptation. Also, construct permeability has been shown to affect the 
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degradation rate of biodegradable scaffolds as it determines the exchange rate of 
degradation byproducts between cells/tissues and scaffolds 57-59.  
Native tissue permeability can be a good starting point for defining scaffold mass 
transport design targets and this parameter is closely linked with metabolic activity of 
tissues. For instance, cartilage is much less metabolically active than other tissues and it 
is much less permeable than any other tissues such as bone or highly vascularized tissues 
20. Low permeability affects oxygen diffusion to cells and regenerated tissues. Partial 
oxygen pressure (PO2) is a factor that can clearly affect chondrocytic differentiation in 
that lower PO2 favors chondrogenic matrix production and maintenance of chondrocyte 
phenotype 8,60. In contrast, a higher PO2 favors bone matrix formation and bone matrix 
related gene expressions by osteoblasts and bone marrow stromal cells 61,62. These results 
prove that a specific tissue may require a specific or favorable permeability range.  
Therefore, permeability should be a main design parameter for tissue/scaffold constructs.  
 
Pore size 
Pore size is one of key players in defining scaffold permeability. It has been 
reported that optimal pore size is of 5μm for neovasculariation, 5-15μm for fibroblastic 
ingrowth, approximately 20μm for the ingrowth of hepatocytes, 20-125μm for 
regeneration of adult mammalian skin, 40-100μm for osteoid ingrowth,  100-350 μm for 
regeneration for bone, and greater than 500 μm for fibrovascular tissues 63-65.   However, 
it is critical to note that determination of these "optimal" pore sizes has been performed 
with scaffolds that have widely varying pore structures, which is why the use of 
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permeability as a design factor that accounts for pore tortuosity should be presented in 
addition to pore size. 
It’s been shown that the scaffold pores for cartilage need to be large enough to 
allow cells to migrate into the structure (~20μm), but small enough to establish a 
sufficiently high specific surface area (~120 μm)56,66 hence pore size affects an individual 
cell’s response in terms of cell adhesion, attachment and proliferation 56,66,67. However, it 
has also been reported that pore size did not affect the formation of cartilaginous tissue 
with chondrocytes in vitro, but rather influenced the cellularity of the tissue, the quality 
of the tissue (i.e. the amount of collagen accumulation per cell in the composition of the 
neo-cartilaginous tissue) 68 and the maintenance of chondrocytic phenotype 69. Al-
Munajjed et al.59 also suggested that the pore size plays a significant role as it influences 
permeability, porosity, and the mechanical properties of scaffolds thereby having an 
effect on chondrogenesis, rather than having a direct influence on chondrogenesis. 
However many of these pore sizes were including micro (diameter < 100μm) and macro 
(diameter > 100μm) pores and determined using random pore geometries, hence do not 
define or represent optimum pore sizes accurately. Rather, they define the broad range of 
pore sizes in which a certain tissue type formation with specific cells was applied, still 
leaving no definite guidelines for the optimal pore size for a specific tissue type.  
 
Pore geometry – pore interconnectivity and pore shape 
Another important design consideration affecting scaffold permeability is pore 
geometry. Pore geometries can be divided into pore interconnectivity and a unit pore 
shape. A scaffold should provide an open porous interconnected structure allowing for 
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smooth cell penetration and evenly distributed nutrient/waste exchanges throughout the 
entire scaffold dimension Quite often viable tissue formation is found only in the 
peripheral regions of scaffolds whereas the interior fails to support viable tissue due to 
lack of adequate nutrient and oxygen supply. In order to minimize mass transport 
limitations and pore occlusions, it is essential that a scaffold possess a high degree of 
interconnectivity in conjunction with a suitable pore size, which has been confirmed in 
bone formation, osteoconduction, and cartilage matrix formation 10,70-73. Unfortunately, 
many conventional scaffold fabrication methods such as porogen leaching and solvent 
casting do not provide a controlled scaffold pore network, with pore geometry being 
difficult to control in fabrication.  Hence pore shape has not been widely studied in 
scaffold tissue engineering. However, it has been recently suggested that a spherical pore 
shape enhances chondrogenesis in SFF fabricated scaffolds 8,74 and both the change from 
cubical to spherical pore shapes with more homogeneous pore structure may be 
responsible for the higher rupture stress and the tensile moduli 59, yet all these studies 
were limited as other mass transport properties such as permeability were never 
characterized experimentally but rather postulated. Hence, we examine the pore shape 
and consequent permeability effects on chondrogenesis characterizing and controlling 
other scaffold design factors in this work to elucidate the effect of scaffold pore shape.   
 
Porosity 
Besides pore size and pore geometry, porosity is highly connected with 
permeability. Porosity and permeability often control the cell migration into and out of 
the 3-D construct as well as nutrient and waste transport. Although it is usually true that 
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an increase in porosity leads to an increase in permeability, this only happens when the 
pores are highly interconnected.  Again, this is why permeability should be treated as a 
single parameter for transport properties as it encompasses a combination of other 
scaffold parameters mentioned in this chapter. Several studies have emphasized the need 
for sufficiently high porosity and high surface area-to-volume ratio in scaffold design for 
ensuring uniform cell delivery and tissue in-growth 63,75,76, however extremely high 
porosity (i.e. over 80%) would compromise the mechanical integrity of the scaffold with 
possible faster degradation rate due to initial lower mass, which still poses a conflict 
between optimizing the porosity and maximizing mechanical properties. Porosity and 
permeability can also have a significant impact on the degradation characteristics of 
biodegradable scaffolds. For instance, low porosity and permeability of scaffold may 
accelerate scaffold degradation exhibiting a decrease in mass, molecular weight, and 
mechanical properties due to the inhibition of autocatalytic degradation with better 
diffusion or waste removal 57. For cartilage, chondrocytes have shown to prefer lower 
porosity and permeability as it mimics native cartilage environment and possible forcing 
cell aggregation in vitro whereas BMSCs prefer higher porosity and permeability even 
for cartilage regeneration 8.  
 
Other related factors 
There are several other additional factors that are not scaffold mass transport 
design factors yet could significantly influence cartilage regeneration including surface 
area, overall mechanical stiffness, and hydrophilicity of scaffold surface. A large surface 
area favors cell attachment and growth and a large pore volume is required to 
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accommodate and deliver cell nutrients and cell waste products. Hence some researchers 
advocated the use of the surface area to volume ratio 63,77 explaining the effects of pore 
geometry on chondrogenesis in that an increase in the surface area: volume ratio due to 
pore geometry may increase cellular attachment and growth and increases the amount of 
extracellular matrix deposition in the scaffold pore space. Again, total scaffold surface 
area is highly linked with pore geometry and porosity and the ideal design for cartilage 
would need a high surface area with highly interconnected pore geometry and low 
permeability.  
 Mechanical properties of the scaffold or tissue/scaffold construct are another 
factor that is closely influenced by architectural factors and likely plays a significant role 
in chondrogenesis. It is predicted that increasing the stiffness of the scaffold increases the 
amount of cartilage formation and reduce the amount of fibrous tissue formation in the 
defect but with a limited threshold stiffness value close to native cartilage 78. Besides, 
surface modification and hydrophilicity due to scaffold material composition has been 
proposed as an important influential factor on chondrogenesis 34,44,73,79. Surface 
modification increasing hydrophilicity may enhance cellular infiltration into the inner 
spaces of scaffolds, rendering more uniform cell distribution, adhesion, and proliferation 
than hydrophobic ones 34,79.  
Due to the complex interaction of this multitude of scaffold design parameters, 
the ability to vary a limited number of design parameters while holding the remaining 
design parameters constant is of paramount importance when testing scaffold design 
hypotheses.  Creating scaffolds that enhance tissue regeneration can only be achieved if 
we can test scaffold design hypotheses to determine if a range of a proposed scaffold 
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design variable enhances tissue regeneration or, indeed, influences tissue regeneration at 
all.  Given this prerogative, the goal in this thesis was to test the relative influence of 
scaffold pore shape, effective permeability and material on cartilage tissue regeneration 
in vitro and in an in vivo sub-cutaneous mouse model, while fixing other scaffold 
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MECHANICAL, PERMEABILITY, AND DEGRADATION  






Tissue engineering requires the use of three dimensional scaffolds as a template 
on which cells differentiate, proliferate, and grow new tissues. Optimal scaffolds should 
be biocompatible, biodegradable, permeable, reproducible, non-cytotoxic, and capable of 
serving as a temporary support for the cells with elastic properties similar to native tissue 
which will allow eventual replacement by tissue matrix1. The choice of scaffold material 
and architecture will determine the effective scaffold mechanical and mass transport 
properties that can significantly influence tissue regeneration. Particularly for cartilage 
regeneration, many researchers have tried to develop novel materials which are 
elastomeric yet mechanically tough. Recently, novel elastomeric materials such as 
poly(1,8-octanediol-co-citrate) (POC) 2-5, poly(glycerol sebacate) (PGS) 6-11, and 
polycaprolactone fumarate (PCLF) 12have been developed and shown to have potential 
for soft tissue applications. Among them, POC has been shown to be a good candidate for 
cartilage tissue engineering 13due to its biocompatibility, biodegradability, and 
compressive properties. Cartilage applications require 3D designed porous architecture 
with well characterized mechanical and mass transport properties. Even though Kang et 
al. 13has shown that POC has potential as a base material for cartilage, the influence of 
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designed POC scaffold porosity on mechanical, mass transport and degradation 
properties has not been elucidated.  
Scaffold architecture, mechanical, and degradation properties are intimately 
coupled.  Scaffold pore architecture in addition to base POC material properties are the 
two determinants of effective POC scaffold mechanical properties.  Furthermore, since 
POC is mainly degraded by hydrolysis of its ester linkages 2, 3, scaffold architecture 
significantly affects scaffold degradation by directing fluid diffusion. To characterize the 
coupling of architecture and materials with mechanical, mass transport and degradation 
properties, we fabricated 3-dimensional (3D) scaffolds with varying porosities, 
characterizing the resulting mechanical, permeability, and degradation properties of 
different designs. Scaffold architecture is defined to include pore shape, pore size, and 
pore interconnectivity.  In order to solely examine the effects of porosity on scaffold 
property changes in this work, pore shape and pore size were kept constant. 
 
4.2 MATERIALS AND METHODS 
Synthesis of pre-Poly (1, 8 Octanediol-co-Citrate) (POC) 
All chemicals were purchased from Sigma-Aldrich (Milwaukee, WI). Poly(1,8 
Octanediol-co-Citrate) pre-polymer (pPOC) was synthesized following protocols 
described by Yang J et al. 2, 3, 5 with some curing process modifications. Briefly, 
equimolar amounts of citric acid and 1,8-octanediol were added to a 500 ml three-neck 
round bottom flask fitted with an inlet and outlet adapter. The mixture was melted at 
160–165 °C for 15-20 min under a flow of nitrogen gas while stirring. The temperature of 
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the system was subsequently lowered to 140 °C for 45 min with constant stirring to create 
a pre-polymer.  
Scaffold Design & Fabrication 
Previously developed image-based design processes and software were used to 
design 3D POC scaffold architectures 5, 14-16.  Porous POC scaffolds (6.35mm Diameter, 
4.0mm Height, 900μm interconnected cylindrical (C) or spherical pores (S), porosity = 
C32%, C44%, S50%, C62 %) were designed using custom IDL programs (RSI, Boulder, 
CO). For description purposes, the scaffold with a cubical pore design and 32% porosity 
is labeled as C32 (similar labeling for other cubical pore porosities, i.e. C44 = 44% 
cubical pore porosity), and the scaffold with a spherical pore design and 50% porosity is 
labeled S50. The details of POC solid and scaffold fabrications were previously reported 
by Kim et al. (2008). 5 In brief, wax molds with 3D-image based design architecture were 
built by a Solidscape PatternmasterTM machine and inversely solid freeform fabricated 
hydroxyapatite (HA) molds were prepared before curing pPOC into architecture scaffolds 
17.  Wax molds that embody the designed 3D architecture are fabricated first.  However, 
as the wax molds melt POC curing temperatures, secondary HA molds were created from 
the wax molds as the HA easily withstands the pPOC curing temperatures that reach over 
100oC.  pPOC was poured into the wells of a Teflon mold and HA molds were embedded 
within the pPOC. The pPOC/HA/Teflon mold unit was post-polymerized at 100°C for 1 
day followed by curing at 100°C for 3 days more with vacuum (-20in.Hg). The HA mold 
was removed using a decalcifying reagent (RDO, APEX Engineering Products Corp, 
Plainfield, IL) followed by incubation in water (Milli-Q water purification system, 
Billerica, Mass, USA) for 24 hr to obtain the final porous POC scaffolds (Figure 4.1). 
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Figure 3.3 in chapter 3 summarizes the complete procedure from design through 
fabrication and evaluation.   
Mechanical Tests 
For scaffold unconfined compression tests, seven porous scaffolds from each 
design were tested in compression (Alliance RT/30 electromechanical test frame, 50N 
load cell with 0.5% error range, MTS Systems Corp., MN) and TestWorks4 software 
(MTS Systems Corp., MN) was used to collect data during compression testing. 
MATLAB (The MathWorks Inc., MA) software was used to fit a nonlinear elasticity 
model, T = A[eBΕ – 1], where T is the 1st Piola-Kirchoff stress, E is the large strain, and A 
and B are constants fit to data.. Specifically, the sum of least square error between the 
model stress and experimental stress was minimized using the LSQNONLIN 
minimization program in the MATLAB optimization toolbox.  Tangent moduli were 
calculated at 1, 10, 30, and 50% strain from fit data 18.   All residuals between model and 
experimental stress were below 1%. The compressive Young’s modulus of 62% porous 
scaffolds (N =4, 0.1M NaOH degradation samples) was determined from the initial slope 
of the stress–strain data (10-20% strain range) obtained from compression tests at a 
crosshead speed of 2 mm/min. The initial height of each scaffold was measured with an 
electronic caliper.  
To determine if POC exhibited viscoelastic properties, confined compression tests 
were performed. The same compression test frame as for the unconfined test was used 
except that the sample was confined by acrylic confined chamber similar to the one 
described in 19-23with a constant chamber temperature of 37°C.  A 6.35mm diameter 
porous metal indenter was used for compression instead of a regular fixed metal platen. 
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Ten solid cylinders (6.35mm in diameter, 4.0mm in height) with the same curing 
conditions as other scaffolds were tested and the resulting data was fit to the nonlinear 
elastic model. 
Tensile mechanical tests were conducted according to ASTM D412a on the same 
test frame equipped with 500N load cell. Briefly, the dumbbell-shaped sample (33x6x2.0 
mm,) was pulled at a rate of 2 mm/sec. Assuming POC to be incompressible, the tensile 
tests were fit to a Neohookean nonlinear elastic model (Holzapfel, G. Nonlinear Solid 
Mechanics, Wiley; 1st edition) 24 of the form: 
( ) ( )2 2 211 2 3 1 2 3, , 2W
μλ λ λ λ λ λ= + +  
Where W is the strain energy function, λi are principal stretch ratios, and μ1 is a model 
constant determined by fitting the model to experimental data.  The Neohookean model 
was fit to experimental data by first deriving the 1st Piola-Kirchoff model stress.  The 
least square error between the model stress and 1st Piola-Kirchoff experimental stress 
was minimized using the MATLAB unconstrained minimization function FMINUNC.  
The Baker-Ericksen inequality (required for physical stability of the model constants) 
was calculated for each fit and found to be satisfied. 
Porosity and Permeability Measurements 
 
Seven scaffolds from each porosity were scanned in air using a MS-130 high 
resolution μCT scanner (GE Medical Systems, Toronto, CAN) at 19 μm voxel resolution, 
at 75 kV and 75 mA. The porosity of each specimen was calculated by defining a region 
of interest that encompassed the entire scaffold and an appropriate threshold level was 
applied to delineate the solid POC material using GEMS Microview software (GE 
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Medical Systems, Toronto, CAN). All porosity scanning was performed before 
mechanical tests to avoid any artifacts due to compression. Also, any possible residuals 
of HA were checked by μCT images by applying a threshold level of HA. The intensity 
threshold of POC is -510 and that of HA is 2000-2500 at grayscale values of Micro-CT 
images viewed by GEHC MicroView.  By applying different threshold values, any HA 
residual within the POC scaffold can be determined.   
Scaffold permeability (N=7, each design) with and without composite Hyaluronic 
Acid (HyA)/collagen I (Col I) gel was measured using a previously built flow chamber 25. 
Permeability was calculated as average mass flow from Bernoulli’s equation (with a 
frictional loss correctional term) 23 with Darcy’s Law used to calculate permeability. 
Permeability of scaffolds with hydrogels was measured to mimic cell loading conditions 
in vitro or in vivo.  
Chondrocytes were seeded into 3D scaffolds by first suspending the cells in media 
with composite HyA/Col I gels and then pushing the gel into the 3D scaffolds 26. The 
gelation procedure is as follows: 625μL of Col I (stock concentration: 8.37mg/mL diluted 
to 6mg/ml with filtered sterile 0.02N Acetic Acid; BD Bioscience Discovery Labs, San 
Jose) with 62.5 μL HyA (stock concentration: 3 mg/mL in 1.5M sodium chloride (NaCl), 
molecular weight 2.4~3 million Da; Hyalogic LLC, Edwardsville, KS) were well-mixed. 
The pH of the HyA/Col I suspension was increased with the addition of 9μL of 0.5N 
sodium hydroxide with 220 mg/mL sodium bicarbonate to initiate gelation. As soon as 
0.5N sodium hydroxide is added to HyA/Col I gel mixture, gel contents were evenly re-
suspended.  Hydrogel mixtures were then dripped down onto pre-prepared sterile POC 
scaffolds until POC scaffolds were fully soaked and filled with gels up to the top surface.   
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This was followed by incubation at 37°C for at least 30 min to solidify gels further. The 
gel mixture volumes used for each design varied depending on porosity of each design. 
Roughly, 90μl, 110μl, 120 μl and 150μl of gel mixtures were used for 32, 44, 50 and 62% 
porous scaffolds respectively. The permeabilities are presented as mean ± standard 
deviation. 
In-Vitro Scaffold Degradation  
 
Four solid cylinders and four porous scaffolds (6.35mm in diameter, 4.0-4.3mm 
thickness) for each design (except S50) were placed in a tube containing 10ml phosphate 
buffer saline (PBS- pH 7.4) for 3 weeks.  Additionally, nine porous scaffolds for each 
design were degraded by 0.1M NaOH for 9, 24, 33hr at 37°C to rapidly obtain relative 
degradation rates among samples. After incubation, samples were washed with water and 
oven-dried at 50°C for 24 hours. Mass loss was calculated by comparing the initial mass 
(W0) with the mass measured at a given time point (Wt), as shown in the following 
equation: Mass loss = [(W0 – Wt)/ W0]*100%. The results are presented as means ± 
standard deviation. For NaOH degradation, four 62% porous scaffolds were mechanically 
tested before and after degradation 2, 3, 5. 
In Vitro Cell Culture & Histology 
Porcine chondrocytes (pChon) were isolated and seeded onto scaffolds following 
the methods previously published 26with some modifications.  In short, cells were re-
suspended at a density of 3.5x106 cells/mL in 600μL of composite HyA/Col I with ~60μL 
of culture medium. Collagen gels are used as a cell carrier for POC scaffolds to provide 
better cell distribution within scaffold pores.   5% hyaluronic acids were added to provide 
a favorable environment for chondrocyte differentiation/proliferation based on our 
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previous work26. The remaining steps were the same as previously described (See 
Porosity and Permeability Measurements section). Scaffolds seeded with pChon were 
cultured with chondrogenic medium (basal medium (DMEM, 10% fetal bovine serum 
(FBS), 1% P/S, Gibco) supplemented with 50 mg/mL 2-phospho-L-ascorbic acid 
(Sigma)), 0.4mM proline (Sigma), 5 mg/mL insulin (Gibco), and 0.1mM non-essential 
amino acids (Gibco)). Chondrocytes were cultured for 3 weeks under gentle agitation on 
an orbital shaker and the media was changed every other day. All polymer samples were 
sterilized by incubation in 70% ethanol for 30 min followed by UV light exposure for 
another 15 min each side before plating cells. After sterilization, all scaffolds were briefly 
rinsed with PBS followed by soaking in basal medium to neutralize. Cell culture was 
maintained in a water-jacket incubator equilibrated with 5% CO2 at 37°C for 4 weeks. 
For histology, constructs were fixed in 10% buffered formalin overnight, dehydrated with 
a series of graded ethanol, and embedded in paraffin. Tissue sections were stained with 
safranin-O (saf-O), to assess cell distribution, morphology, and sGAG staining as a 
measure for cartilage application. Three slides (4 sections/slide) were obtained from the 
center of each scaffold (top to bottom and left to right). 
Statistical Analysis 
Data are expressed as mean ± standard deviation. The statistical significance 
among different porosities was calculated using linear regressions and one way ANOVA 
with post-hoc comparison (Tukey). Data were taken to be significant when a P-value of 





Scaffold Fabrication and Mechanical Tests 
 
Figure 4.1 shows the digital pictures (A) and micro-CT images (top (B) and side 
views(C)) for successfully fabricated four different 3D scaffold designs. The porosity of 
each scaffold was quantified using micro-computed tomography (microCT) images. The 
micro-CT calculations revealed that the porosities of scaffolds (32.7 ± 2.27, 44.0 ± 1.92, 
50.0 ± 1.62, 62.3 ± 2.36%) were slightly less than that of the design files (26, 45, 52, 66%, 
respectively) except the 32% design, yet each scaffold maintained its pore diameters (902 
± 6 μm) relative to designed pore sizes (900μm).  
 
Figure 4.1: The digital images (A) and microCT images of top (B) and side (C) view for 
successfully fabricated 3D-designed POC scaffolds. The letter ‘C’ indicates cylindrical pore 
shape and ‘S’ indicates spherical pore shape. The following number represents the porosity of 
each scaffold design.  
 
 
Figure 4.2 (a) shows that unconfined compressive tests of POC solid and 
scaffolds produced stress–strain curves characteristic of elastomeric materials. As 
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porosity of scaffolds increased, tangent moduli decreased. Solid and 32% porous 
scaffolds exhibited non-linear behavior with increased strain level while 44, 50 and 62% 
porous scaffolds were more linear, which suggests that there is a possible threshold 
porosity which determines the behavior of nonlinearity. Figure 4.2 (b) is an example of 
nonlinear model fit for a 44% porous scaffold. 





























(b) Nonlinear model fit of compression test 
 
Figure 4.2: (a) a tangent moduli (MPa) vs. Strain (%) curve from unconfined compression tests 
and nonlinear model fit (N=7, p<0.05 for all porosities) (b) an example of compressive test data 
and corresponding nonlinear model fit for a 44% porous scaffold 
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Table 4.1 and 4.2 summarize tangent moduli and compressive young’s moduli for 
each design at various strain levels (%). Porous POC scaffolds could provide load bearing 
within cartilage defect sites as their mechanical properties fall either within or close to the 
ranges of native cartilage’s compressive young’s moduli. However, when implanting 
scaffolds in vitro into in vivo or actual defect sites, it is probably better to choose a 
slightly lower range of designed scaffold stiffness as the tissue matrix will add more 
stiffness to the overall tissue/scaffold constructs after cell infiltration and tissue in-growth. 
For this application, we also need to consider other factors such as permeability, surface 
area, pore shape etc., which will affect degradation and tissue matrix formation along 
with the initial stiffness of scaffolds. In the following chapters, two designs (S50 and 
C62) were chosen to compare their performance for in vitro and in vivo subcutaneous 
models of cartilage regeneration.  These two designs have distinctively different 
permeabilities mainly due to pore shape differences, but have similar porosity, pore size 
and initial mechanical stiffness (tangent modulus) at 10% strain (Table 4.2) which is 
close to native cartilage equilibrium modulus. 
 
Tangent Moduli (MPa) 
(N=4-7) Scaffold Design (Pore Shape, Porosity)   
Strain 
(%) Solida C32%b C44%c S50%d C62%e 
1 0.674 ± 0.147 0.372 ± 0.048 0.327 ± 0.046 0.199 ± 0.010 0.147 ± 0.046
10 0.933 ± 0.209 0.523 ± 0.061 0.355 ± 0.037 0.235 ± 0.004 0.170 ± 0.052
30 1.922 ± 0.475 1.115 ± 0.123 0.427 ± 0.035 0.344 ± 0.019 0.244 ± 0.089
50 3.977 ± 1.113 2.392 ± 0.343 0.519 ± 0.082 0.504 ± 0.062 0.365 ± 0.182
 Table 4.1: Tangent moduli (MPa) of POC sold and scaffolds at various strain (%) presented as 










Solid 0.93-1.92 1.37 ± 0.32 
C32 0.52-1.12 0.78 ± 0.08 
C44 0.35-0.43 0.39 ± 0.03 
C62 0.17-0.24 0.24 ± 0.04 
S50 0.13-0.40 0.29 ± 0.01 
Human Articular Cartilage* - 0.4-0.8 
Table 4.2: Summary of tangent moduli and compressive young’s moduli at 10% strain for solid 
and all scaffold designs with comparative value of human articular cartilage, which was measured 
by Moutos et al.35.  
 
 
In cartilage engineering, many researchers have tried to design and fabricate 
scaffolds with stress relaxation properties mimicking the poroelastic biomechanics of 
cartilage. In order to determine if POC solid cylinders or scaffolds were also either 
viscoelastic or poroelastic, we have performed confined compressive tests as described as 
19-21. Results of stress-relaxation tests demonstrated that POC does not exhibit significant 
stress relaxation and thus can be considered as a nonlinear elastic material and not 
viscoelastic.  Porous scaffolds also did not demonstrate stress relaxation, indicating that 
pores of the designed size did not exhibit poroelastic behavior.  
Tensile test data for solid coupons exhibited nonlinear elastic behavior and was fit 
well with the Neohookean model (Figure 4.3).  The coefficients differed with synthesis 
conditions, with 1 day of curing at 100oC followed by 4 days at 120oC giving a μ1  value 
of 0.172 ± 0.022 MPa while 5 days of 100oC giving a μ1 value of 0.142 ± 0.013 MPa.  
The coefficient of determination for all fits was greater than 0.99, indicating good fits for 
the nonlinear model27.  In addition, all coefficients satisfied the Baker- Eriksen criteria 
for material stability.  This demonstrates higher curing temperature gives an overall 
stiffer behavior for solid POC.  These results also demonstrate that POC can be 
considered as a nonlinear elastic elastomeric material.  
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Figure 4.3: An example of tensile test data and corresponding Neohookean model fit  
 
The major difference between linear and non-linear elasticity is that in linear 
elasticity the material modulus is constant over the entire deformation while for non-
linear elasticity the modulus will change with deformation.  In general, soft tissues 
including cartilage are shown to exhibit strain stiffening in which the tangent modulus 
increases with increasing strain.27 If we accept the fact that mechanical strain magnitude 
can affect tissue regeneration in that cells may modulate matrix synthesis in response to 
strain levels, matching only the linear versus non-linear behavior could have significant 
consequences for tissue regeneration.  If only a material exhibiting linear behavior is used 
for a scaffold, we are faced with the choice of matching either the low modulus under 
small strains or the higher modulus under large strains.  Matching the small strain low 
modulus may provide sufficient strain to stimulate cells under small deformation, but if 
large deformations are seen than the cells may be damaged.  If we match the large 
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deformation higher modulus with a linear scaffold, this may protect the chondrocytes 
under large strain, but may shield the chondrocytes for sufficient mechanical stimulus 
under small strain.  A nonlinear material that can match both regions may provide better 
strain microenvironments to chondrocytes.  Of course, this is currently conjecture, but 
such hypotheses can only be tested if we can engineer scaffolds with both linear and 
nonlinear elastic behavior.  
Based on previous reports29-34, aggregate modulus of human articular cartilage 
ranges from 0.1 to 3.10 MPa and unconfined compressive modulus ranges from 0.4 to 0.8 
MPa with 10~30% strain depending on ages and health conditions. POC scaffold tangent 
moduli range from 0.13 MPa (62% porosity at 1% strain) to 1.12 MPa (33% porosity at 
30% strain).  Thus, POC tangent moduli encompass the range of human articular 




Table 4.3 shows permeability of scaffolds without and with hydrogels for various 
porosities.  Generally, it is known that an increase in interconnected porosity results in an 
increase in permeability. However, permeability depends not only on scaffold 
architecture, but also on base materials due to the presence of micropores, hydrophilicity, 
and number of crosslinkages. The spherical pore shaped scaffold shows the lowest 
permeability out of all designs despite having higher porosity than the 32 and 44% porous 
scaffolds.  This is probably due to the small pore to pore necking areas and the irregular 
shape of the pores compared to the regular cylindrical channel type of pores. 
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Design (N=7-9) S50, Low C32 C44 C62, High 
Pore Size (μm) 902 ± 6 
Pore Shape Spherical Cubical 
Porosity (%) 50.0 ± 1.6 32.7 ± 2.3 44.0 ± 1.9 62.3 ± 2.4 
Expt Permeability  
without gel (10-7 m4/N·s) 3.5 ± 1.0 5.4 ± 1.2 29.8 ± 2.1 47.4 ± 1.2 
Expt Permeability  
with gel (10-7 m4/N·s) 1.7 ± 0.5 3.11 ± 0.4 3.7 ± 0.3 4.1 ± 0.7 
Table 4.3: Permeability of scaffold designs with and without collagen I gel is presented based on 




Permeability with and without gel
y = 1.3666x - 35.306




























Figure 4.4: POC scaffold permeability with and without gel for different porosity designs is 
accompanied with a linear regression lines (N=7, p<0.05). 
 
 
Without gels, permeability increased dramatically with a linear regression 
coefficient of 0.1524 whereas permeability did not vary substantially between different 
designs with gel, having a linear regression coefficient of 0.0032 (Figure 4.4). The 
differences in permeability between cases with and without gel become more critical 
when cells are seeded onto scaffolds for tissue in-growth. Even though scaffold 
architectures may have significantly different permeabilities, the use of gels for scaffold 
cell seeding may temporarily cause a significant drop in permeability.  However as the 
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relatively quick hydrogel degradation will cause a steady increase in scaffold 
permeability.  
 
In Vitro Degradation 
 
Yang J et al. 3demonstrated that the degradation rate could be adjusted by varying 
synthesis and fabrication conditions of POC solids.  They demonstrated that increased 
curing temperature and post-polymerization time resulted in a higher tensile strength and 
a higher Young’s modulus due to higher crosslink density and fewer un-reacted monomer 
groups, but those synthesis conditions tend to make a material that degrades slower. 
However, they did not investigate how different scaffold architectures could affect POC 
degradation and associated changes in compressive mechanical properties. The data for 
degradation of POC scaffolds with various porosities are presented in Figure 4.5. Both 
fast (0.1M NaOH) and slow (PBS) degradation showed a similar trend in terms of 
different degradation profiles for each design.  
 









































Figure 4.5: Degradation studies of POC solid and scaffolds with various porosities in (a) 0.1M 
NaOH solution at room temperature (N=9, each porosity) (all designs are statistically significant 
each other at 32h; p≤0.05) and (b) PBS at 37 °C for 3 weeks (N=4, each porosity) (all designs are 
statistically significant each other; p≤0.05). 
 
 
Degradation, perhaps due to both bulk and surface erosion for scaffolds, was 
highly dependent on scaffold porosity and permeability (Figure 4.5).  Both the 32% and 
44% scaffolds showed loss of architecture and complete pore collapse after 3 week 
degradation in PBS (Figure 4.5(b)). Of note, only the cylindrical pored scaffold designs 
were used in the 3 week PBS degradation study as we wanted to see a general profile of 
degradation due to porosity difference (without any pore shape effects taken account). 
But for the 0.1M NaOH accelerated degradation study, the spherical pore design (S50) 
was also included to see a general profile compared to other cylindrical pored designed 
scaffolds as well (Figure 4.5 (b)). All designs showed loss of architecture after 24 hours 
in 0.1M NaOH.  A significant portion of the 62% porous scaffold showed pore collapse, 
although the top layer of the scaffold maintained the pore structure.  Based on these 
results, it is not possible to make a definitive conclusion as to the mechanism of 
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degradation, bulk versus surface.  The nature of the pore collapse suggests that both 
mechanisms may be involved.   
In this study, the lower porosity scaffolds with thicker struts showed a greater 
degree of collapse than the 62% porous scaffolds with the thinnest struts.  If the sole 
mechanism of degradation was surface erosion, one would expect that the 62% porous 
scaffold with the thinnest struts would collapse sooner, as the struts would lose thickness 
and geometry first.  However, the thinnest struts did not collapse first, suggesting that 
bulk degradation with autocatalysis could play a role in POC porous architecture 
degradation.   
Tangent Young's modulus (10-20% strain range) for 62% scaffolds decreased 
from 0.070 to 0.037 MPa after PBS degradation. In Figure 6(a), initial degradation rate 
did not seem to vary much depending on different porosities, however permeability 
effects were associated with higher degradation rates at longer time periods as determined 
by weight loss.  
 
Biocompatibility Evaluation 
Cartilaginous-like tissue was formed within POC scaffolds and chondrocytes in 
lacuna were evenly distributed within the tissue.  These cells maintained a rounded form 
indicating maintenance of the chondrocytes phenotype (Figure 4.6 (B)). The void spaces 
shown in Figure 4.6 (A & B) are areas occupied by POC scaffolds. The chondrocytic 




Figure 4.6: Histological image of a POC scaffold with chondrocytes cultured for 4 weeks. The 
sections were stained with safranin-O/Fast Green counter staining. Stars indicate areas occupied 




4.4  Discussion and Conclusions 
 
The success in development of novel biodegradable polymers for scaffolds relies 
on appropriate mechanical properties, degradation rates, and biocompatibility.  It is 
critical to understand how scaffold architectures affect mechanical, mass transport and 
degradation properties of scaffolds as these properties will significantly influence tissue 
regeneration.  A typical solid elastomer shows nonlinear behavior in compression and 
tension3. However, the degree of nonlinearity in compression depended significantly on 
scaffold porosity. As porosity increased, nonlinear behavior decreased and 44, 50 and 
62% porous scaffolds had a trend towards more linear behavior without any significantly 
noticeable pore shape effect. Due to the inherent POC nonlinear behavior, solid and 32% 
porous scaffolds showed a distinct increase in compressive tangent moduli compared to 
higher porosities.  
Permeability showed a more complex relationship to scaffold architecture, 
depending on the presence or absence of gel cell carriers.  Scaffold permeability without 
gel showed a linear relationship with porosity (Figure 4.4) for the same pore shape; 
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however the effect of pore shape on permeability seemed to be more influential than 
porosity such that 50% porous spherical pore shape scaffold had the lowest permeability 
despite not having the lowest porosity. Based on permeability without gel, we may 
deduce that water could penetrate through both gel and POC itself at similar rates because 
the regression coefficients did not depend significantly on porosity when the scaffold 
contained gel.  This data is especially important when considering seeding cells with gels 
onto POC scaffolds. The degradation rates were also highly dependent on porosity and 
permeability especially within the same pore shape designs. 62% porous scaffolds 
exhibited faster and accelerated degradation rates with time whereas 32, 44 and 50% 
porous scaffolds showed a steady linear increase in degradation rates with time, which 
suggests that pore shape or permeability does not play much in the degradation profiles 
especially when there is no cell involved (Figure 4.5a). Data for bulk degradation with 
PBS for 3 week in vitro showed an interesting phenomenon in that only 62% porous 
scaffolds maintained some porous architecture at 3 week time point while other designs 
all exhibited distorted inner architectures due to degradation. For compressive modulus, 
Young’s modulus of 62% porous scaffolds was decreased by up to 47% after 3 weeks.  
In vitro histological evaluation of POC scaffolds with gel confirmed that they 
supported synthesis of cartilage matrix by chondrocytes. Also, chondrocytic morphology 
of scaffold was also maintained showing its promising potential as a scaffold for cartilage 
regeneration. 
The above characterization provides us with a comprehensive understanding of 
the physical properties of POC scaffolds and proves that POC scaffolds can be fabricated 
successfully with desired porosity, permeability, and architectures via SFF fabrication. 
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POC scaffolds hold promise for serving as a supporting template for cartilage and other 
soft tissue regeneration with tunable biodegradation and nonlinear compliant mechanical 
properties. Also, this characterization provides us with a foundation to study cell behavior 
and tissue in-growth on different scaffold architectures in order to elucidate the relation 
between scaffold architectures, mechanical properties, biodegradation, and consequent 
cell growth and morphology, and matrix formation, which will be discussed in next 
following chapters.  
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THE EFFECTS OF 3D POC SCAFFOLD  





 The field of tissue engineering continues to advance with the discovery of new 
biomaterials, growth factors, and scaffold fabrication techniques. The use of 
biodegradable scaffolds as a template on which cells differentiate, proliferate, and grow 
new tissues has been crucial in the recent advances of cartilage tissue engineering.  
However, there is still no definitive conclusion as to how scaffold design factors affect 
chondrogenesis.  The choice of scaffold material and geometry will determine the 
effective scaffold structural and mass transport properties that can significantly influence 
cartilaginous tissue regeneration. As thoroughly reviewed in chapter 3, the structural, 
mechanical and mass transport properties of scaffolds are determined by combination of 
many factors such as pore size, pore shape, porosity, pore interconnectivity, permeability, 
scaffold surface area, scaffold effective stiffness and scaffold material.   These factors 
cannot be rigorously controlled unless scaffolds are designed with specific architecture 
and this architecture is realized by controlled fabricated techniques such as solid freeform 
fabrication (SFF). Many previous studies examining the effect of scaffold designs on 
chondrogenesis have not rigorously controlled scaffold design parameters like pore shape 
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and permeability, making it difficult to assess what specific design factor had the most 
influence on chondrogenesis 1-8.  
 Based on our own previous work 2, designed PCL scaffolds with lower 
permeability enhanced chondrogenesis using primary chondrocytes.  However, this study 
examined one pore shape in polycaprolactone (PCL) scaffolds and did not examine 
changes in scaffold/tissue construct mechanical properties with tissue in-growth.   We 
also have demonstrated that  chondrocytes cultured in ellipsoidal pores produced more 
robust ECM with higher sGAG concentrations in comparison to cubical pores due to 
increased aggregation of local chondrocytes inside each pore of poly (propylene 
furmarate) (PPF) 9,10.   However, the permeability of these scaffolds was not 
experimentally characterized, making it difficult to determine if permeability was 
significantly different between designs. Poly(1,8-octanediol-co-citrate) (POC) has been 
shown to be a good candidate for cartilage tissue engineering due to its biocompatibility, 
biodegradability, and mechanical properties 11-13, yet there is no data on how POC 
scaffolds with rigorously controlled pore architectures (i.e. pore shape, pore size, 
permeability, and regular pore interconnectivity) influence chondrogenesis and how 
mechanical properties of POC scaffolds change with tissue development.   The goal of 
this study was to determine how POC scaffolds with designed and rigorously controlled 
scaffold permeability and pore shape influence chondrogenesis as determined by 
chondrogenic gene expression, matrix production and tissue/scaffold mechanical 
properties.  Scaffold design parameters including permeability, pore shape, and surface 
area were controlled by computational design, and control of these parameters in the final 
fabricated scaffolds was verified by micro-computed tomography (micro-CT). 
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Additionally, since type I collagen gel was used as a cell carrier within the POC scaffolds, 
we determined how collagen I gel concentration affected chondrogenesis prior to 
assessments of the 3D tissue/scaffold constructs.   
 
5.2 Materials and Methods 
Collagen I/Hyalurinoic Acid (Hya) Hydrogel  
 High concentration collagen I hydrogels and hyaluronic acid were purchased from 
BD Bioscience Discovery Labs (San Jose, CA) and Hyalogic LLC (Edwardsville, KS) 
respectively. High concentration collagen I hydrogels were diluted with 0.02N sterile 
acetic acid for desired concentration (9.92mg/ml, 6mg/ml, and 4mg/ml) and 5% (w/w) 
hyaluronic acid was combined with collagen I hydrogel based on our previous results 
showing that collagen I gel with 5% hyaluronic acid enhanced chondrogenesis.  
Scaffold Design & Fabrication 
 Poly (1, 8 Octanediol-co-Citrate) pre-polymer (pPOC) was synthesized as 
previously described (chapter 4) 13. The scaffolds were designed and fabricated in the 
same way as previously described in chapter 4. Porous POC scaffolds (6.35mm Diameter, 
4.0mm Height), with 900μm interconnected spherical or cylindrical pores, (porosity: 
50 %( spherical (S50)), 62 %( cubical (C62)), permeability: High (C62) = Low x 13.5 
(S50)) were designed using custom IDL programs (RSI, Boulder, CO).  
Scaffold Characterizations  
 
 For mechanical tests, four to six porous scaffolds or tissue grown scaffolds per 
each design were tested in unconfined compression (Alliance RT/30 electromechanical 
test frame, 50N load cell with 0.5% error range, MTS Systems Corp., MN) and 
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TestWorks4 software (MTS Systems Corp., MN) was used to collect data during 
compression testing. The data was analyzed and processed the same way using the 
nonlinear elasticity model fit as previously described in chapter 4. Tangent moduli (=AB 
eBε) were calculated at 1, 10, and 30% strain from fit data and all residuals between 
model and experimental stress were below 1%. Also, all porosity and permeability 
measurements were performed under the same conditions as described in chapter 4 
following the same methods.  
In Vitro Cell Culture & Histology 
 Primary porcine chondrocytes (pChon) were isolated and seeded onto scaffolds 
following the methods previously published with some modifications 19.  The detailed 
gelation and cell seeding procedure was as follows: 770μL of Col I hydrogels (stock 
concentration: 9.92, 6, or 4mg/mL; BD Bioscience Discovery Labs, San Jose, CA) with 
77 μL HyA (stock concentration: 3 mg/mL in 1.5M sodium chloride (NaCl), molecular 
weight 2.4~3 million Da; Hyalogic LLC, Edwardsville, KS) were well-mixed. The pH of 
the HyA/Col I suspension was increased with the addition of 11μL of 0.5N sodium 
hydroxide with 220 mg/mL sodium bicarbonate to initiate gelation. As soon as 0.5N 
sodium hydroxide is added to HyA/Col I gel mixture, gel contents were evenly re-
suspended.  Chondrocytes at a density of ~30x106 cells/mL well-suspended in ~50μL of 
culture medium were well-mixed with composite hydrogels immediately. The 
cell/hydrogel mixtures were then dripped down onto pre-prepared sterile scaffolds placed 
inside the well of a sterile Teflon mold until scaffolds were fully soaked and filled with 
gel to the top surface.   This was followed by incubation at 37°C for at least 30 min to 
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solidify gels further. Roughly, 121 and150μl of cell/gel mixtures were used for 50 and 
62% porous scaffolds respectively in order to keep the same cell density per volume. 
 Scaffolds seeded with pChon were cultured with chondrogenic medium (basal 
medium (DMEM, 10% fetal bovine serum (FBS), 1% P/S, Gibco) supplemented with 50 
mg/mL 2-phospho-L-ascorbic acid (Sigma)), 0.4mM proline (Sigma), 5 mg/mL insulin 
(Gibco), and 0.1mM non-essential amino acids (Gibco)) in 12-well plates. Chondrocytes 
were cultured for 0 (1d), 2 or 4 weeks under gentle agitations on an orbital shaker and the 
media was changed every other day. All POC scaffolds were sterilized in an autoclave 
and presoaked in DMEM for 24 hours and briefly rinsed with PBS prior to cell seeding. 
Cell culture was maintained in a water-jacket incubator equilibrated with 5% CO2 at 
37°C. For histology, constructs (N=3/material) at each time point were fixed in 10% 
buffered formalin overnight, dehydrated with a series of graded ethanol, and embedded in 
paraffin. Tissue sections were stained with safranin-O/Fast Green counterstaining, to 
assess cell distribution, morphology and sGAG production. Eight to ten slides (4 
sections/slide) were obtained from the center of each scaffold (top to bottom and left to 
right). 
sGAG and DNA quantification 
 
 For comparing the effects of collagen I gel concentration on chondrocytes, at 7 
days sGAG and DNA contents of collagen/cell hydrogels (N=4-5/concentration) were 
quantified using the same methods as for scaffolds. At 2 and 4 weeks, scaffolds (N=8) at 
each time point or each design were removed from culture, finely diced, and placed 
immediately into 1ml of pre-prepared papain solution (papain (10 units/mg: Sigma 
Aldrich #P4762), 1X PBS, 5mM cysteine HCL, 5mM EDTA, pH=6.0; mixed for 2h at 
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37°C then filtered). Scaffolds were digested in papain solution for 24 hours at 60°C then 
immediately stored at -20°C. The digested tissue-scaffold solution was analyzed by a 
dimethylmethylene blue (DMMB) assay. Briefly, 10ul of sample was mixed with 200ul 
of DMMB reagent and absorbance was read on a plate reader (MultiSkan Spectrum, 
Thermo, Waltham, MA) at 525 nm. A standard curve was established from chondroitan 
6-sulfate from shark (Sigma, C4384) to compare absorbance for samples 20,21. The total 
sGAG were normalized by DNA content which was measured using Hoechst dye 33258 
methods (Sigma, #DNA-QF). In brief, 10ul digested sample was added to 200ul pre-
prepared Hoechst solution and read with excitation at 355nm and emission at 460nm 
(Fluoroskan Ascent FL, Thermo, Waltham, MA) in a 96 well plate. Readings were 
compared to standard curves made from calf thymus DNA (Sigma, #DNA-QF) 22. 
 Quantitative-PCR 
 
 Cartilage specific gene (Type II collagen & aggrecan),chondrocyte de-
differentiation marker gene (Type I & X collagen) and glycerol-dehyde-3-phosphate 
dehydrogenase (GAPDH) gene expression were determined by quantitative PCR (qtPCR) 
using a Gene Amp 7700 sequence detection system (Applied Biosystems, Foster City, 
CA USA). For different concentration of collagen gels (N=4-5), only Type II & I 
collagens and aggrecan gene expressions were quantified with normalization with 
GAPDH at 7 days. Collagen hydrogels or scaffolds (N=8-10/design) at each time point 
were removed from culture, briefly rinsed with PBS, chopped into smaller pieces, and 
then placed into RNAlater (Qiagen, Inc., Valencia, CA). Scaffolds immersed in RNAlater 
were kept at 4°C for 24 hours and stored at -20°C until analysis. Total RNA was 
extracted using a RNeasy Mini Kit (Qiagen, Inc., Valencia, CA) and reverse transcription 
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was carried out using the SuperScript First-Strand synthesis kit (Invitrogen). A positive 
standard curve for each primer was obtained by qtPCR with serially-diluted cDNA 
sample mixtures. Samples were prepared using a Taqman universal PCR master mix 
(Applied Biosystems) and custom designed porcine primers. The quantity of gene 
expressions was calculated with standard samples and normalized with GAPDH or/and 
low permeable design (S50).  
Statistical Analysis 
 
 Data are expressed as mean ± standard deviation. The statistical significance 
among different materials was calculated using linear regressions and one way ANOVA 
with post-hoc comparison (Tukey) or student t-test using SPSS software (SPSS for 
Windows, Rel 14.0. 2005 Chicago: SPSS Inc.). Data were taken to be significant, when a 





The effects of collagen I gel concentration on chondrogenesis 
 Before examining the design effects of scaffolds on chondrogenesis in vitro, we 
wanted to optimize the microenvironment conditions for cells to grow in 3D POC 
scaffold. Previously, the effects of hyaluronic acid combined with collagen I gel have 
been elucidated in our lab 9, yet the effects of collagen I gel concentration on 
chondrogenesis using chondrocytes has not been studied. As our goal for this study was 
to provide a favorable microenvironment for chondrocytes to form cartilage tissues in our 
3D scaffolds, the effects of collagen I gel concentrations on chondrogenesis were in terms 
of matrix production and the messenger RNA expression relevant to chondrogenesis.  
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When comparing 4mg/ml, 6mg/ml, and 9.92mg/ml collagen I gel concentrations (Figure 
5.1(top)), there was a significant difference in terms of matrix production between 
6mg/ml and 9.92mg/ml only with 6mg/ml Col I gel supporting formation of the highest 
amount of matrix. 
 
 
Figure 5.1: The effects of collagen I gel concentration on porcine chondrocytes for 7 days are 
evaluated by quantification of sGAG/DNA and mRNA expressions. The content of sGAG/DNA 
(top) represents the overall matrix production for different concentration of collagen I gels (N=4-
5, *p≤0.05, One way ANOVA). The relative mRNA expression (bottom) is normalized to 




 However in mRNA gene expression (Figure 5.1 (bottom)), lower concentrations 
of Col I gels caused less de-differentiation indicated by an increasing trend of the ratio of 
collagen 2 gene expressions to collagen 1 gene expression of cells (Col2/Col1, known as 
“chondrocyte differentiation index (DI) 23,24). Aggrecan expression was not significantly 
affected by Col I concentration although the 4mg/ml concentration showed a trend for 
higher aggrecan expression. Overall, 4mg/ml seemed to be the best concentration out of 
three concentrations and our results showed that lower Col I gel is preferred by 
chondrocytes in terms of differentiation. However, the gelation time of 4mg/ml collagen I 
gel was too long to keep cells evenly distributed from top to bottom (cells tended to sink 
down at the bottom before complete gelation), thus we decided to use 6mg/ml instead of 
4mg/ml still for evenly distributed cell seeding in 3D POC scaffolds.   
Scaffold design, fabrication, and Mechanical characterization 
 Three dimensional (3D) scaffolds were fabricated from poly (1, 8 Octanediol-co-
citrate) (POC), which imparted variations in pore shape (either spherical or cubical) while 
maintaining a consistent pore size and a regular interconnectivity (Table 5.1). Example 
scaffolds are shown in Figure 5.2. For description purposes, the scaffolds with a cubical 
pore design and 62% porosity are labeled C62, and the scaffolds with a spherical pore 









Table 5.1- Scaffold Descriptions   
Design Name (N=8) S50, Low* C62, High* 
Porosity (%) 50 ± 1.62 62 ± 2.36 
Permeability without gel (10-7 m4/N·s)** 3.51 ± 0.95 47.4 ± 1.15 
Permeability with gel (10-7 m4/N·s)** 1.72 ± 0.45 4.14 ± 0.73 
Surface Area (mm2)*** 288 ±38 243 ± 15 
Pore Shape Spherical Cubical 
Pore Size 900μm 900μm 
*Note that design names are based on its pore shape and porosity, for example ‘S’ in S50 is from ‘spherical 
pore shape’ and ‘50’ indicates its porosity. It is the same for C62 with ‘C’ from ‘cubical pore shape.’ Low 
and high are based on relative permeabilities.   
** Significant (p≤ 0.05, t-test)   
*** Not significant (p≤ 0.05, t-test) 
 
 
Figure 5.2: Digital pictures of two different scaffold designs 
 
 By varying pore shape and porosity, fabricated scaffold permeability was 
significantly different between designs (Low = 3.51 ± 0.95 × 10−7 m4/N s (S50), 
High = 47.4 ± 1.15 ×10−7 m4/N s (C62, 13.6 × Low) (t-test, p ≤ 0.05)). With collagen 
I/HyA hydrogel, scaffold permeability values all decreased from the original scaffold 
permeability as expected yet continued to exhibit a similar trend between designs (Low, 
High = 2.4 × Low). Since collagen gels degrade typically in a week, permeability without 
gel most likely represents the permeability of scaffolds at 2-4 weeks without tissue 
ingrowth whereas permeability with gel represents the scaffolds at 0 wk with initial cell 
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seeding. Thus, permeability is dynamically changing within the 4 week period.   However 
it is likely that the trend of different permeability between the different designs remains.  
Table 5.2(a) and (b) summarize the nonlinear model fit coefficients and compressive 
tangent moduli for different scaffold designs.  
 
Table 5.2(a) - T = A*(eBε-1) Nonlinear model fit coefficients & Tangent Moduli 
Empty Scaffolds Nonlinear model Coefficients 
Design\Coefficients or Strain (%) A B fval 
S50 0.11 ± 0.03 1.89 ± 0.36 8.88E-04 
C62 0.013 ± 0.004 4.34 ± 0.58 6.92E-04 
 
 
Table 5.2(b) - Tangent Moduli (MPa) at 1, 10, 30% Strain 
Design\Strain (%) 1 10 30 
S50 0.199 ± 0.010 0.235 ± 0.004 0.344 ± 0.019 
C62 0.057 ± 0.014 0.085 ± 0.021 0.201 ± 0.048 
 
























Figure 5.3(a): Comparison of compressive stress vs. strain model fit for low (S50) and high 




 As Figure 5.3(a) shows, the more porous scaffold, the more linear behavior with 
lower stiffness representing the reduction of POC material (which is nonlinear elastic) 
supporting load. Unlike the relation between porosity and stiffness, there was no 
significant trend or relation between permeability and scaffold stiffness. 
 
Table 5.3(a) - Model fit for scaffolds with cells:  




A B A B 
S50 2wk 0.003 ± 0.001 6.51 ± 1.08 0.060 ± 0.014 2.24 ± 0.41 
C62 2wk 0.003 ± 0.000 6.55 ± 0.37 0.024 ± 0.027 4.13 ± 2.08 
S50 4wk 0.023 ± 0.006 3.79 ± 0.23 0.28 ± 0.33 3.00 ± 1.15 
C62 4wk 0.011 ± 0.005 4.55 ± 1.26 0.114 ± 0.175 3.35 ± 1.65 
 
 
 Table 5.3(a) and (b), and Figure 5.3(b - c) summarize nonlinear model fit 
coefficients and compare compressive tangent moduli for different scaffold designs with 
or without cells at different time points (2 and 4 weeks).  
 
Table 5.3(b) - Tangent Moduli at 10% Strain  
Scaffold Design(N=4)\conditions Control Cells 
S50 2wk 0.038 ± 0.006 0.161 ± 0.005 
C62 2wk 0.042 ± 0.003 0.095 ± 0.061 
S50 4wk 0.125 ± 0.027 0.550 ± 0.045 
C62 4wk 0.072 ± 0.002 0.156 ± 0.055 
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Figure 5.3(b) Comparison of compressive stress vs. strain model fit of different scaffold designs 
for with or without cells (control) at 4 week time point. Control represents scaffolds that were 
NOT seeded with cells yet they were subjected to degradation by culture media over 4 weeks 
whereas scaffolds with cells represent that cells were seeded onto scaffolds and were subject to 
both degradation and tissue formation for 4 weeks. 
 
 
 Control here represents scaffolds seeded with gels only which were subjected to 
the same conditions as those scaffolds seeded with cells/gels. At 2 weeks, there was no 
significant difference in control vs. cell seeded scaffolds, however at 4 weeks both 
designs with cells have shown a significant increase in tangent moduli compared to 
control scaffolds (Figure 5.3b). The lower permeability (S50) scaffold design showed a 
higher increase (~10 times) in tangent moduli from control and this is probably due to the 
faster tissue formation rate over scaffold degradation rate compared to the higher 
permeable design (C62). It is also interesting to see that as more tissue formed, the 
mechanical behavior became more nonlinear with higher strain stiffening. 
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Figure 5.3(c): Comparison of compressive stress vs. strain model fit for different scaffold designs 
at 0 and 4 week time points without cells (control). This represents a sole degradation effect on 
mechanical strength of the scaffolds. High permeable design (C62) causes less acid accumulation 
resulting in slower and less degradation overall. 
 
 
 Figure 5.3c showed the effects of architectural scaffold design on scaffold 
degradation when no cells were involved; it is interesting that low permeability design 
decreased its stiffness significantly over 4 weeks but not the high permeability design. 
From 2 weeks to 4 weeks, both designs increased in stiffness and nonlinearity indicating 
active tissue formation inside scaffold pores for those two weeks period. Overall, all three 
figures (5.3b-d) suggest that tissue formation is dominant over scaffold degradation in 
determining overall scaffold/tissue construct mechanical properties up to 4 weeks, 
especially in the low permeable design. 
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Figure 5.3(d): Comparison of compressive stress vs. strain model fit for different scaffold 
designs at 2 and 4 week time points with cells. More matrix formation and lower permeability 
reformed by tissues result in increases in mechanical strength of tissue/scaffold construct. Greater 
increase in stiffness of low permeable design (S50) represents more tissue formed, which is 
reflective of sGAG/DNA content shown in Figure 5.4.    
 
In vitro cell culture - matrix production and mRNA expression 
 
 Chondrocytes proliferated and produced cartilaginous matrix during the 2 and 4 
weeks in vitro culture periods (Figure 5.4). The low permeable design (S50) attained 
significantly higher sGAG/DNA content at both time points and showed a significant 
increase of sGAG/DNA content from 2 to 4 weeks (39.62 -> 55.94, ~140% increase) 
whereas the high permeable design (C62) did not show a significant increase in matrix 
production from 2 to 4 weeks. An increase in sGAG/DNA content implies that a single 
cell is more geared towards chondrocytic phenotype with more matrix production. At 2 
weeks sGAG/DNA content of S50 was 1.6 times higher than that of C62 and at 4 weeks 




Figure 5.4: The representation of scaffold matrix production for different architectures: The 
sGAG/DNA content was normalized to that of 0wk. (N=7-8, One way ANOVA, *p≤0.05)  
 
 Quantitative-PCR was used to measure the messenger RNA expression for 
collagens by cells and for aggrecan found in cartilage at 4 week time point (Figure 5.5). 
The collagen types II, IX, XVIII, & Q and the proteoglycans aggrecan, fibromodulin, & 
chondroadherin are considered to be markers of differentiation with the increase in 
relative mRNA expression levels, while the collagen types I, III, IV, & XI, and the 
proteoglycans biglycan, decorin, & versican are suggested to be markers of 
dedifferentiations with the increase in relative mRNA expression levels. The ratio of 
collagen type II/I or aggrecan/versican is therefore proposed as a differentiation index 
(DI).31 Only Col2/Col1 (DI) and Col10 expression showed a significant difference 
between two designs, yet we can certainly see a trend with other gene expressions as well. 
The main components of healthy articular cartilage are a highly organized network of 
collagens and proteoglycans. Type II collagen is the main collagen type of hyaline 
cartilage responsible for the stability and cell biological functions of healthy articular 
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cartilage32, accounting for 90–95% of the overall collagen content and determining 
mechanical behavior 25 hence it is often used as a marker for cartilaginous like tissues. 
When Type II collagen is destroyed, it is replaced with a type I collagen fibro-cartilage 
that does not have the same functional properties as type II collagen and again this is why 
DI is frequently used as a marker for chondrocytic differentiation. The low permeable 
design (S50) showed higher collagen 2 and lower collagen 1 expression resulting in DI to 
be 1.6 times higher than the DI of the high permeable design (C62) implying that the low 
permeable scaffold design yielded more hyaline-like cartilage (or less fibro-cartilage) 
than the high permeable scaffold design. 
 
Figure 5.5: Relative mRNA expression ratio comparisons between different scaffold designs at 4 
weeks: mRNA expression levels were first normalized to endogenous GAPDH then further 
normalized to S50 for comparison (N = 8-10, t-test, * p≤ 0.05). 
 
  Aggrecan is the main proteoglycan found in cartilage, and is a typical marker of 
differentiated chondrocytes along with collagen II. Even though the aggrecan expressions 
of both designs were not significantly different, S50 was slightly higher than C62. Type 
X collagen serves as a marker of the terminally differentiated (hypertrophic) chondrocyte 
phenotype, and detection of the type X collagen gene transcript and translation product 
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are useful for studies of chondrocyte growth and de-differentiation 26,27. The type X 
collagen expression of C62 was significantly higher than that of S50 (2.2 times higher 
than S50) implying a greater tendency to hypertrophy.  
Histology 
 Safranin-O staining (Figure 5.6) supported the sGAG quantification data such that 
low permeable design (S50) showed a larger area of sGAG staining overall and each pore 
was more packed with sGAG containing tissues. Also, even for outer layer tissues formed 
around the edges of scaffolds, low permeable design had darker sGAG staining with 
more vivid chondrocytic cell phenotypes (i.e. round shape with lacuna) than high 




Figure 5.6: Safranin-O/Fast-Green staining of scaffolds at 4 weeks: more chondrocytic cells with 
vivid lacunae and darker sGAG staining were present in the low permeable design with spherical 
pore shape (S50). All the sections were taken from the center of the scaffolds cross-sectionally 




5.4 Discussion and Conclusion 
 There are many structural parameters which characterize and affect the overall 
function and performance of 3D scaffolds including pore size, porosity, pore shape, 
degrees of interconnectivity, and scaffold surface area. Each of these structural 
parameters influences permeability and their aggregate combination determines the final 
permeability, which in turn affects mass transport. Because of these interrelated structural 
parameters, it is almost impossible to look at a sole effect of one structural parameter on 
cartilage regeneration 28. In our study, we designed scaffolds such that pore size, surface 
area and degrees of interconnectivity were rigorously controlled within narrow ranges.  
Thus, the effects of porosity, pore shape and surface area on permeability and mass 
transport were minimized.  In our previous study 2, we examined the effects of scaffold 
permeability on chondrogenesis by varying both porosity and surface area within a 
spherical pore shape.  This study demonstrated that scaffolds with reduced permeability 
improved in vitro chondrogenesis by primary chondrocytes.  However, since permeability 
was decreased by changing the spherical neck connection size, lower permeable scaffolds 
would have increased surface area.  Although we postulated that surface area was not a 
major factor in that study since the chondrocytes were not seen on histology to attach to 
the scaffold surface, it nonetheless raises the question as to whether increased surface 
area played a role in the increased chondrogenesis with decreased permeability.  
 In this work, we designed scaffolds to examine the effects of permeability due to 
pore shape while eliminating surface area as a potential confounding factor.  In addition, 
the porosity difference between the two designs was minimal (1.2 x between designs) 
compared to the permeability differences (13.5x between designs).  Thus, in this work, 
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we have isolated the major differences in scaffold architecture to permeability and pore 
shape (cylindrical versus spherical).  Since the overall impact of scaffold design on 
cartilage regeneration should not just be measured in terms of cartilage matrix production 
and gene expression, we also determined how scaffold architecture affected scaffold 
degradation and scaffold mechanical behavior with and without seeded cells.  Scaffold 
behavior with seeded cells obviously represents the overall mechanics of the 
scaffold/regenerated tissue construct. 
 The lower permeability with spherical pore shape design scaffold (S50) led to 
increased cartilage matrix production and increased cartilage gene expression (Figure 5.4, 
5.5, and 5.6).  The spherical pore shape may have helped creating denser cell aggregation 
within the pore volume, conditions that would be favorable to chondrogenesis.  In 
addition, as we have earlier suggested 2, lower permeability may enhance chondrogenesis 
due to decreases in oxygen tension and lower reactive oxygen species (ROS) around cells 
that results from lower permeability and higher cell concentration.  Finally, lower 
permeable design may demonstrate enhanced cartilage matrix production due to retained 
sGAG molecules that could diffuse out from lower permeable designs.  These three 
factors, 1) increased cell aggregation, 2) decreased O2 tension resulting from lower 
permeability, and 3) increased sGAG retention in lower permeable designs, could all 
contribute to enhanced chondrogenesis in the spherical pore shapes.  Thus, the spherical 
pore shape may enhance chondrogenesis due to its unique capability of generating a 
larger pore volume for cell aggregation while maintaining low permeability for sGAG 
retention and low O2 tension.  
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 In addition to significantly affecting cartilage matrix production, scaffold 
architecture design had significant affects on scaffold mechanics (empty without cells) 
and scaffold degradation (empty without cells).  Architecture design significantly 
affected the inherent effective nonlinear elastic properties.  Despite having only 12% less 
porosity, the stiffness of the S50 (low permeable) design as measured by tangent modulus 
(Figure 5.3a and Table 5.2b) was from 1.5 to 4 times greater than the C62 (high 
permeable) design depending on strain magnitude.  The C62 design exhibited greater 
nonlinear behavior, as seen in Figure 5.3a and as demonstrated that the larger B 
coefficient in the nonlinear elastic model σ = A(ebε-1), where a higher B coefficient 
indicates greater nonlinear behavior.  Thus, it is clear that 3D arrangement of material 
greatly affects the stiffness and nonlinearity of scaffold mechanics for nonlinear 
elastomers like POC, even when the amount of material used in the scaffolds is very 
similar. 
 Architecture design greatly influenced in vitro scaffold degradation as well 
(Figure 5.3c).  The S50 design without cells demonstrated a significant decrease in 
effective tangent moduli, but the nonlinearity of the stress-strain curve increased.  The 
C62 design demonstrated slight overall decrease in tangent moduli between 0 and 4 
weeks, although the nonlinearity appeared unchanged.  These mechanical results would 
suggest a significant change in polymer crosslinking and molecular weight for the S50 
(Low) design, but not for the C62 (High) design.  Again, given that the amount of 
material is similar between designs, it is likely the arrangement of material in 3D space as 
well as the permeability that most influenced degradation. 
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 Of significant interest for eventual in vivo application is the combined effect of 
cartilage matrix production and scaffold material degradation on overall scaffold/tissue 
construct mechanical properties.  Here again, there is a significant influence of scaffold 
architecture design.    There is a tremendous increase in both the stiffness (tangent 
moduli) and nonlinearity of both designs with seeded cells, although the increase is even 
more dramatic for the S50 design.  This reflects the greater increase in cartilaginous 
matrix within the S50 design over the C62 design.  This increased cartilaginous matrix is 
reflected in the increased mRNA expression (Figure 5.5), sGAG/DNA quantification data 
(Figure 5.4) and sGAG staining of different scaffold designs (Figure 5.6). Higher 
expressions of collagen 2 and aggrecan and lower expressions of collagen 1 creating a 
higher differentiation index (higher collagen 2 to collagen 1 ratio), coupled with low 
collagen 10 expression of low permeable design (S50) are all positive indications of 
higher chondrocytic differentiation and matrix production, and less hypertrophy. Damage 
to the collagen type II meshwork is reported as a critical event in the early development 
and pathology of osteoarthritis33 and some previous in vitro studies34, 35 have shown a 
significant switch in production from collagen type II to collage type I in de-
differentiating chondrocytes in cell culture32. The high permeable design (C62) seemed to 
cause more rapid de-differentiation marked by higher expression of collagen 1 with high 
tendency towards hypertrophy.  Thus, in both cases, the ability to rapidly generate 
cartilage matrix within the pores more than overcame the material degradation effects on 
mechanical properties. 
  The final component in our system that can affect cartilage matrix production is 
the cell seeding gel.  The use of collagen gels allows cells to be evenly seeded through 
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the 3D architecture.  Our results (Figure 5.1) showed that lower collagen I gel 
concentration provided a more preferable microenvironment for porcine chondrocytes in 
terms of matrix production and chondrocytic differentiation and this founding becomes 
more important and useful when collagen I gel is used as a primary scaffold. This can be 
explained by comparing to the environments of chondrocytes in normal cartilage. 
Chondrocytes are known to be sensitive to the macromolecular organization of collagen 
fibrils and the spherical chondrocytes in normal cartilage are surrounded by a network of 
hyaluronan and glycosaminoglycan molecules containing Type II collagen fibrils 29,30. 
The abundance of Type I collagen instead of hyaluronan, glycosaminoglycan, and Type 
II collagen surrounding chondrocytes may have led to morphological changes of 
chondrocytes and unbalanced ECM demonstrating that lower content of collagen I gel 
was actually better in production and maintenance of matrix (sGAG) than higher content 
of collagen I gel.   
 Our study clearly shows that chondrocytes prefer lower permeable scaffolds in 
terms of matrix production and differentiation; pore shape not only plays a role in 
determining effective scaffold permeability but also it may play an additive role ensuring 
abounded pore space for enhancing cell aggregation and sGAG retention.  The enhanced 
cartilage matrix production in the low permeable design resulted in superior mechanical 
properties for the scaffold/tissue construct for this design.  In addition, designed pores 
architecture significantly influenced empty scaffold degradation kinetics in addition to 
effective mechanical and permeability properties.  The results of this study motivate 
further investigation to separate pore shape and permeability effects on chondrogenesis.  
It further suggests that designed scaffold architecture is a component affecting the 
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success or failure of tissue engineered cartilage that should be further studied in 
appropriate in vivo cartilage defect models.   
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THE EFFECTS OF 3D POC SCAFFOLD  




Current therapeutic strategies such as microfracture, osteochondral transplantation 
and autologous chondrocyte implantation (ACI) have been applied with relative success 
for more than a decade, yet are still limited to small defect sizes, and suffer from donor-
site morbidity restricting their clinical application 1-5. These limitations have increased 
interest in tissue engineering approaches combining degradable biomaterial scaffolds 
with or without cell therapy.  While it is widely postulated that scaffolds play a major 
role in the success or failure of cartilage repair, there is very limited data on how scaffold 
architecture and material should be designed to enhance cartilage repair using tissue 
engineered approaches.  Specifically, the mechanical and mass transport environments 
provided to seeded cells or host cells by implanted scaffolds may significantly affect cell 
activity, dictating the outcome of cartilage repair.  These environments are determined by 
scaffold structural parameters including pore geometry, pore size, porosity, pore 
interconnectivity, etc.  To create scaffolds that enhance chondrogenesis, we must first be 
able to test hypotheses concerning how scaffolds design affects chondrogenesis, which 
requires fabricating scaffolds with controlled architectures.  In this chapter, we have 
taken one step further from chapter 5 to implant pre-cultured chondrocytes/ poly (1, 8 
Octanediol-co-Citrate) (POC) scaffold constructs in vivo subcutaneously to examine the 
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coupled effects of designed pore shape and permeability on matrix production, mRNA 
gene expression, and differentiation of chondrocytes in vivo, as well as the resultant 
mechanical property changes of scaffold/tissue constructs due to tissue formation and 
scaffold degradation. As thoroughly illustrated in chapter 4 and 5, POC has been shown 
to support cell attachment, proliferation, and matrix production with chondrocytes 6 and 
POC scaffolds had compressive mechanical properties similar to native articular cartilage 
(Table 6.2) 8.  
Our previous work7, 9-11 demonstrated that a low permeable design with a 
spherical pore shape promotes chondrogenesis in vitro for different materials using 
chondrocytes and the in vitro study of POC scaffolds in chapter 5 also showed that 
chondrocytes responded more favorably towards the low permeable design with a 
spherical pore shape.  The purpose of this part was to investigate whether low permeable 
spherical pore designs also supported enhanced chondrogenesis in vivo at an ectopic site.  
Specifically, we tested the hypothesis that POC scaffolds designed with a spherical pore 
shape and low permeability would enhance chondrogenesis in vivo in a sub-cutaneous 
model as well.   Chondrogenesis in chondrocytes seeded POC scaffolds was assessed by 
cartilaginous matrix production, cartilage specific gene expression and tissue/scaffold 
compressive mechanical properties, including how tissue formation and scaffold 
degradation interact in determining final construct mechanics in the same way we 
evaluated chondrogenesis in chapter 5 for the in vitro study. For this purpose, we first 
cultured seeded primary chondrocytes in designed POC scaffolds using collagen 
I/hyaluronic acid hydrogels as a cell carrier cultured for one week in vitro. These 
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cell/scaffold constructs were then implanted for six weeks in vivo in a sub-cutaneous 
model 12.  
 
6.2 Materials and Methods 
Collagen I/Hyaluronic Acid (Hya) Hydrogel  
 High concentration collagen I hydrogels and hyaluronic acid were purchased from 
BD Bioscience Discovery Labs (San Jose, CA) and Hyalogic LLC (Edwardsville, KS) 
respectively. High concentration collagen I hydrogels were diluted with 0.02N sterile 
acetic acid for 6mg/ml concentration and 5% (w/w) hyaluronic acid was combined with 
collagen I hydrogel based on our previous results that showed that collagen I gel with 5% 
hyaluronic acid enhanced chondrogenesis 12.  
Synthesis of pre-Poly (1,8 Octanediol-co-Citrate) (POC) 
All chemicals were purchased from Sigma-Aldrich (Milwaukee, WI). Poly (1, 8 
Octanediol-co-Citrate) pre-polymer (pPOC) was synthesized as previously described 13. 
Briefly, equimolar amounts of citric acid and 1,8-octanediol were added and the mixture 
was melted at 160–165 °C for 15 mins under a flow of nitrogen gas while stirring and 
then further lowered to 140 °C for 40 mins to create a pre-polymer.  
Scaffold Design & Fabrication 
3D POC scaffold architecture was designed using previous methods and software 
12, 14-16.  Porous POC scaffolds (6.35mm Diameter, 4.0mm Height) with 900μm 
interconnected spherical or cubical pores (porosity: 50% (spherical (S50)), 62% (cubical 
(C62) ), permeability: High (C62) = 13.5 x Low  (S50)) were designed. The details of 
POC scaffold fabrication were the same as previously described in chapter 5 13,16,17.  
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Mechanical Tests  
 
Porous scaffolds (N=4-6/design/time), gel seeded scaffolds (N=4-6/design/time), 
or scaffolds with tissue in-growth (after in vitro pre-culture (=0 week in vivo) or 3 or 6 
weeks of in vivo implantation, N=4-6/design/time) were tested in unconfined 
compression (Alliance RT/30 electromechanical test frame, 50N load cell with 0.5% 
error range, MTS Systems Corp., MN, data collected using TestWorks4 software) . 
MATLAB (The MathWorks Inc., MA) software (LSQNONLIN) was used to fit a 
nonlinear elasticity model, σ = A[eBε – 1] to experimental data where σ is the 1st Piola-
Kirchoff stress, ε is large strain and A and B are model coefficients. Tangent moduli 
(=AB eBε) were calculated at 10 % strain from the fit. 
Porosity and Permeability Measurements & cell seeding 
 
Porosity and permeability measurements were performed the same way as 
described in chapters 4 and 5. Scaffold permeability (N=6-7, each material) with and 
without composite HyA/collagen I (6mg/ml) gel and for tissue/scaffold constructs after 6 
week in vivo implantation was measured using a permeability test set up13, 18. The cell 
seeding and gelation procedures were performed the same way as described in chapter 5. 
In vitro pre-culture & In vivo implantation 
Porcine chondrocytes were isolated from the joints of domestic pigs and seeded 
onto scaffolds following previous methods12 with some modifications 12.  Cells were re-
suspended at a density of ~30x106 cells/mL in 770μL of composite HyA/Col I with 
~50μL of culture medium. The remaining steps were the same as previously described 
(chapter 5). Twenty four scaffolds per design (15/design for 6 week in vivo implantation, 
9/design (in vivo 0 week)) seeded with pChon were pre-cultured with chondrogenic 
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medium (basal medium (DMEM, 10% fetal bovine serum (FBS), 1% P/S, Gibco) 
supplemented with 50 mg/mL 2-phospho-L-ascorbic acid (Sigma)), 0.4mM proline 
(Sigma), 5 mg/mL insulin (Gibco), and 0.1mM non-essential amino acids (Gibco)) in 12-
well plates for 1 week before in vivo implantation. Chondrocytes were cultured under 
gentle agitations on an orbital shaker and the media was changed every other day. All 
POC scaffolds were sterilized in an autoclave, presoaked in DMEM for 24 hours and 
rinsed with PBS prior to cell seeding. For observing mechanical stiffness changes over 
time due to degradation gel seeded scaffolds with no cells (N = 4-6/design/time) were 
subjected to the same in vitro conditions as cell/gel seeded scaffolds. 
After pre-culture in vitro, thirty cell-seeded POC scaffolds (15/design) and twenty 
gel-seeded POC scaffolds (no cell) (10/design: N = 4/design for 3 week, N=6/design for 6 
week) were implanted subcutaneously in 6-8 week-old immuno-compromised mice 
(N:NIH-bg-nu-xid; Charles River, Wilmington, MA). The mice implantation procedure 
was following the methods previously published with some modifications12. Four dorsal 
subcutaneous pockets were created by blunt dissection, and a POC scaffold from each 
group (cell, no cell, spherical, cubical pores) was placed in each pouch and in a different 
pouch location in each mouse (Figure 1b) 12. The animals were housed in groups with 
free access to food and water and killed after 3 or 6 weeks for evaluation. 
sGAG and DNA quantification and Quantitative-PCR 
 
The sGAG content of the dissolved solution at each time point (0 and 6 weeks in 
vivo implantation) for scaffolds (N=3/design 0 week, N=4/design 6 week) tested was 
assayed using the DMMB method and the total sGAG were normalized by DNA content 
which was measured using Hoechst dye 33258 method.7, 19-21 
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For quantitative-PCR, cartilage matrix specific genes (Type II collagen & 
aggrecan),chondrocyte de-differentiation marker genes (Type I & X collagen), matrix 
degradation indicator genes (matrix metalloproteinases 3 and 13 (MMP3, MMP13) and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene expressions were determined 
by quantitative PCR (qtPCR) using a Gene Amp 7700 sequence detection system 
(Applied Biosystems, Foster City, CA USA) for scaffolds (N=4-6/design at each time 
point) after removal from culture in vitro or in vivo implantation following the procedures 
described in chapter 5. The quantity of gene expression was calculated with standard 
samples and normalized with GAPDH and then further normalized to low permeable 
design (S50) for easy comparison.  
Histology  
 
 For histology, constructs (N=3/design) at each time point were fixed in 10% buffered 
formalin overnight, dehydrated with a series of graded ethanol, and embedded in paraffin. 
Tissue sections were stained with hematoxylin and eosin (H&E) for scaffolds without 
cells or Safranin-O/Fast Green counterstaining for scaffolds with cells, to assess cell and 
tissue distribution, cell morphology and sGAG production. Eight to ten slides (4 
sections/slide) were obtained from the center of each scaffold (top to bottom and left to 
right) 12.  
Statistical Analysis 
 
Data are expressed as mean ± standard deviation. The statistical significance among 
different designs or time points was calculated using linear regressions and one way 
ANOVA with post-hoc comparison (Tukey) or student t-test using SPSS software (SPSS 
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for Windows, Rel 14.0. 2005 Chicago: SPSS Inc.). Data were taken to be significant 
when a P-value of 0.05 or less was obtained. 
 
6.3 Results 
Scaffold design and Permeability, Mechanical characterization 
 Three dimensional (3D) scaffolds were fabricated from poly (1, 8 Octanediol-co-
citrate) (POC) using solid freeform fabrication methods.  The scaffolds were designed 
with either a spherical or cubical pore shape, with resultant significant differences in 
permeability.  Pore size and a regular interconnectivity were maintained between scaffold 
designs (Figure 6.1a, Table 6.1).  
 
Figure 6.1: (a) scaffold design pictures (top: digital pictures, mid: center cut of side view of 
scaffold micro CT images, bottom: isosurfaced 3D scaffold microCT images) (b) a digital picture 
of a scaffold with tissues taken out of mice after 6 week in vivo implantation and digital pictures 
of scaffold removal from subcutaneous sites of mice 
 
 The fabricated scaffold permeability was the same as shown in chapter 5, which 
was significantly different between designs (Low = 3.51 ± 0.95 × 10−7 m4/N s (S50), 
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High = 47.4 ± 1.15 ×10−7 m4/N s (C62 (high) = 13.6 × S50 (Low)) (t-test, p ≤ .05)). The 
difference in permeability is far greater than the difference in porosity (High = Low x 
1.2).  Surface area was also not significantly different between designs (S50 = 288 ± 38 
vs. C62 = 243 ± 15 mm3). Thus, among design parameters permeability and pore shape 
exhibited the greatest variations between designs. 
 
 * N=4/design, t-test, p ≤ 0.05, not statistically significant (after 6 weeks of in vivo implantation) 
Table 6.1- Scaffold Descriptions   
Design Name (N=8) S50, Low C62, High 
Porosity (%) 50 ± 1.62 62 ± 2.36 
Permeability without gel (10-7 m4/N·s ) 3.51 ± 0.95 47.4 ± 1.15 
Permeability with gel (10-7 m4/N·s) 1.72 ± 0.45 4.14 ± 0.73 
Permeability with tissues (in vivo) (10-7 m4/N·s)* 0.52 ± 0.01 0.51 ± 0.01 
Surface Area (mm2)** 288 ±38 243 ± 15 
Pore Shape Spherical Cubical 
Pore Size 900µm 
** Not statistically significant (t- test, p≤ 0.05) 
 
 Even though both POC and gels are subjected to degradation, hydrogels degrade 
much faster than POC, being completely degraded by 1-2 weeks. Hence, the permeability 
without gels most likely represents the permeability of scaffolds during 6 weeks of in 
vivo implantation without tissue in-growth whereas permeability with gels represents the 
scaffolds at 0 wk with initial cell seeding. As most of collagen gels are degraded in a 
week during tissue formation, scaffold permeability is dynamically changing within the 6 
week in vivo implantation period with scaffold degradation, tissue in-growth from seeded 
chondrocytes, and tissue formation around the scaffold by cells from mice. The 
permeabilities measured with tissues grown after 6 week in vivo implantation for both 
designs were significantly lower than the permeabilities with gels indicating extensive 
growth of tissue into scaffolds during in vivo implantation. The gel seeded scaffold 
permeability for the low permeable design (S50: 1.72 x 10-7 m4/N·s) was 3.3 times higher 
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than the permeability of scaffold with tissue in-growth (0.52 x 10-7 m4/N·s), whereas that 
for the gel-seeded high permeable design (C62: 4.14 x 10-7 m4/N·s) was 8.1 times higher 
than the permeability of scaffold with tissue in-growth (0.51 x 10-7 m4/N·s). However, 
there was no significant difference in permeability between tissue/scaffold constructs 
between designs after 6 week in vivo implantation.  
 In order to observe mechanical stiffness changes due to scaffold degradation and 
tissue formation in vivo, we implanted gel seeded scaffolds (which are also cultured in 
vitro for 1 week before implantation) in mice and measured their stiffness at 0, 3, and 6 
weeks  in vivo to determine changes in effective nonlinear scaffold stiffness.  
Table 6.2 - Tangent Moduli (MPa) at 10% strain    
Time\Design  
(In vivo implantation, N=4-6)* 
S50, Low C62, High 
without cells with cells without cells with cells 
0wk 0.059 ± 0.019 0.192 ± 0.047 0.054 ± 0.015 0.122 ± 0.022
3wk 0.531 ± 0.159 -  0.185 ± 0.026  - 
6wk 0.525 ± 0.173 0.701 ± 0.131 0.202 ± 0.097 0.467 ± 0.092
* Note that all of the scaffolds were pre-cultured for 1 week in vitro with the same condition before in vivo 
implantation no matter whether the cells are present or not. 
 
 Table 6.2 summarizes compressive tangent moduli at 10% strain for different 
scaffold designs after applying the nonlinear model fit for gel seeded or tissue grown 
scaffolds at each time point. For both designs, the tangent modulus increased from 0 to 3 
or 6 weeks when cells were not seeded.  The low permeable design demonstrated greater 
increase over the 6 week implantation period (9 times vs. 3.4 times increase) than the 
high permeable design. There were no significant changes in stiffness from 3 to 6 week 
period for both designs. Unlike the case without cells, both designs with cells showed 
roughly the same increase (~3.8 x) in stiffness from 0 to 6 weeks in vivo. When 
comparing cases with and without cells, scaffolds with cells all showed higher 
mechanical stiffness. 
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 In Figure 6.2a, the stress-strain curve presents the pattern of how the nonlinear 
mechanical stiffness curve changes over time for each design without cells. The stress-
strain curve for low permeable design (S50) increases from 0 to 3 weeks whereas it drops 
down from 3 to 6 weeks. However, the curve for high permeable design (C62) keeps on 
increasing from 0 to 3 week and then from 3 to 6 weeks.  


























Figure 6.2(a): Comparison of compressive stress vs. strain nonlinear model fit for different 
scaffold designs at 0, 3 and 6 week time points without cell seeded in vivo. This represents a sole 
degradation effect on mechanical strength of the scaffolds with minor influences of fibroblastic 
cell infiltration of mice.  
 
 C62 (high) shows less nonlinear behavior than S50 (low) at 3 week time point but 
at the 6 week time point the C62 (high) shows more nonlinear behavior due to possible 
increased tissue matrix deposition from host cells within the pores, coupled with slower 
scaffold degradation. When cells were present (Figure 6.2b), both designs increased in its 
stiffness over 6 weeks and showed more nonlinear behavior after implantation due to 
tissue formation inside pores. However when comparing scaffold with cells vs. without 
 117
cells at 6 weeks, the low permeable design (S50) showed a larger increase in nonlinear 
stiffness than the high permeable design (C62).  






















S50 no cell 6wk
C62 0wk
C62 6wk
C62 no cell 6wk
 
Figure 6.2(b): Comparison of compressive stress vs. strain nonlinear model fit for different 
scaffold designs at 0 and 6 week time points with cells seeded and pre-cultured 1 week in vitro 
followed by in vivo implantation. Both designs formed matrix noted by increase in mechanical 
stiffness curve however when comparing cell-seeded vs. control (no cell) at 6 weeks high 
permeable design with cubical pore shape did not show any significant difference whereas cell-




Matrix production and mRNA expression before and after in vivo implantation 
 Chondrocytes seeded in low permeable design (S50) showed a significant 
increase in matrix formation (sGAG/DNA contents) over 6 week in vivo implantation 
whereas high permeable design (C62) did not (Figure 6.3). An increase in sGAG/DNA 
content implies that a single cell is more geared towards chondrocytic phenotype with 
higher matrix production/maintenance rate. Even though it was not significantly different, 
the low permeable design (S50) showed a 22% higher matrix production than high 
permeable design (C62) at 6 weeks, which were opposite of the results at 0 week (right 
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after 1 week in vitro pre-culture), where the high permeable design formed 35% higher 
matrix than the low permeable design. This flipping pattern between the designs over the 
6 week implantation period happens again for relative mRNA expression.  
 
Figure 6.3: Matrix production is quantified by amount of sGAG per DNA for different scaffold 
designs at each time point in vivo (*p≤0.05, **p≤0.1, N=4). Low permeable design with spherical 
pore shape (S50) showed higher matrix amount at 6 week in vivo and significantly higher 
increase in matrix formation from 0 to 6 weeks in vivo. 
 
 Quantitative-PCR was used to measure the messenger RNA expression for 
collagens by cells and for aggrecan found in cartilage at 0 and 6 week in vivo 
implantation (Figure 6.4a & b). All mRNA expressions except col10 (a typical marker for 
terminally differentiated chondrocytes28), the typical biomarkers of differentiated 
chondrocytes and cartilaginous tissues 23-26 such as col2 and aggrecan as well as the 
typical marker of the de-differentiated 27 chondrocytes (col1), showed higher ratios for 
the low permeable design than the high permeable design at 0 week in vivo (Figure 6.4a). 
The differentiation index (DI, col2/col1), and the aggrecan expressions for the low 
permeable design (S50) in particular were significantly higher than the expressions for 
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the high permeable design (C62). A higher DI value indicates a more chondrocytic 
genotype, while a lower value indicates a more fibroblastic gene expression 22.  
 
Figure 6.4: Relative mRNA expression comparison for cartilage or hypertrophy related proteins 
among different scaffold designs at 0 (left) and 6 (right) weeks of in vivo implantation. Data are 
first normalized to GAPDH and then normalized to Low, S50 design in order to compare ratios 
between designs (*p≤0.05, N=4/design/time points). 
 
 In contrast, the high permeable design (C62) showed higher values than the low 
permeable design (S50) after 6 week in vivo implantation for all expressed genes (Figure 
6.4b). Type I collagen and aggrecan expressions for C62 were significantly higher (~4 
times) than those for S50.  Thus, results for all gene expression were higher for the C62 
design after 6 weeks in vivo, whereas all gene expression was higher for the S50 design 
after 1 week in vitro culture (Figure 6.5a & b).  
 Since total sGAG (Figure 6.3) is a result of not only matrix formation and 
secretion but also matrix degradation and sGAG leaching out of the scaffolds, mRNA 
expressions of matrix degradation proteins are also important to investigate; hence 
evaluation of MMP mRNA expressions was added to further elucidate the results for 
sGAG quantification data. MMP-13 and MMP-3 play critical roles in extracellular matrix 
degradation in cartilage. MMP-13 appears to be the primary collagenase of articular 
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cartilage and is also critical for cartilage turnover and chondrocyte hypertrophy in the 
growth plate29, 30. MMP-3 is elevated in arthritis, which degrades non-collagen matrix 
components of the joints. In addition to collagen, MMP-13 also degrades the 
proteoglycan molecule, aggrecan, giving it a dual role in matrix destruction31-33.  
 
Figure 6.5:  Relative mRNA expression comparison for matrix degradation proteins among 
different scaffold designs at 0 (left) and 6 (right) weeks of in vivo implantation. Data are first 
normalized to GAPDH and then normalized to Low, S50 design in order to compare ratios 
between designs (*p≤0.05, N=4-6/design/time points). 
 
 Both MMP-13 and MMP-3 mRNA expressions for low permeable design (S50) 
were significantly higher than high permeable design (C62) at 0 week, which then 
reversed after 6 week in vivo implantation. Over 6 weeks, both MMPs expressions 
greatly increased for high permeable design whereas the low permeable design 
maintained relatively constant mRNA expression levels of MMPs. In general, mRNA 
expression levels were high for low permeable designs at 0 week whereas mRNA 






 Safranin-O staining (Figure 6.6) supported the sGAG quantification data (Figure 
6.3) in that more vivid and darker sGAG staining inside the scaffolds was observed after 
6 weeks for both designs compared to the 0 week time point.  
 
Figure 6.6: Safranin-O/Fast-Green staining of scaffolds at 6 weeks in vivo implantation for both 
designs showed chondrocytic cell phenotype with vivid lacunae but low permeable design with 
spherical pore shape (S50) contained darker sGAG staining with wider staining area. Dark 
reddish purple color represents POC materials. 
 
 For the 0 week time point, it was hard to determine which scaffold design 
contained more sGAG inside the scaffold. However, after 6 weeks of implantation, the 
low permeable design (S50) showed wider staining areas over the entire scaffold with 
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darker sGAG staining compared to the high permeable design (C62). Especially the most 
inner parts of the low permeable scaffolds (top to bottom and right to left) had rich Saf-O 
staining, demonstrating that sGAG were formed and maintained inside the scaffold. The 
chondrocytic phenotype was easily observed with lacunae as well for both designs at 6 
weeks.  
 
Figure 6.7: H & E staining for scaffolds implanted without cells, which are subjected to scaffold 
degradation and cell infiltration from surrounding mice skin at 3 and 6 weeks in vivo implantation 
for both designs. Magnification is noted at the bottom. 4x magnification images show the entire 
scaffold center sections from top to bottom section. The 10x magnification area is marked by a 
white box in the 4x magnification 6 week-implantation image.   
 
 H & E stained images (Figure 6.7) for scaffolds without cells at 3 and 6 weeks 
were similar between designs.  This infiltrated tissue was likely fibrous tissue resulting 
from in-growth of surrounding host tissue fibroblasts.  The combination of fibrous tissue 
formation with scaffold degradation likely dictated the change in mechanical properties 
of scaffolds without seeded chondrocytes.  The C62 (High) showed deeper cell 
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infiltration into the pore architecture towards the scaffold center, likely due to the higher 
permeability allowing greater and more rapid cell migration.   
 
6.4 Discussion and Conclusion 
 The focus of this study was to determine effects of 3D POC controlled scaffold 
pore shape and permeability on chondrogenesis in vivo.  Our previous in vitro studies 7, 
9demonstrated that scaffolds with lower permeability and spherical pore shapes increased 
cartilage matrix production and gene expression.  The question then is whether scaffold 
permeability and pore shape still influence chondrogenesis in vivo.  Although the ultimate 
test for in vivo chondrogenesis would be an articular defect, such a defect would also 
entail mechanical compression and stimulus effects on chondrogenesis, confounding the 
investigation of pore shape and permeability influences on chondrogenesis.  Thus, we 
chose a subcutaneous mouse model for the in vivo chondrogenesis, to better isolate the 
pore shape and permeability affects on chondrogenesis using scaffolds with different 
controlled designs manufactured from the same material.  Using the same scaffold 
material also helps isolate design effects, since we have also shown that scaffold material 
significantly influences chondrogenesis 7.   In order to evaluate the effects of POC 
scaffold pore architectures and resulting permeability on tissues and the quality of 
engineered cartilage/scaffold constructs, we examined constructs before and after in vivo 
implantation.  Specifically, in this way, we would be able to tell how scaffold 
architectures and resulting permeabilities may affect chondrogenesis differently in vitro 
and in vivo. Some studies have reported that cells are predominantly distributed in the 
outer or surface zones of scaffolds when cultured in vitro via static seeding. 34Thus we 
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tested pre-cultured POC/cell constructs in vitro before implantation to ensure that cells 
deposited in the scaffold pores and synthesized cartilage ECM (Figure 6.3 & 6.6). Both 
designs showed the capability to form matrix (Figure 6.3) and to synthesize articular 
cartilage specific proteins (Figure 6.4a & 5a) before in vivo implantation.  
 For the in vitro pre-culture period, there was no significant difference between 
designs in terms of matrix production (Figure 6.3).  The high permeable design (C62) 
produced slightly more matrix. However for relative mRNA expressions, the low 
permeable design (S50) demonstrated a trend of having relatively high mRNA 
expressions for all proteins except the collagen type 10 (col10).  Of note, the 
differentiation index (col2/col1) and aggrecan expressions were significantly higher in 
S50 scaffolds. This can be explained related to permeability. For initial cell seeding and 
with regular supply of nutrients during 1 week of in vitro culture, cells in both designs are 
exposed to excessive nutrients and permeabilities that differ in relative magnitude 
between designs as regulated by permeability and pore shape (Table 6.1). The low 
permeable design had higher expressions of type 2 collagen, type 2 collagen/type 1 
collagen, and aggrecan, which are indicators of differentiated chondrocytes closely 
related to sGAG formation, than the high permeable design (Figure 6.4a).  In addition 
both MMP13 and 3 expression levels for low permeable design (S50) were almost 10 
times higher than high permeable design (C62) indicating active matrix remodeling. 
Hence overall sGAG/DNA content at 0 week for the low permeable design attained lower 
values than that for the high permeable design since sGAG/DNA would be an outcome of 
sGAG secretion/production inside the scaffolds, matrix degradation, and possible sGAG 
loss by leaching out of scaffolds.  
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 At 6 weeks after implantation however, the results were opposite of the short term 
1 week in vitro results. At 6 weeks after implantation, the low permeable design (S50) 
produced more matrix than the high permeable design (C62) and demonstrated a 
significant increase in matrix production compared to the 1 week in vitro data (Figure 
6.3). However for relative mRNA expressions, the high permeable design (C62) showed 
a trend of having relatively high mRNA expressions for all proteins, with type I collagen 
and aggrecan expressions significantly higher (Figure 6.4b & 5b). This again can be 
explained by scaffold permeability. The environment of native articular cartilage is well 
known for its low permeability, avascularization (thus low nutrient supply), and hypoxic 
conditions. Unlike the in vitro conditions, there is probably limited chondrogenic nutrient 
supply around scaffolds in vivo.  The low permeable design with spherical pore shape 
likely allows even lower nutrient exchange from outside. The scaffold permeability 
differences between designs would increase with time due to gel and POC degradation 
(Table 6.1) while tissue production would fill up pore spaces lowering the entire 
tissue/scaffold construct permeability still more. For low permeable design, sGAG would 
be deposited and maintained inside the scaffold better due to low permeability and 
chondrocytes inside the spherical pores would tend to aggregate further, limiting sGAG 
leaching out of tissue/scaffold constructs.  
 Several studies36-38 have demonstrated phenotypical changes in OA chondrocytes 
in vivo compared with normal chondrocytes; the expression of genes belonging to 
hypertrophic cartilage (collagen type X) and more primitive cartilage (collagen type I and 
III) was increased, while the expression of genes characteristic for a mature articular 
cartilage phenotype (aggrecan) was significantly decreased in comparison with normal 
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cartilage37,38. Also some reported that the OA-related alterations affect bioactivity and 
matrix gene expression negatively when cultured in vitro39,40.  
 In addition, even though mRNA expressions of relevant cartilage-like tissue 
formation proteins such as type II collagen and aggrecan are lower for the low permeable 
design, the activities of MMP-13 and -3 are also lower (2 fold lower for MMP-13 and 10-
fold lower for MMP-3).  Given that the elevation or overexpression of several MMPs in 
cartilage and synovial tissues are considered as an early sign of OA development 41, the 
lower activities of MMP-13 and -3 in the tissues grown from S50 at 6 weeks in vivo 
should be taken as a positive sign for our engineered cartilage. Furthermore, mRNA 
expressions of both MMPs remain relatively constant over 6 weeks after implantation for 
the low permeable design (Figure 6.4b & 5b). This suggests that the low permeable 
design may be better at retaining sGAG due to its limited nutrient flux coupled with 
lower matrix degradation. These results are in line with histological data (Figure 6.6) 
clearly showing darker staining present in the wider area of the middle of the low 
permeable scaffolds.  There is especially intense sGAG staining near the necks of the 
spherical pores, further support for the postulate that the spherical pore shape helps retain 
cartilage matrix.  Regardless of scaffold pore architectures and permeabilities though, 
Figure 6.6 proves that the pores of the POC scaffold in vivo appear to be filled with 
cartilaginous tissue produced by the implanted chondrocytes and the scaffold still 
maintains its architecture after 6 weeks implantation.   Along with biochemical and 
histological assessments, mechanical assessments such as changes in nonlinear 
mechanical properties of entire tissue/scaffold constructs before and after implantation 
are important as mechanical performance is another important factor determining the 
 127
success of regenerated tissues. Martinez-Diaz et al.35 recently demonstrated that rabbit 
articular cartilage had nonlinear elastic properties and more successful repair strategies 
better replicated the nonlinear elastic cartilage behavior.  POC itself behaves nonlinearly 
elastic13, 16 and exhibits nonlinear elastic properties ranging up to the low end of articular 
cartilage, depending on scaffold architecture.  With increasing matrix production, both 
scaffold designs demonstrated increased nonlinear elastic properties.  Compared to data 
from the study by Martinex-Diaz et al.35, our spherical design scaffold/tissue constructs 
matched normal rabbit articular cartilage nonlinear elasticity up to 25% strain while our 
cubical pore design matched nonlinear elastic properties up to approximately 10% strain.  
Scaffolds with no cells or after one week in vitro culture had nonlinear elastic properties 
below those of normal cartilage.  Thus, even though placed subcutaneously, the nonlinear 
elastic properties of both designs increased into the range of normal articular cartilage.  
The spherical pore design demonstrated a greater increase in nonlinear elastic properties, 
closer to those of articular cartilage than the cubical pore design. 
 When there were no implanted cells inside scaffolds, both high and low 
permeable designs demonstrated significant scaffold stiffness increases over 3 weeks 
showing stronger nonlinear behavior and shifting the stress-strain curve upwards. 
However, from 3 to 6 weeks of implantation period, the C62 (high permeable) design 
kept on increasing its stiffness with more nonlinear behavior while the S50 (low 
permeable) design showed a significant drop in the nonlinear elastic properties. This may 
reflect a deposition of fibroblastic tissues that would cause an increase in the mechanical 
properties and relatively different rates of scaffold degradation (Figure 6.2a & 7). For the 
low permeable design, cell infiltration and fibroblastic tissue formation may be 
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responsible for an increase in nonlinear elastic properties over the first 3 weeks, followed 
by a decrease in mechanical properties over the next 3 weeks due to more rapid 
degradation of the spherical pore design over cubical design (also seen in our in vitro 
studies in chapter 5).  Based on Figure 6.7, we could not see any significant differences in 
cell infiltration and tissue formation by surrounding cells between two designs especially 
at 6 weeks. Even though there was active cell infiltration and formation of fibroblastic or 
fat-like tissues within both scaffolds, there were no cartilaginous-like tissues formed, 
which was confirmed by the lack of sGAG for any designs at any time points (data not 
shown). While cell infiltration takes place over 6 weeks, during the first 3 weeks, cell 
infiltration and tissue formation are possibly more dominant than scaffold degradation in 
determining scaffold mechanical properties.  Over the next 3 weeks, scaffolds become 
more vulnerable to degradation due to acid accumulation inside scaffolds leading to a 
decrease in mechanical properties. However it should be borne in mind that this stress-
strain curve rise and fall pattern is taking place within very small stress ranges. 
Examining changes in tangent moduli at 10% strain (Table 6.2) from 0, 3, & 6 weeks, 
reveals no significant differences between 3 and 6 weeks results within the same design.  
Furthermore, all designs without cells showed the same increased trend in mechanical 
properties, indicating cell infiltration into scaffolds and tissue formation around scaffolds.       
Figure 6.2b is more relevant to the effect of chondrogenesis by seeded chondrocytes on 
tissue/scaffold mechanical properties. Both designs demonstrated increased mechanical 
stiffness with neotissues packed into pores after 6 week implantation.  However, the low 
permeable design (S50) showed higher absolute stiffness and a greater relative stiffness 
increase than the high permeable design (C62).  This increase in mechanical properties at 
 129
6 weeks reflects the overall cartilage matrix production results (Figure 6.3). In 
comparison between cell-seeded vs. empty scaffolds at 6 weeks, the high permeable 
design showed no significant difference implying that tissue formation and scaffold 
degradation are taking place at the same rates balancing out each other in terms of 
stiffness. However, low permeable design results suggest that cartilage tissue formation is 
occurring more rapidly than scaffold degradation, giving stiffer and more nonlinear 
behavior of entire tissue/scaffold constructs (Figure 6.2b). Regardless, both designs 
proved to give sufficient mechanical support for cells to grow in and form tissue 
organization and the tangent moduli of entire constructs after 6 weeks implantation were 
within the ranges of articular cartilage stiffness. 
 Results of this study parallel those of our earlier in vitro work (chapter 5) 
demonstrating that lower permeability and a spherical pore design were beneficial for 
chondrogenesis using primary chondrocytes as assessed mechanically, histologically, and 
with gene expression.  Although both POC scaffold designs supported chondrogenesis, 
the spherical pore design demonstrated enhanced chondrogenesis over the cubical pore 
design.  This is particularly interesting given the implantation in a sub-cutaneous site.  
The results suggest that pre-seeded POC controlled scaffolds are capable of providing 
mechanical integrity and suitable microenvironments for cartilage tissue regeneration.   
Pore shape plays an additive role by ensuring pore volume for keeping ECM and 
chondrocytes phenotype around pore necking areas and preventing any extra leakage of 
sGAG out of the scaffolds. Given that low permeability and spherical pore shapes 
enhance chondrogenesis in vitro and sub-cutaneously, the next step is to investigate these 
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factors in a cartilaginous defect where mechanical environment will exhibit a significant 
interactive role with designed scaffold pore shape, permeability and scaffold material.   
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THE INFLUENCE OF SCAFFOLD MATERIALS ON IN VITRO CARTILAGE 




 The biomaterial and scaffold architecture design that best enhances 
chondrogenesis for Matrix Assisted Chondrocyte Implantation (MACI) remains an open 
yet critical question. So far, we have explored the feasibility of POC as a cartilage 
scaffolding material, and evaluated scaffold architectural effects on chondrogenesis using 
POC scaffolds. As a result we could obtain useful information on how scaffold pore 
shape and permeability are coupled to affect chondrogenesis in vitro and in vivo. Then we 
came to a critical question of whether scaffold architectural effects would still prevail and 
have the same effects on chondrogenesis when created in any material.  In other words, 
what is the relative influence of scaffold material and design on chondrogenesis? A 
number of biomaterials with mechanical and surface properties attractive for cartilage 
regeneration have been put forth.  However, there have been almost no head to head 
comparisons of these different materials as cartilage scaffolds.  True material influences 
can only be ascertained if all materials are fabricated with the exact same architecture, as 
architecture itself can influence chondrogenesis.   
 In this chapter, we compare three biomaterials for cartilage tissue engineering: 1) 
Polycaprolactone (PCL), 2) Poly (Glycerol-co-Sebacate) (PGS), and 3) Poly (Octanediol-
co-Citrate)(POC) in terms of mechanical properties, permeability properties,  cartilage 
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matrix production and cartilage-related gene expressions.   All three materials were 
fabricated into the exact same architecture design which was previously found to 
facilitate matrix production and cellular differentiation of chondrocytes in vitro1.  Thus, 
we eliminate scaffold architecture as a confounding variable to completely focus on 
material influences on chondrogenesis.  One material, PCL, has a long history in tissue 
engineering while the other two, PGS and POC are relatively recently developed 
materials for tissue engineering. The rationale for selection of the three candidate 
materials was based on their mechanical stiffness (within or close to published ranges for 
articular cartilage), hydrophilicity, and potential use in the field of cartilage engineering. 
Furthermore, we wanted to be able to fabricate all chosen materials with the same 
architecture to remove architecture as a confounding influence on chondrogenesis. All 
three materials were seeded with primary chondrocytes in the same 3D scaffold design 
with spherical voids, which was found to enhance chondrogenesis in terms of matrix 
production and cellular differentiation of chondrocytes in vitro from a previous study in 
our laboratory 1.  
 Polycaprolactone (PCL) is one of the polyester polymers that have been most 
frequently used in the field of orthopedic tissue engineering. It is a biocompatible 
material that is FDA approved for cranial burr hole fillers and trapezoid joint spacers that 
is readily fabricated and biodegradable.  Previous research has shown that PCL is a good 
candidate for cartilage tissue engineering in terms of cell attachment, proliferation, and 
matrix production 1-4. Unlike PCL, PGS and POC are relatively new biomaterials in the 
field of tissue engineering and there are few published reports on their use for cartilage 
regeneration 5-7. Both PGS and POC are rubber-like biodegradable polyester elastomers 
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which are made by reacting an acid and alcohol monomers via condensation using high 
temperature and vacuum. Both are degraded by hydrolysis with non-toxic and natural 
metabolic intermediates degradation products. Due to these characteristics, both materials 
have been proposed as good scaffold candidates for soft tissue engineering (i.e. cartilage 
and blood vessels) 5, 7-11.  
 Due to their recent development, and the lack of controlled 3D scaffold 
architectures, there has been no direct comparison of PGS and POC for cartilage scaffold 
materials.  Such comparisons are critical to make informed design choices for cartilage 
tissue engineering matrices for use with autologous chondrocyte therapy or even with 
current cartilage resurfacing techniques like microfracture or mosaicplasty.  However, 
rationale design decisions to determine optimal cartilage tissue engineering scaffolds will 
require studying material influences using the same architectures and then studying 
architectural influences using the same material.  The goal of this study was to compare 
PCL, PGS, and POC material influences on chondrogenesis in terms of mechanical 
properties, cell activity, cartilage matrix production and gene expression utilizing 
scaffolds of the same fixed 3D designed architecture.   
 
7.2 Materials and Methods 
 
Synthesis of pre-Polymer 
Poly (1, 8 Octanediol-co-Citrate) (POC) 
 All chemicals were purchased from Sigma-Aldrich (Milwaukee, WI). Poly (1, 8 
Octanediol-co-Citrate) pre-polymer (pPOC) was synthesized as previously described in 
previous chapters.10,12-13   
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Poly (glycerol sebacate) (PGS) 
 PGS pre-polymer (pPGS) was synthesized following methods described by Gao et 
al.14. Equimolar sebacic acid and glycerol were reacted under N2 at 120°C.  After 24 
hours, the N2 was removed and a vacuum of 50mTorr was pulled for an additional 48 
hours, with a condenser attached.  
Scaffold Design & Fabrication 
 Previously developed image-based design processes and software were used to 
design 3D POC scaffold architectures 13, 15-18.  Porous polycaprolactone (PCL), PGS, and 
POC scaffolds (6.35mm diameter, 3.5mm height, 50% porosity, 900μm interconnected 
spherical pore shape with 310-320μm diameter of the windows between the pores) were 
designed using custom IDL programs (RSI, Boulder, CO) following previously reported 
methods5,13,19. In brief, wax molds with 3D-image based design architecture were built by 
a Solidscape PatternmasterTM machine and the wax molds were used directly to melt-cast 
PCL scaffolds in PTFE molds. PCL powder (43-50 kDa, Polysciences) packed into PTFE 
molds was melted at 115°C with -30 in.Hg vacuum for 2 hours and then wax molds were 
pushed into the warm PCL liquid.  The wax molds were dissolved by ethanol after cool-
down (Figure 3.5).  
 For PGS and POC scaffolds, inversely solid freeform fabricated hydroxyapatite 
(HA) molds were prepared before curing pPGS and pPOC into architecture scaffolds.  As 
the wax molds melt at PGS and POC curing temperatures, the HA secondary molds were 
created from the wax molds as the HA easily withstands the pPGS and pPOC curing 
temperatures that reach over 100oC.  pPGS or pPOC was poured into the wells of a 
Teflon mold and HA molds were embedded within each pre-polymer. The 
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pPGS/HA/Teflon mold unit was post-polymerized at 150°C for 3 days. The 
pPOC/HA/Teflon mold unit was post-polymerized at 100°C for 1 day followed by curing 
at 100°C for 3 days more with vacuum (-25 in.Hg). The HA mold was removed using a 
decalcifying reagent (RDO, APEX Engineering Products Corp, Plainfield, IL) followed 
by incubation in water (Milli-Q water purification system, Billerica, Mass, USA) for 24 
hours to obtain the final porous POC scaffolds (Figure 3.3).  
Mechanical Tests  
 
 For scaffold unconfined compression tests, four to six porous scaffolds per each 
material were tested in compression (Alliance RT/30 electromechanical test frame, 50N 
load cell (POC, PGS) or 500N load cell (PCL) with 0.5% error range, MTS Systems 
Corp., MN) and TestWorks4 software (MTS Systems Corp., MN) was used to collect 
data during compression testing. MATLAB (The MathWorks Inc., MA) software was 
used to fit a nonlinear elasticity model, σ = A[eBε – 1] to experimental data. The sum of 
least square errors between the model stress and experimental stress was minimized using 
the LSQNONLIN minimization program in the MATLAB optimization toolbox.  
Tangent moduli were calculated at 10 and 30% strain from fit data and all residuals 
between model and experimental stress were below 1%. 
In Vitro Cell Culture & Histology 
 The porosity and permeability measurements were performed with the same 
procedures and conditions as described in previous chapters. Chondrocytes were seeded 
into 3D scaffolds by first suspending the cells in media with composite HyA/Col I gels 
and then pushing the gel into the 3D scaffolds17. The gelation procedure is as follows: 
625μL of Col I (stock concentration: 8.37mg/mL diluted to 6mg/ml with 0.2N acetic 
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acid; BD Bioscience Discovery Labs, San Jose, CA) with 62.5 μL HyA (stock 
concentration: 3 mg/mL in 1.5M sodium chloride (NaCl), molecular weight 2.4-3 million 
Da; Hyalogic LLC, Edwardsville, KS) were well-mixed. The pH of the HyA/Col I 
suspension was increased with the addition of 9μL of 0.5N sodium hydroxide with 220 
mg/mL sodium bicarbonate to initiate gelation. As soon as 0.5N sodium hydroxide is 
added to HyA/Col I gel mixture, gel contents were evenly re-suspended.  Hydrogel 
mixtures are then dripped down onto pre-prepared sterile scaffolds until scaffolds were 
fully soaked and filled with gel to the top surface.   This was followed by incubation at 
37°C for 30 min to solidify gels further. 125μl of gel mixtures were used for each 
scaffold.  
 Porcine chondrocytes (pChon) were isolated from the full depth of 
metacarpophalangeal joints of domestic pigs and seeded onto scaffolds following 
methods previously published 17 with some modifications.  In short, cells were re-
suspended at a density of 20x106 cells/mL in 625μL of composite HyA/Col I (6mg/ml) 
with ~50μL of culture medium. The cell seeding and gelation procedures of composite 
HyA/Col I hydrogels were the same as described in chapter 5 & 6 20. Before cell culture, 
PGS and POC scaffolds were sterilized by autoclave and PCL scaffolds were sterilized 
by incubation in 70% ethanol for 1 hour. After sterilization, all scaffolds were neutralized 
to physiological pH level by media incubation for 24-48 hours with brief PBS rinse prior 
to cell seeding. Scaffolds seeded with pChon were cultured with chondrogenic medium 
(basal medium (DMEM, 10% fetal bovine serum (FBS), 1% P/S, Gibco) supplemented 
with 50 mg/mL 2-phospho-L-ascorbic acid (Sigma)), 0.4mM proline (Sigma), 5 mg/mL 
insulin (Gibco), and 0.1mM non-essential amino acids (Gibco)) in 12-well plates. 
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Chondrocytes were cultured for 0 (1d), or 4 weeks under gentle agitation on an orbital 
shaker and the media was changed every other day. Cell culture was maintained in a 
water-jacket incubator equilibrated with 5% CO2 at 37°C. For histology, constructs 
(N=3/material) at each time point were fixed in 10% buffered formalin overnight, 
dehydrated with a series of graded ethanol, and embedded in paraffin. Tissue sections 
were stained with safranin O/Fast green counterstaining to assess cell distribution, 
morphology and sGAG production. Six to eight slides (4 sections/slide) were obtained 
from the center of each scaffold (top to bottom and left to right). Immunohistochemistry 
was used to detect collagen II following a previously established protocol 20. Four slides 
(4 sections/slide) were obtained from the center of each material scaffold. 
sGAG and DNA quantification 
 
 Before cell analysis, excessive out-layer tissues were removed from PCL 
scaffolds and analyzed separately for both sGAG/DNA quantification and mRNA gene 
expression analysis. Scaffolds (N=6) at both the 0 and 4 week time points were removed 
from the culture and sGAG and DNA were quantified using the same methods as 
described in chapter 5 & 6. The digested tissue-scaffold solution was analyzed by a 
dimethylmethylene blue (DMMB) assay following a previously established protocol 
5,21,22. The total sGAG were normalized by DNA content which was measured using 
Hoechst dye 33258 methods (Sigma, #DNA-QF).1,23 
Quantitative-PCR 
 
 Cartilage matrix specific genes (Type II collagen & aggrecan),chondrocyte de-
differentiation marker genes (Type I & X collagen), matrix degradation indicator genes 
(matrix metalloproteinases 13 and 3 (MMP13, MMP3) and glyceraldehyde-3-phosphate 
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dehydrogenase (GAPDH) gene expression were determined by quantitative PCR (qtPCR) 
using a Gene Amp 7700 sequence detection system (Applied Biosystems, Foster City, 
CA USA) for PCL, PGS, and POC Scaffolds (N=6/material). The remaining procedures 
were the same as described in chapter 6. The quantity of gene expressions were 
calculated with standard samples and normalized with GAPDH and further normalized 
by PCL for easy comparison.  
Statistical Analysis 
Data are expressed as mean ± standard deviation. The statistical significance among 
different materials was calculated using linear regressions and one way ANOVA with 
post-hoc comparison (Tukey) or student t-test using SPSS software (SPSS for Windows, 
Rel 14.0. 2005 Chicago: SPSS Inc.). Data were taken to be significant, when a P-value of 




Scaffold design, fabrication, and characterization 
 
 In order to isolate design effects from material effects on chondrogenesis, scaffold 
designs were kept the same for all three materials in terms of pore shape, pore size, 
surface area, and porosity (Table 7.1, Figure 7.1). Due to material influences, PCL, PGS, 
and POC had different effective scaffold modulus and permeability (Table 7.1). Figure 
7.1 shows example micro-CT images of scaffolds and a digital picture for the POC 
scaffold design (other scaffolds are similar in images thus not shown here). With no 
tissue in-growth, the PCL scaffold tangent modulus was roughly two hundred times the 
PGS and POC effective scaffold tangent modulus at 10 % strain. However, with in-
growth of cartilaginous tissues at 4 weeks in vitro, the PCL  effective scaffold tangent 
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modulus was only twice that of the PGS and POC scaffolds at the same strain rate, which 
is likely due to the composite PCL/tissue tangent modulus being dominated by tissue 
growing on top of the PCL scaffolds.  Even though scaffold designs were kept the same, 
effective scaffold permeability differed significantly between the different materials.  
Scaffold design permeability, a single physical design parameter that describes how 
multiple structural properties including pore size, pore shape, interconnectivity, porosity, 
and fenestration size affect mass transport, depends not only on scaffold design but also 
on scaffold material 1, 24.   
 
 
Figure 7.1: (A) Top view of MicroCT image of a scaffold (B) a digital picture of a POC scaffold 







Table 7.1- Scaffold Descriptions (N=6-8)    
Material PCL PGS POC  
Porosity (%) 48 ± 3.62 49 ± 2.36 50 ± 1.62 
Permeability without gel (10-7 m4/N·s) 2.93 ± 0.73 8.31± 3.91 3.51 ± 0.95 
Permeability with gel (10-7 m4/N·s) 0.66 ± 0.24 3.0 ± 0.18 1.72 ± 0.45 
Equilibrium Water contact angle 
(hydrophilicity) (°) 77.0 ± 1.4 60.8 ± 6.3 32.8 ± 2.0 
Surface Area (mm2) 288 ± 38 
Pore Shape Spherical 
Designed Pore Size 900μm 
Designed Pore Strut Size 315μm 
 
 
 Permeability without gel likely represents the permeability of scaffolds at 4 weeks 
without tissue in-growth whereas permeability with gel represents the scaffolds at 0 wk 
with initial cell seeding. As most of collagen gels are degraded in a week during tissue 
formation, permeability is dynamically changing within the 4 week period.   However it 
is likely that the trend of different permeability between the different materials remains.  
PCL, POC, and PGS are in order of increasing permeability without gel, 2.93 ± 0.73, 3.51 
± 0.95, and 8.31± 3.91 (10-7 m4/N·s).  With gel, the same permeability rankings hold with 
PCL, POC, and PGS having 0.66 ± 0.24, 1.72 ± 0.45, and 3.0 ± 0.18 (10-7 m4/N·s) 
permeability, respectively (Table 7.1).  
Table 7.2 - Mechanical Properties (N=4-6)    
Material PCL PGS POC  
Tangent modulus without tissues (0wk) (MPa)* 21.8 ± 4.43 0.19 ± 0.06 0.13 ± 0.04 
Tangent modulus with tissues (4wk) (MPa)* 1.43 ± 0.56 0.89 ± 0.19 0.73 ± 0.37 
Tangent modulus with tissues (4wk) (MPa)** 13.49 ± 3.53 2.44 ± 0.69 1.26 ± 0.33 
*measured at 10% strain, ** at 30% strain    
 
 Table 7.2 summarizes compressive tangent moduli for each material scaffold with 
or without tissues. PCL is more than 100 times stiffer than PGS and POC whereas PGS 
and POC have similar effective scaffold tangent moduli at 10% strain rate. After tissues 
were formed for 4 weeks, the tangent compressive moduli of both PGS and POC were 
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increased ~ 400% compared to that of PGS and POC without tissues measured at the 
same strain rate. The effective scaffold tangent moduli of PCL at 4 week were only two 
times higher than that of PGS and POC at 10% strain. This result is probably due to 
excessive tissues outgrown on the top of PCL scaffolds. Thus effective scaffold tangent 
compressive moduli more likely reflected the properties of the formed tissues on the top 
of PCL scaffolds rather than the combined scaffold and tissue properties.  This was not 
the case for PGS and POC as regenerated cartilaginous tissues were contained within the 
scaffolds (see Figure 7.2B and C). At 30% strain, tangent moduli of all the scaffolds 
reflect better the entire tissue/scaffold construct (Table 7.2). The POC/tissue construct 
was the most compliant at 30% strain, followed by PGS (2x stiffer than POC) and PCL 
(10x stiffer than POC and 6x stiffer than PGS). 
 
Figure 7.2: Digital pictures of three different material scaffolds with tissues grown for 4 weeks. 
 
In vitro cell culture-proliferation, differentiation, and matrix production 
 Chondrocytes proliferated and produced cartilaginous matrix during the 4 week in 
vitro culture period (Figure 7.2). Excessive outer tissues were grown on the top and 
bottom of the PCL scaffold whereas tissue were contained completely within the PGS 
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and POC scaffolds (Figure 7.2) Since we were interested in the amount of tissues formed 
inside the scaffold, we separated excessive outer tissues from PCL, denoting assays on 
tissue within the PCL scaffold as PCLin, assays on tissue outside the PCL scaffold as 





Figure 7.3: (A) Amount of DNAs per construct at 4 weeks for different materials (PCLin: tissues 
inside PCL scaffolds only, PCLout: excessive outer layers removed from PCL scaffolds, PCLtotal = 
PCLin + PCLout) (Annotations ‘a’, ‘b’, ‘c’ shown in the graphs are statistically significant each 
other; PCLin, POC are significant to all other groups, PGS are significant to PCLin and POC only) 
(B) Changes in DNA content of chondrocytes for different materials over time is measured by 
amount of DNAs per scaffold suggesting some possible cell migration (especially for PCL) and 
exterior tissue growth. (Asterisk represents statistical significance. p≤0.05, N=6) (C) Matrix 
production per scaffold is quantified by amount of sGAG per construct for different materials. 




 POC produced the highest DNA content (531 ± 39 ng/μl) per construct, whereas 
PCLin produced the lowest content (54 ± 22 ng/μl) per construct\. PGS and PCLtotal 
showed similar DNA contents (363 ± 22 ng/μl and 346 ± 59 ng/μl respectively) per 
construct (Figure 7.3a). Over 4 weeks, POC showed highest proliferation rate, with an 
increase of DNA content from 322 ± 24 ng/μl to 531 ± 39 ng/μl per construct. PGS 
showed no significant difference in the amount of DNA over time. Note that PCLin 
showed a decrease from 269 ± 52 ng/μl to 54 ± 22 ng/μl per construct, likely reflecting 
the fact that more cells grew outside the PCL scaffold than inside (Figure 7.3b).    
Sulfated-glycosaminoglycan (sGAG) content, measured through a DMMB assay, was 
used to quantify cartilaginous matrix production by chondrocytes (Figure 7.3c). This 
showed a similar trend to the DNA content. POC produced the most amount of sGAG per 
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scaffold (1.88 ± 0.88 μg/μl) which was roughly eight times more than PCLin (0.22 ± 0.10 
μg/μl) and two times more than PCLtotal (1.12 ± 0.53 μg/μl) and PGS (0.92 ± 0.32 μg/μl). 
However, PGS and PCLtotal were not significantly different from each other.  
In vitro cell culture-gene expression 
 Quantitative-PCR was used to measure the messenger RNA expression for 
collagen by cells and for aggrecan and MMPs found in cartilage (Figure 7.4). As 
mentioned in the previous chapters, healthy articular cartilage is composed of a highly 
organized network of collagen and proteoglycans. The most abundant and major fibrillar 
collagen of articular cartilage, Type II collagen, determines the mechanical behavior of 
native tissue 25. When Type II collagen is destroyed and replaced by a type I collagen 
fibro-cartilage, the mechanical behavior subsequently alters as a type I collagen does not 
have the same functional properties as type II collagen. Of note again, collagen type II 
and the proteoglycan aggrecan are considered to be markers of chondrocytic 
differentiation or hyaline-like cartilage with the increase in relative mRNA expression 
levels, while collagen types I is suggested to be a marker of dedifferentiation or more 
fibrocartilige with the increase in relative mRNA expression levels 38. This is why the 
differentiation index (col2/col1) is used as an indicator for chondrogenesis by comparing 
col2/col1 values (i.e. chondrocytic if a higher col2/col1 value and fibroblastic if a lower 
col2/col1 value) 26. 
 The differentiation index of POC was 4.31, significantly higher than that of PCLin, 
PGS, and PCLout (0.92, 1.31, 1.21 respectively), reflecting the sGAG quantification data. 
In contrast, the differentiation indexes of PCL and PGS were not significantly different 
from each other. PCL and PGS seemed to provide environments for cells to be active 
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causing elevated expressions of both type II collagen and type I collagen genes. In 
contrast, POC was good for keeping type I collagen expression low while promoting type 
II collagen expression. 
 
Figure 7.4: Relative mRNA expression comparison for proteins among different materials. (PCL 
= PCL inner tissues only) (Annotations ‘a’, ‘b’, ‘c’ shown in the graphs are statistically 
significant each other. N=6, p≤0.05 for a-c) 
 
 As introduced in chapter 6, aggrecan is the main proteoglycan found in cartilage, 
and is a typical marker of differentiated chondrocytes. The aggrecan expression of PGS 
and POCout were significantly higher than that of PCLin and POC. The type X collagen 
expression, a marker of the terminally differentiated (hypertrophic) chondrocyte 
phenotype 27,28, also showed a similar trend as the type I collagen and aggrecan 
expressions among different materials with significance (p<0.1). PGS and PCLout showed 
the highest tendency to hypertrophy.  
 MMP-13 and MMP-3 play critical roles on extracellular matrix degradation but 
their degradation roles are slightly different. MMP-13 is a product of the chondrocytes 
that reside in the cartilage and it not only degrades collagen but also degrades the 
proteoglycan molecule, aggrecan, giving it a dual role in matrix destruction 29-31. On the 
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other hand, MMP-3 is elevated in arthritis, which degrades non-collagen matrix 
components of the joints. When comparing the gene expressions of MMP-13 and MMP-3 
for inner tissues, PGS showed the highest MMPs’ expressions which were five to ten 
times higher than PCLin and POC implying that degradation of collagens and aggrecan 
were actively taking place.  
Histology and Immunohistochemistry 
 Safranin-O staining (Figure 7.5) supported the sGAG quantification data. POC 
showed the highest sGAG content with pores fully packed with sGAG stained tissues 
whereas PCL and PGS showed less tissues formed with sGAG stained. Also, even for 
outer layer tissues of POC, sGAG staining was darker than any other materials showing 
higher sGAG content. The safranin O staining of PCL confirmed that not much 
cartilaginous tissues formed inside the scaffold pore (less sGAG staining) and most of 
cartilage tissues were formed outside the PCL scaffold.  
 
 
Figure 7.5: Safranin-O/Fast-Green staining for sGAG. Dark crimson colored regions shown in 





Figure 7.6: Immunohistochemical analysis for Type II collagen (brown) with hematoxylin 
staining (purple) (A: tissues between pores: 10x magnification, B: tissues inside a pore: 20x 
magnification, C: Outer layer tissues: 20x magnification).    
 
 Immunostaining of type II collagen (Figure 7.6) tracked relative mRNA 
expression data (Figure 7.4) such that PCL (inner and outer tissues combined) showed the 
strongest intensity of immunostaining for type II collagen and PGS and POC followed 
respectively. For cell morphology, PCL and POC showed more vivid chondrocytic 
phenotype with lacunae inside pore, between pores, and the most outer part of scaffolds, 
whereas more fibroblastic cells were found across the entire PGS scaffold, which also 
matched with type I collagen relative mRNA expression data (Figure 7.4) indicating 
higher de-differentiation. In general, outer tissues for all materials maintained a more 
chondrocytic cell morphology than the center part of the scaffold.  
 
 152
7.4 Discussion and Conclusions 
 This is the first time a true apples to apples comparison of scaffold material 
influence on chondrogenesis has been performed with the same designed 3D porous 
architecture. Many studies have reported how one or two materials affect chondrogenesis 
yet they cannot make a completely unfounded comparison of material effects due to lack 
of controlled scaffold design and the resultant differences in scaffold architecture 17,32,33. 
Since scaffold design is also a critical factor affecting tissue regeneration within scaffold1, 
we cannot isolate material effects on chondrogenesis unless we can test different scaffold 
materials fabricated with the same 3D architecture.  Here, using an identical scaffold 
design for all three materials, we could make a direct comparison of scaffold material 
effect on chondrogenesis.  
 The most significant difference in terms of material effects, PCL, PGS, and POC 
scaffolds were seen in the permeability, hydrophilicity, and effective scaffold tangent 
moduli differences. Even though scaffold architectural permeability was kept the same 
for all materials, there were effective permeability differences among materials 
themselves. PGS was significantly more permeable than POC and PCL (Table 7.1) PCL 
showed significantly higher tangent moduli than other two materials (Table 7.2) with or 
without tissues. In general, the degradation rates of PGS and POC are much faster than 
that of PCL and the degradation rates and the rates of tissue formation are related to 
mechanical tangent moduli 8,10,34,35.  
 PGS and POC tangent moduli increased significantly by 4 weeks, suggesting that 
tissue formation occurred faster than scaffold degradation.  However, the tangent 
modulus for the PCL/tissue construct decreased greatly from 0 to 4 weeks of tissue 
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culture.  This was more likely because cartilage tissue grew over the scaffold, and thus 
dominated the compressive properties over the scaffold material.  In terms of tangent 
modulus, PGS and POC were more similar to native cartilage tissues than PCL 5,7, which 
may be more advantageous when applying these scaffolds in cartilage defects.  
Cell proliferation measured by amount of DNA (live cells) per construct at 0 and 4 weeks 
clearly shows that POC provided the most favorable environment for cell proliferation in 
terms of overall or inner parts of scaffolds. When considering tissues formed in the inner 
parts of scaffolds only, PCL seemed to be least favorable material yet when comparing 
overall effects PGS and PCLtotal were not significantly different (Figure 7.3A). 
Proliferation over time (Figure 7.3B) also supports this contention since PGS and POC 
proliferated or at least kept the same number of cells whereas PCLin showed a significant 
decrease in cell numbers. This may be explained by low permeability, hydrophobicity 
and low wettability of PCL scaffolds compared to the other two materials.  
 As cells started to grow and tissues were formed, less nutrients from the media 
would flow in and out due to lower permeability for all materials. However, since PGS 
and POC may better retain fluid due to hydrophilicity, there would be more nutrients 
from media that are soaked into these materials available to cells inside of the scaffold.  
Excessive growth of tissue outside the PCL scaffolds may have further prevented nutrient 
diffusion within the PCL scaffold, leading to reduced cell proliferation.   
 It was reported that chondrocytes prefer decreased scaffold permeability within 
PCL scaffolds in terms of cartilaginous matrix production, promoting increases in 
aggrecan content and collagen 2: collagen 1 gene expression ratios (the differentiation 
index: DI) 1. This was true for POC which had a relatively lower permeability than PGS 
 154
and showed the highest sGAG contents (Figure 7.3C and 5). Also, in terms of gene 
expression, its DI (Col2/Col1) was the highest with relatively low type X collagen 
expression indicating a reduced tendency towards hypertrophy. However, even though 
PCL had permeability similar to POC, the results for PCL chondrogenesis were more 
similar to PGS in terms of matrix production and gene expression. When comparing inner 
tissues only, PCL showed the lowest cell number (Figure 7.3A), proliferation rate (Figure 
7.3B), and thus lowest matrix production (Figure 7.3C). This could be again due to the 
presence of excessive outer tissues preventing sufficient nutrient supply to the innermost 
cells within the scaffold, causing these cells not to proliferate and to produce less sGAG.  
However tissues on the outside of the PCL scaffolds exposed to media still proliferated 
well and had high level of gene expressions,  confirming a high level of cell activity.  
PCLout and PGS showed similar pattern in terms of total amount of DNA, sGAG content, 
and relative mRNA expressions. Especially for relative mRNA expressions, PCL and 
PGS seemed to cause lower chondrocyte differentiation (shown by Col2/Col1 ratio) yet 
higher aggrecan production, higher rates of matrix degradation (shown by MMPs), and a 
higher tendency towards hypertrophy (shown by Col X). Even though POC did not show 
the highest expression of type II collagen and aggrecan, it did show a high differentiation 
index, lower hypertrophy tendency, and lower matrix degradation with the highest DNA 
and sGAG contents. Thus we could probably conclude that overall POC maybe the 
material that best enhances chondrogenesis out of the three materials examined. This is 
probably due to benefits delivered from combined effects of higher hydrophilicity and 
wettability retaining more media inside, and sufficiently low permeability to keep sGAG 
inside the scaffold while still allowing media flow. PCL and PGS seemed to promote 
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chondrocyte proliferation and activity in terms of gene expressions, however these 
chondrocytes may be more likely to proceed to hypertrophy as seen by the type X 
collagen expression and increased matrix degradation suggested by increased MMP3 and 
13 gene expression.   
 Histological data (Figure 7.5) supported sGAG quantification data and type II 
collagen immunostaining supported type II collagen gene expression data. However, 
from Figure 6 we should note that while type II collagen immunostaining may give some 
useful qualitative information, it only gave partial information on chondrocytic 
differentiation. As Figure 7.4 shows, PCLtotal and PGS had high expression of type II 
collagen however they also had high expression of type I and X collagen as well 
compared to POC. It would not be possible to calculate a quantitative differentiation 
index using type I and type II immunostaining. Combining histological and 
immunohistological images with sGAG quantification and mRNA expression data likely 
gives the most complete picture of chondrogenesis.   
 The in vitro results presented here showed a significant dependence of 
chondrogenesis on scaffold material, eliminating pore architecture as a confounding 
variable by fabricating all scaffolds with the same architecture.  However, these results 
must obviously be verified in in vivo cartilage defects, since mechanical loading, oxygen 
tension and host cells may affect chondrogenesis in this situation.  For instance, 
engineered cartilage grown in scaffolds may cause chondrocytes to proceed to 
hypertrophy and matrix degradation such that they would end up promoting 
endochondral ossification before sufficient cartilage formation. In order to overcome 
these limitations, more in-vivo studies with small and large animals would be necessary 
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for future clinical applications.  Still, in vitro results are important since many in vivo 
studies will utilize in vitro culture periods to boost cartilage matrix production before 
transplantation. 
 Overall, this work confirms that scaffold material selection is an important factor 
that affects chondrogenic cellular differentiation and matrix production. It has been 
widely postulated yet never proven that the choice of material directly affects cell 
differentiation and chondrogenesis, since previous studies saw variation in both scaffold 
material and architecture, which confounds interpretation of experimental results.  This 
work points to the capability to modulate and ultimately enhance chondrogenic potential 
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From the experiments comparing 3D PCL, PGS, and POC scaffolds for 
chondrogenesis in vitro shown in chapter 7, we could conclude that POC is the best 
choice of scaffold material for chondrogenesis in terms of matrix production, 
chondrocytic cell phenotype and sGAG staining in histology, and cartilaginous tissue 
relevant gene expressions for the low permeable scaffold design with the spherical pore 
shape (S50). However, we still could not elucidate why chondrocytes actually favor POC 
for chondrogenesis.  One postulate is that hydrophilicity could be one factor influencing 
chondrogenic response on different polymers.  In order to compare the direct cell-
material interactions for each material without the intermediate gel seeding or 3D 
architecture, we conducted a short parallel follow-up study of the 3D scaffold study 
shown in chapter 7 with two dimensional (2D) discs instead of 3D environments. 
Additionally, one more additional material, the Arg-Gly-Asp (RGD)-modified PCL, was 
added to examine the possible effects of hydrophilicity on chondrocytes (chondrogenesis). 
Hence, the four material groups compared in this study were PCL, PGS, POC, and RGD-
modified PCL (PCL-RGD). RGD-modified PCL has been shown to have a higher 
hydrophilicity than PCL and a better cell adhesion, attachment and proliferation for bone 
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marrow stromal cells in our previous study 1,2 and Hsu et al. reported that RGD-modified 
substrate could improve the adhesion of chondrocytes 3. 
The rationale behind adding RGD-modified PCL is that the hydrophobicity of 
PCL is known to prevent effective cell aggregation and attachment initially, which can 
explain why chondrocytes don't favor PCL, given that cell aggregation is desirable for 
chondrocytes and chondroprogenitor cells to form cartilaginous matrix in 4. RGD-
modified PCL not only has a higher hydrophilicity than PCL but also it has the degree of 
hydrophilicity closer to POC and PGS. In this set-up, if the hydrophilicity is the main 
factor providing a favorable environment for chondrocytes, we should be able to see a 
trend according to different degrees of hydrophilicity among materials.  Also, hydrophilic 
materials tend to absorb and retain media more, which may help chondrocytes by 
providing more immediate nutrients. Both PGS and POC are relatively highly hydrophilic 
yet POC is slightly more hydrophilic based on the equilibrium water contact angle than 
PGS (32.8° vs. 60.8°) (Table 8.1).  
Table 8.1 Water contact angle represents hydrophilicity of each material. 
Material PCL PCL-RGD PGS POC 
Equilibrium water contact angle
(hydrophilicity) (°)* 77.0 ± 1.4 46.4 ± 3.0 60.8 ± 6.3 32.8 ± 2.0 
 
Even though least complicated way in general is to examine cell-material 
interactions is to directly seed  cells in a two dimensional (2D) culture such as discs or 
films, as mentioned in chapter 2, several studies have confirmed that chondrocytes de-
differentiate in a 2D environment even at 7 days 7.   Hence we chose to culture 
chondrocytes for a short term (1 week) to observe the initial chondrocyte response to 
each material using the same characterization methods used in previous chapters.  
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8.2 Materials and Methods 
 
2D discs fabrication 
Pre-polymer of PGS and POC were synthesized following the protocol previously 
described in chapter 7. First, each sheet of PCL, PGS and POC were cured in a tensile 
specimen Teflon mold using the same curing conditions described in chapter 7. Ten 2D 
cylindrical discs (7mm (D) x 1.25mm (H)) per each material were punched out of cooled 
down solid polymer sheets using 7mm biopsy punch for cell culture. PCL discs were 
modified with RGD following the previously established method in our lab 1 In short, the 
PCL discs were immersed into a 10% w/v solution of 1, 6-hexanediamine (Sigma) 
prepared in isopropanol at 37oC for 1 hr for the aminolysis. After the exposure, the discs 
were thoroughly washed in deionized distilled water for 24 hrs and were dried under 
vacuum at room temperature. The aminated PCL discs were then pre-washed with 
activation buffer 3 times (0.1 M phosphate buffered saline contained 0.15 M NaCl, pH 
7.2). For conjugation of RGDC peptides to the surface of aminated PCL disc, the 
heterobifunctional crosslinker sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-1-
carboxylate (sulfo-SMCC) (Pierce Biotechnology, Rockford, IL) was used. 4 mg/ml of 
the sulfo-SMCC solution was pipetted onto aminated PCL discs and incubated for 1 hr at 
room temperature, followed by washing with conjugation buffer (activation buffer 
contained 0.1 M EDTA, pH 7.0). The RGDC peptide (Bachem California, Inc., Torrance, 
CA) was dissolved at a concentration of 0.125 mg/ml in conjugation buffer. The peptide 
solution was applied onto the sulfo-SMCC-treated PCL disc and incubated overnight at 
4 °C. Peptide conjugated PCL discs were washed thoroughly with conjugation buffer 
twice and PBS for 3 times and dried under vacuum at room temperature. For all 
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subsequent experiments, the following PCL samples were created and used: untreated 
PCL (PCL) and RGD-modified PCL (PCL-RGD). 
In Vitro Cell Culture 
All discs were sterilized by immersion in 70% ethanol for 45 mins followed by 
neutralization to physiological pH level by incubation in serum-free cell media prior to 
cell seeding. Porcine chondrocytes were isolated using the same method as in previous 
chapters and a density of 1 x 106cells/cm2  (3.4 x 105 cells/disc) cells suspended in 40μl 
media were seeded onto the discs directly in the 24 ultra-low attachment well plates and 
cultured for 1 week in vitro with the same conditions described before. 
sGAG and DNA quantification & Quantitative-PCR 
 
The sGAG content of the dissolved solution at 1 week for all discs (N=4/design) 
was assayed using the DMMB method and the total sGAG were normalized by DNA 
content measured using Hoechst dye 33258 method as described previously in chapter 5. 
For quantitative PCR, Type II, I, X collagens, aggrecan, matrix metalloproteinases 3, 13 
(MMP3, MMP13), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA 
expressions were quantified by real-time PCR using Gene Amp 7700 sequence detection 
system (Applied Biosystems). A positive standard curve for each primer was obtained by 
quantitative PCR with serially-diluted cDNA sample mixture. The quantity of gene 
expression was calculated with standard samples and normalized with GAPDH then 
further normalized to PCL for easy comparison. 
Statistical Analysis 
Data are expressed as mean ± standard deviation. The statistical significance among 
different materials was calculated using linear regressions and one way ANOVA with 
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post-hoc comparison (Tukey) using SPSS software (SPSS for Windows, Rel 14.0. 2005 




 sGAG and DNA quantification 
For DNA quantification shown in Figure 8.1, POC discs had the statistically 
significant higher DNA contents than the other four materials, by a factor of nearly 100 
(4267 ± 63 ng/μl). PCL discs showed the lowest DNA contents (24.56 ± 8.88 ng/μl) and 
the amount of DNA present in PGS and RGD-modified PCL (PCL-RGD) discs were very 
similar each other (44.2 ± 10.5, 42.6 ± 8.83 ng/μl, respectively). However PCL, PGS, and 
RGD-PCL discs were still not significantly different in terms of total amount of DNA per 
dick.  
 
Figure 8.1: The amount of DNA per disc was quantified (N = 4-5, *p ≤ 0.05). 
For the amount of total sGAG produced per disc, the same pattern as DNA was 
shown (Figure 8.2). The amount of sGAG secreted on POC disc was significantly higher 
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than any other materials (11.4 ± 1.85 μg/μl, 10 folds higher), yet there was no significant 
difference among PCL, PGS and PCL-RGD discs (0.17, 0.23, 0.70 μg/μl, respectively).  
 
 
Figure 8.2: The total amount of sGAG per disc was quantified (N = 4-5, *p ≤ 0.05). 
When the amount of sGAG was normalized to the amount of DNA (sGAG/DNA 
shown in Figure 8.3) however, which represents a tendency of single cell towards 
chondrogenesis, PCL-RGD showed a significantly (5 times) higher tendency towards 
chondrogenic differentiation than any other materials.   Among PCL, PGS, and POC, 
there was no trend or significance shown.  
 
Figure 8.3: The total amount of sGAG per disc was normalized to the total amount of DNA for 
chondrogenesis (N = 4-5, *p ≤ 0.05). 
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mRNA gene expressions 
The mRNA gene expressions for cartilaginous tissue markers (col2, aggrecan), 
chondrocytic differentiation marker (col2/col1), de-differentiation marker (col1), terminal 
differentiation (known as chondrocytic ossification) marker (col10), and degradation 
proteins (MMP3 & 13) were quantified and compared between materials as illustrated in 
Figure 8.4. There was no significant difference or pattern in the differentiation index 
(col2/col1), expressions of col10, MMP13 or MMP3.  
 
Figure 8.4: The mRNA gene expression levels of chondrocytes seeded on 2D discs of each 
material were presented as ratios compared to PCL (via first normalization by gapdh and further 
normalization by PCL for comparison) (N=3-4, *p≤0.05). 
 
8.4 Discussion and Conclusion 
We hypothesized that hydrophilicity was one of the major factors driving the 
difference in chondrocytic response to polymer material.  In this case, POC has the 
greatest hydrophilicity, followed by PGS and RGD-modified PCL.  Based on DNA and 
sGAG quantification data (Figure 8.1 and 8.2), it is clear that POC discs exhibit 
significantly better cell-material interaction for cell adhesion, cell attachments, 
proliferation, and formation and maintenance of matrix even in 2D environments. In fact, 
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POC has the lowest water contact angle and thus the highest degree of hydrophilicity 
among all four materials, which correlates to the results shown in quantification of the 
amount of DNA and sGAG. The degree of hydrophilicity indeed seemed to affect 
chondrocyte proliferation in the direct cell-material interactions as the amount of DNA 
parallels to the degree of hydrophilicity (Figure 8.1, Table 8.1). However, this does not 
hold true for sGAG quantification; for instance, PGS should be the next best material for 
sGAG formation if the degree of hydrophilicity is the main factor in matrix production 
and maintenance. In fact, PCL-RGD which has slightly higher water contact angle and is 
thus more hydrophobic than PGS.  However, PCL-RGD has shown to form slightly 
higher amounts of sGAG suggesting that there is some material/chemical factor of PGS 
material which causes an unfavorable environment for chondrogenesis. Regardless, PCL 
was shown to be the least favorable material for chondrogenesis.   PCL-RGD was shown 
to be better than PCL for both chondrocyte proliferation and matrix formation, leading to 
the conclusion that the hydrophobic and non-adhesive surface nature of PCL may be a 
major hindrance to cartilage formation. For sGAG/DNA normalized data, there were no 
significant material effects among PCL, PGS, and POC on the tendency of single cell 
towards chondrogenesis. In contrast, PCL-RGD surface modification tends to help single 
chondrocytes for chondrogenesis. Not only do the increases in hydrophilicity affect cell 
attachments and matrix synthesis, but also RGD-induced signal transduction can be 
involved in chondrogenesis. Some studies8-10 have reported that an adhesive sequence, 
RGD, promotes survival of cells and has shown to induce early stages of chondrogenesis, 
while its persistence can limit complete differentiation. Hwang et al.10 showed that RGD 
seemed to cause cartilage-specific gene up-regulation and extracellular matrix production. 
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However there were some contradictory reports11,12 demonstrating that integrin-mediated 
adhesion within a three-dimensional environment inhibits bone marrow stromal cells 
(BMSC) chondrogenesis through actin cytoskeleton interactions and the effects of RGD-
adhesion on mesenchymal differentiation are lineage-specific and depend on the 
biochemical composition of the cellular microenvironment. This controversy still remains 
open as to how RGD affects chondrogenesis and there is no report that elucidates how 
RGD affects chondrocytes in chondrogenesis in terms of signal transductions to date. 
Hence, it is possible that RGD induces cell signaling events that may drive and promote 
more matrix formation by chondrocytes, however this is only a speculation at this stage 
and further investigation needs to be conducted to elucidate the mechanism involved. 
The mRNA gene expressions of any proteins do not seem to give any clear 
conclusions and no significant trends among different materials could be found. For 
cartilaginous tissue gene expression markers, it was shown that PCL-RGD (col2) and 
POC (aggrecan) were preferred materials yet PGS was shown to be the best material for 
differentiation (col2/col1). PCL and PCL-RGD demonstrated a highest tendency towards 
de-differentiation (col1), terminal differentiation (col10), and matrix degradation 
(MMP13), which are somewhat contradictory to the results of cartilaginous markers. 
POC showed the least collagen type II level with the significantly highest level of 
aggrecan, both of which are considered to be indicators for cartilage differentiation. 
Based on the mRNA gene expressions, it is hard to make a conclusion of favorable 
materials and there seems to be no definitive trends among materials for any genes 
involved in chondrogenesis. This is probably due to several reasons: first, one week of 
culture time is too short for cells to lay matrix and form cartilaginous tissues. Secondly, 
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chondrocytes tend to de-differentiate in 2D environments even within a week, thus no 
matter what materials are used, the 2D environment is not favorable for chondrogenesis.  
From this short simplified experiment comparing biomaterials and the effects of 
hydrophilicity on chondrogenic proliferation and differentiation of chondrocytes, we can 
conclude that the degree of hydrophilicity does play a role in terms of cell attachments 
and proliferation. However, the amount of matrix formation is not necessarily dependent 
on or directly correlated to the degree of hydrophilicity. We did observe, however, that 
PCL should be somehow modified to increase its hydrophilicity and adhesive surface 
characteristic to provide more suitable environments for chondrocytes in chondrogenesis. 
Regardless of its relatively high hydrophilicity, there is some material based disadvantage 
of PGS which does not enhance chondrocytic based chondrogenesis despite its being 
hydrophilic.  However, in order to elucidate the mechanism behind, the morphology of 
cell attachment, careful characterizations of surface chemistry and surface morphology, 
possible impacts imposed by degradation byproducts from POC and PGS etc. need to be 
further evaluated for future. 
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Poly (1, 8 Octanediol-co-citrate) scaffold for cartilage engineering 
The quest for alternative and effective treatments to repair articular cartilage 
damage and the prevalence of osteoarthritis in a growing population are forcing the 
advancement of tissue engineering methods.   Tissue engineering utilizes synthetic 
matrices seeded with chondrocytes or chondrogenic precursor cells to attempt to 
regenerate articular cartilage matrices.  This work explores how scaffold architecture and 
material affect scaffold permeability, mechanics and degradation and in turn how these 
measures influence chondrogenesis.  Solid freeform fabrication (SFF) is used as a method 
of fabrication for all scaffolds, but especially to examine the feasibility of poly (1, 8 
Octanediol-co-citrate) (POC) as a scaffold material for cartilage engineering. SFF allows 
the fabrication of precisely controlled and reproducible scaffold architectures such that 
the mechanical, permeability, and degradation properties of 3D designed POC scaffolds 
could be characterized, and thus how these architectural scaffold properties influence 
chondrocytes in vitro and in vivo. Also due to the control and reproducibility in 
fabrication, POC scaffolds could be compared to poly (ε-caprolactone) (PCL) and poly 
(glycerol sebacate) (PGS) scaffolds with the identical 3D design to delineate an optimal 
material for cartilage regeneration. 
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The first part of this work was devoted to testing the feasibility of fabricating 
POC scaffolds via SFF and characterizing the architectural, degradation, and mechanical 
properties of each design. POC scaffolds exhibit controllable biodegradation and 
nonlinear mechanical properties which are suitable for cartilage. Increasing porosity 
decreases stiffness and the degree of nonlinear behavior, but increases permeability and 
degradation rate of POC scaffolds. Thus, when designing scaffolds for soft tissue 
application, the trade off between effective scaffold mechanical, mass transport and 
degradation behavior resulting from designed porosity should be taken into account. The 
characterization of 3D POC scaffolds and the relation between scaffold architectures and 
mechanical properties provide a basic foundation for determining how scaffold 
architecture affects tissue regeneration, and thus, how to design cartilage tissue 
engineering scaffolds.   
 
From the four scaffold designs explored, two designs, S50 (low permeable, 
spherical pore shape) and C62 (high permeable, cubical pore shape), were chosen to 
compare and observe the effects of scaffold pore shape and permeability on 
chondrogenesis in vitro and in an in vivo sub-cutaneous model.  These designs were 
chosen as they were significantly different in pore shape and resultant permeability while 
the other mechanical or physical scaffold properties of the other designs were similar. We 
found that chondrocytes prefer lower permeable scaffolds with a spherical pore shape in 
terms of matrix production and differentiation both in vitro and in vivo. However, it was 
interesting to see how in vitro vs. in vivo culture environments could change the trends of 
mRNA expressions as they showed a reverse pattern. The mRNA expressions at 4 weeks 
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in vitro were reflective of sGAG quantification data in vitro in that all cartilaginous tissue 
indicators (col2, col2/col1, aggrecan) for cartilaginous tissues had higher expression in 
the low permeable design (S50). In contrast, the mRNA expressions at 6 weeks in vivo 
demonstrated the opposite of in vitro study such that all cartilaginous tissue indicators 
(col2, col2/col1, aggrecan) for cartilaginous tissues were expressed higher in the high 
permeable design (C62).  In fact, all the gene expressions including the de-differentiation 
marker (col1), the chondrocytic ossification marker (col10), and the matrix degradation 
proteins (MMPs) in the high permeable design were higher than those in the low 
permeable design in vivo, which explained why the low permeable design contained 
higher sGAG contents than the high permeable design in vivo, just like the in vitro case. 
Overall though, we could still come to a conclusion that the low permeable scaffold 
design with a spherical pore shape is favored by chondrocytes for chondrogenesis both in 
vitro and in vivo. 
Scaffold pore shape not only plays a role in determining effective scaffold 
permeability and degradation kinetics but also it seems to play an additive role ensuring a 
bounded pore space for enhancing cell aggregation and sGAG retention.  The enhanced 
cartilage matrix production in the POC scaffolds especially for the low permeable design 
(S50) resulted in superior mechanical properties for the scaffold/tissue construct proving 
the potential of POC scaffolds as a frame for cartilage regeneration both in vitro and in 





PCL vs. PGS vs. POC for scaffold material in chondrogenesis 
There are numerous synthetic biomaterials developed and used for tissue 
engineering scaffolds, yet there have been almost no head to head comparisons of these 
different materials as cartilage scaffolds due to irreproducible scaffold designs and 
inconsistent random scaffold architectures resulting from traditional fabrication methods.  
The last part of this work involves a comparison study among different biomaterials with 
an identical scaffold design, which has never been reported. The study demonstrates that 
the 3D POC scaffold was more suitable for chondrocytes to form cartilaginous tissues in 
vitro compared to 3D PCL and PGS scaffolds when using the same scaffold design. POC 
showed the highest DNA and sGAG contents after 4 weeks of in vitro cell culture with 
the highest differentiation index and the lowest hypertrophy and matrix degradation gene 
expression compared to PCL and PGS. Both PCL and PGS promoted chondrocytes to 
proliferate and express genes related to cartilage formation, but they promoted gene 
expression for cartilage destruction and ossification, which were not desired for cartilage 
regeneration.  In order to obtain reasonable explanations why POC is particularly 
preferred, a simple follow-up study of the direct cell-material interactions for all three 
materials as forms of two dimensional (2D) disks was performed.  It was speculated that 
the different degrees of hydrophilicity of each material may be the main reason why 
different materials produced. However, the short study did not show that the degrees of 
hydrophilicity were directly related to overall material performance in chondrogenesis.  
However, hydrophilicity still seemed to impact cell-cell interaction, aggregation, and 
cell-adhesion, attachment to the surface, and proliferation even in the 2D environment. 
POC was shown to have the greatest capability of supporting chondrocyte attachment and 
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proliferation along with sGAG matrix production significantly even with the rather 
unfavorable conditions of a short culture time (1 week in vitro) and 2D culture. The 
mRNA expressions did not confirm any trends among materials in 2D study probably due 
to a short culture time and 2D culture set-up such that chondrocytes were not stabilized 
enough to express cartilaginous related genes strongly with a specific trend.  
Throughout this work, we verified that POC is a potential and suitable material 
for cartilage engineering and it can be easily and effectively tailored in terms of 
architectural and mechanical properties via the SFF fabrication technique. We also 
proved that the low permeable scaffold design with a spherical pore was preferred by 
chondrocytes for chondrogenesis.  This clearly shows that scaffold pore shape and 
permeability are important design parameters affecting the overall success of cartilage 
regeneration both in vitro and in vivo. Furthermore, our study of 2D and 3D material 
comparison verifies that POC is the most optimal choice of scaffold material among PCL, 
PGS, and POC for cartilage scaffold-aided tissue engineering in terms of matrix 
formation and retention, mRNA expressions, and cell attachments and proliferation. Here, 
our studies indicate how carefully scaffold architecture and material must be chosen to 
best enhance cartilage regeneration. These results emphasize the importance of 
microenvironments provided by scaffolds as a key to the success in cartilage regeneration 






9.2 Future Directions 
Exploring the effects of other scaffold design parameters  
The experiments conducted in this work are an initial step in understanding how 
scaffold materials and architectures influence cartilage tissue regeneration. Determining 
if low permeable designs in general versus the specific spherical pore shape are the 
critical influence on chondrogenesis is important for determining a potential optimal 
architecture design.  Furthermore, exploring methods to further automate manufacture of 
POC scaffolds using different SFF techniques will be important given the significant 
advantages of using POC as a cartilage scaffold material. However, as thoroughly 
reviewed in chapter 3, there are many other scaffold architectural properties such as pore 
size and porosity, which are yet to be fully characterized in terms of mechanical and mass 
transport properties and the consequent effects on chondrogenesis. As one of the biggest 
advantages in SFF fabrication is that scaffold designs can be easily controlled, designed, 
and fabricated, studies of other design parameters with similar assessments and 
characterizations performed in this work would complete a full comprehensive review of 
the effects of scaffold designs on chondrogenesis.  
 
Effects of initial cell seeding density and other cell types 
The initial cell seeding density (20-30x106cells/ml) used in this work is within the 
range of the densities that are shown to stimulate chondrogenesis for cartilage tissue 
engineering.1-3 In general, higher cell seeding densities will increase the cell aggregation 
and packing densities per pore yet there will be a ceiling limit on the number of cells that 
can survive within a limited pore space with limited nutrients and wastes exchange. 
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Varying the cell densities within the same scaffold design would give a better 
understanding of how cells recognize pore space and pore architecture.  
In addition, the same experimental set-up to examine the effects of scaffold 
architectures and materials on chondrogenesis can be future explored with other cell 
types such as adipose derived stem cells (ADSCs) and bone marrow stromal cells 
(BMSCs) used in cartilage tissue engineering instead of primary chondrocytes. Our 
previous studies 4,5 have shown that BMSCs prefer higher permeability in PCL scaffolds 
and the spherical pore shape tends to be favored as it creates pre-condensation of BMSCs 
in poly(propylene fumarate) (PPF) and PCL scaffolds, which would in turn lead to the 
chondrocytic differentiation. It would be a great interest to see how different cell types 
respond to the same microenvironments, which would broaden the use of SFF fabricated 
scaffolds and material selections. To date, no one has reported the use of ADSCs or 
BMSCs with POC scaffolds for cartilage regeneration yet, hence further work to explore 
the effects of scaffold architectures and materials on those cell types would advance the 
understanding of POC scaffolds for cartilage application. 
 
Evaluation of constructs at an actual defect site in a large animal model 
Given the feasibility of SFF fabricated POC scaffolds for cartilage tissue 
engineering in vitro and in vivo subcutaneous mice model, the evaluation of those pre-
cultured cell/POC constructs implantation at an actual defect or orthotopic site will be the 
next  logical step to further evaluate the cartilage regeneration with our designed pore 
architectures and with other different scaffold materials. The microenvironments around 
the actual joint sites will be different from even in vivo subcutaneous model such as 
 180
mechanical stimuli, nutrient availability, and oxygen tension. Not only this will give 
more in depth and comprehensive evaluation of our designed scaffolds and scaffold 
materials to closely relate to future clinical applications but also it may allow us to 
differentiate the performance of the three biomaterials that were used in this thesis clearly 
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APPENDIX A: poly (1, 8 Octanediol-co-citrate) (POC) scaffold fabrications 
 
________________________________________________________________________ 
Name of Procedure: Synthesis of pre-polymer (pPOC) and 3D POC scaffolds 
Prepared by: Claire Jeong 
Location: This procedure is performed in LBME 2420 
Hazards: none 
Protective equipment: Use latex gloves when working with RDO, or to keep your hands 
protected from hot pPOC. 
Waste disposal: contaminated bin or waste bottle 
________________________________________________________________________ 
 
Synthesis of pre-polymer (pPOC) for 1:1 molar ratio & scaffold fabricaiton 
 
Materials/equipments: citric acid anhydrous (Fisher Chemical: #A940-500), 1,8 octanediol 
(sigma aldrich: #3303) 
 
Synthesis of pre-polymer 
1. For POC synthesis, equimolar amounts of citric acid and 1,8-octanediol (i.e. 19.21g (CA) 
+ 14.62g (OD) were added to a 250 ml or 500ml (for 2x amount) three-neck round-
bottom flask fitted with an inlet and outlet adapter. Use high temperature silicone oil bath 
and its temperature controllers. One neck should be connected to nitrogen flow in, the 
middle is clogged by a stopper, and the third neck should be connected to a tube coming 
out. (It would be good if you connect the bubbler to check the constant flow of the 
nitrogen in and out.) 
2. The mixture was melted at 160–165 °C for 15 min under a flow of nitrogen gas while 
stirring. The temperature of the system was subsequently lowered to 140 °C for 30 min - 
45 min under stirring to create a pre-polymer. Nitrogen should be constantly flowing 
through.  
3. You can keep this in -20C freezer with desiccators after cool down OR used as is for 
further post-polymerizing or cross linking. 
POC Scaffold fabrication 
1. The pre-polymer was cured at 100°C for 1 day without vacuum and continued curing at 
100°C for 3 days with vacuum (-30 in.Hg.) with HA scaffolds. (You can cure at 60 - 
120 °C under vacuum or no vacuum for times ranging from 1 day (120°C) to 2 weeks 
(60°C) to create POC with various degrees of cross-linking). Heat up the already 
assembled Teflon mold upto the temperature that you are going to cure. Also, Heat up 
pre-polymer upto 110-120°C for 5-10 mins to decrease the viscosity and pore it into the 
well of Teflon mold then push HA scaffolds into the well slowly.  
2. After post-polymerization completes, clean up the extra layers of POC around HA 
scaffolds (let all the sides of HA expose to RDO).  
3. Dissolve HA out of RDO for 6-12 hours. (Try to reduce this RDO immersion time by 
putting less scaffolds per RDO volume or change RDO frequently (i.e. every 4 hours)). 
4. Neutralize POC scaffolds in mili-Q water for 2-3 days until it reaches pH7.0-7.5. Sterilize 
with 70% ethanol for 30min-1hr or dry them then autoclave.  
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APPENDIX B: PROTOCOL FOR MEASURING DNA CONTENT 
________________________________________________________________________ 
Name of Procedure: Hoechst 33258 protocol for measuring DNA content 
Prepared by: Claire Jeong (modified from Huina Zhang) 
Location: This procedure is performed in LBME 2420 
Hazards: Hoechst 33258 is toxic. Please read MSDS carefully before use. 
Engineering Controls: none 
Protective equipment: safety glasses, gloves 
Waste disposal: Hoechst waste bottle 
 
Scaffold Preparation before DNA content measurements and Papain digestion 
 
1. Prepare papain solution: (papain #p4762, Sigma Aldrich, 10u/mg protein) Dissolve 50mg 
of papain in 50ml 1x PBS (papain needs to be 10u/ml for digestion) with 43.9mg Cystein 
(5mM) and 0.5ml EDTA. Check the pH and make it to be 6.0 by either adding 1x PBS or 
EDTA. Filter the papain solution to make it sterile.  
2. Label 1.5ml microcentrifuge tubes (sterile) and aliquot 1ml of papain solution (#1). 
3. Rinse all the scaffolds briefly with PBS. Cut scaffolds into smaller pieces (1-1.5mm3) 
with scalpel blade (for each scaffold, sterilize the blade with 70% Ethanol).  
4. As soon as you cut them into smaller pieces, place them into the papain solution (#1) 
aliquoted in the tube. Also, make sure you have a control papain which does not have any 
scaffolds in. 
5. Set the degradation oven at 60°C and place all the sample containing tubes on a vortex 
shaker placed inside the degradation oven. Incubate and shake (1000rpm) the samples for 
16-24 hours inside the degradation oven at 60°C. Store at -20--80C for DNA content and 




Prep: DNA quantitation kit, Fluorescence assay (#DNA-QF, sigma), ultra-purified water, 96 
multiwell plates, fluorometer (excited at 360nm, emission at 460nm), ice. 
 
1. Place all the samples in ice. Make all the solutions according to kit protocols. 
2. Put STD DNA (100 and 10ug/ml) inside the degradation oven at 50C for 30 mins (no 
longer than 30 mins!). Vortex well. Put them back into ice. 
3. Make standard DNA solutions according to kit protocols (blank, 50, 100, 200, 500, 1000, 
2000 ng).  
4. Mix H33258 (1mg.ml) 40ul + 2ml of 10x assay buffer + 18ml ultra-pure water in 50ml 
tube (for 1 plate of 96 well plate reading) and aliquot 200ul per well and 10ul of each 
sample. For standards, do replicates and for samples, do triplicates for accuracy.  











APPENDIX C: PROTEOGLYCAN PRODUCTION ASSAY PROTOCOL (DMMB) 
 
_______________________________________________________________________ 
Name of Procedure: Dimethylmethylene Blue (DMMB) Assay for measuring s-GAG content 
Prepared by: Claire Jeong (modified from protocols by Huina Zhang and Jessica Kemppainen) 
Location: This procedure is performed in LBME 2420 
Hazards: none. 
Engineering Controls: none 
Protective equipment: gloves 
Waste disposal: DMMB waste bottle 
 
1. Make DMMB reagent:  
Dissolve 8 mg 1,9 dimethyl-methylene blue dye (Sigma, # 341088) 
1.52 g Glycine 
              1.185 g NaCl 
              47.5 ml 0.1M HCl in 500ml of ultra-pure or distilled H2O and check pH to be 3.0 
 
2. Make standards from shark chondroitan-6-sulfate (CS) (Sigma, # C4384) (a stock 
concentration of 5mg/ml). Mix 390ul 1x PBS with 10ul 5mg/ml CS solution to make a 400ul of 
STD1 = 0.125mg/ml = 2.5ug; STD2 = 0.0625mg/ml = 1.25ug etc.), then do a serial dilution (i.e 
STD2 = 200ul STD1 + 200ul 1xPBS, STD3 = 200ul STD2 + 200ul 1xPBS and so on.) upto 
STD7. Here, you have 7 standards plus a blank for a standard curve. 
 
3. Aliquot 200ul of DMMB reagent into each 96 well of the plate using multi-channel pipettor. 
 
4. Measure sGAG content of samples and standards: Test your sample concentration to determine 
how much volume you need to add by comparing color changes. Add 20 ul of standards OR 2, 5, 
or 10ul sample (well-mixed, centrifuged at 14,000, 10 min, 4°C if you need to remove polymer 
residue) into the DMMB reagent. (Note: DMMB is extremely light sensitive.) Read immediately 

















Type II Collagen: 
Forward: TYIICOLL-ANYF TCCTGGCCTCGTGGGT  
Reverse:  TYIICOLL-ANYR GGGATCCGGGAGAGCCA 
 
Type I Collagen: 
Forward: TYPEICOLLA-ANYF CCGTGCCCTGCCAGATC  
Reverse:  TYPEICOLLA-ANYR CAGTTCTTGATTTCGTCGCAGATC 
 
Type X Collagen: 
Forward: TYPEXCOLLA-ANYF GGCACCCAGGTCCATCTG 
Reverse:   TYPEXCOLLA-ANYR CAGCCCTGGCTGTCCTT 
 
Aggrecan:  
Forward: AGGRECAN-A1BF CGAGGCACCGTGATCCT  
Reverse:  AGGRECAN-A1BR GGCAGTGGCCCCTGT 
 
MMP3: 
Forward: MMP3_F ACTGGATTTGCCAAGAAGTGTTATTGA  
Reverse:  MMP3_R GAATGTAAGCGGAGTCACTTCCT 
 
MMP13: 
Forward: MMP13_F AGTTTGGCCATTCCTTAGGTCTTG  
Reverse:  MMP13_R GGCTTTTGCCAGTGTAGGTATAGAT 
 
GAPDH: 
Forward: GAPDH-1A2F CCATCTTCCAGGAGCGAGATC  
Reverse: GAPDH-1A2R AGTGGACTCCACGACATACTCA 
 
 
